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Summary of Thesis 
Optimising Outcome for Achilles Tendinopathy: An 
Exploration into Cognitive and Contextual Factors 
 
Achilles tendinopathy is a debilitating condition for both active and sedentary people. 
Clinically it is characterised by a painful response felt in and around the 
tendon predominantly during tasks involving plantarflexion load; hopping for example. 
Whilst exercise appears to be a promising intervention for the condition, it remains 
unclear how exercise influences outcome. Hence, in order to optimise outcomes for 
our patients, further research is required to better understand factors which may 
influence exercise-led interventions. 
It is acknowledged that further research is required to understand the ‘specific’ 
influences of exercise, for example, the ideal exercise type, number of sets and 
repetitions remain uncertain. However, this thesis aimed to develop insight into 
optimising outcomes by considering factors not previously investigated in tendinopathy 
research; the ‘non-specific’ influences of psychological, cognitive and contextual 
variables.  
To achieve this insight, this thesis comprises a systematic review investigating the 
association of psychological variables and tendinopathy. Overall, the review’s findings 
were contradictory, suggesting the need to consider further factors which may 
underpin psychological variables. Consequently, a further narrative review was 
undertaken. This review considers how the cognitive and contextual factors of working 
alliance, adherence, self-efficacy and outcome expectation might interact with 
psychological variables and potentially influence outcome from exercise-led 
interventions for people with tendinopathy. This is then highlighted as an area in need 
of research.  
Developed from this series of reviews, this thesis reports the feasibility of a study 
utilising a bespoke online platform for data collection to investigate the association of 
working alliance, self-efficacy, adherence and outcome expectation with clinical 
outcome for people with Achilles tendinopathy. The feasibility study comprised of a 
multi-centre, longitudinal cohort study (n=24) which was conducted in the UK. As part 
of the development for this study, a final narrative review was undertaken to evaluate 
the usefulness of the most commonly used patient reported outcome measure used 
for people with Achilles tendinopathy; the Victorian Institute of Sport- Achilles. 
Concerns over the measure’s validity, reliability and readability, led to the use of an 
alternative measure, the Lower Extremity Functional Scale. 
The feasibility study reports quantitative assessment of recruitment and retention rates 
alongside a qualitative study to identify obstacles and enablers to engagement with 
the untested online platform. The results suggest a future large cohort study is 
warranted and feasible; a basis from which future research has been developed, 
alongside an enhanced understanding of cognitive and contextual factors which may 
influence optimal outcome for people with Achilles tendinopathy and hence new 
knowledge has been generated. 
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Glossary of Terms 
 
Working alliance - the working rapport or positive social connection between 
the patient and the therapist 
Efficacy expectations - beliefs about one’s ability to perform a given task 
Outcome expectations - a person’s estimate that a given behaviour will lead 
to certain outcomes 
Adherence – commitment to the action agreed from a shared decision-making 
process between the patient and therapist 
Catastrophisation - the tendency to magnify the threat value of pain and to 
feel helpless in the context of pain 
Anxiety - a physiological state characterized by cognitive, somatic, emotional, 
and behavioural components producing fear and worry 
Depression - a pervasive low mood, loss of interest in usual activities and 
diminished ability to experience pleasure 
Kinesiophobia – a debilitating fear of physical movement and activity through 
a feeling of susceptibility to painful injury or re-injury 
Distress - an aversive state in which a person shows maladaptive behaviours 
Minimal Detectable Change (MDC) - the smallest change that falls outside 
the measurement error in the score of an instrument used to measure a 
construct  
Minimal Important Difference (MID) - the smallest differences in the construct 
to be measured between patients that is considered important 
Minimal Important Change (MIC) - the smallest change in score in the 
construct to be measured which patients perceive as important 
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Chapter 1: Setting the Scene  
Summary 
This chapter sets the scene for this PhD thesis. The aim of this thesis is to 
better understand how to optimise exercise-led interventions for people with 
Achilles tendinopathy (AT). To achieve this, the thesis focuses on factors not 
previously investigated in tendinopathy research; cognitive and contextual 
factors. The purpose of this chapter is to introduce relevant terminology as well 
as providing an overview of the burden of AT as a clinical entity. Specifically, 
the role of exercise-led management by physiotherapists is explored in depth. 
Justification for undertaking further work is considered before the aim and 
objectives of the PhD are presented. 
 
1.0 Introduction 
The Achilles tendon originates from the merging of the soleus muscle with the 
two bellies of the gastrocnemius and inserts distally onto the calcaneus [1]. The 
Achilles tendon is reported to be the strongest and longest tendon in the body 
[2] and, as is common to all tendons, its function is to transmit force from the 
muscles described above to its insertion on the calcaneus (figure 1.1).   
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Figure 1.1 Anatomy of the (right) Achilles tendon, posterior view (A–D) 
[3]. The (1) medial head of the gastrocnemius muscle, (2) lateral head of the 
gastrocnemius muscle, (2a) fibres from the lateral head of the gastrocnemius, 
(3) soleus muscle, (3a) fibres from the soleus muscle, (4) aponeurosis of 
soleus muscle and (5) fascicle from the medial head of the gastrocnemius 
muscle 
 
The Achilles tendon is prone to load-based injuries and as such is a location 
for musculoskeletal pathology and a site of patient-reported pain [4]. Tendon-
related pain and its associated functional limitations, termed tendinopathy, can 
be traumatic or insidious in onset and short-lasting or persistent in nature [5]. 
Tendinopathy can be characterised by a reduced ability of the tendon to sustain 
tensile load [6]. People with AT present with activity-related pain located 2-7cm 
proximal to the calcaneal enthesis [7]. Whilst symptoms may occur at the 
calcaneal insertion (termed insertional Achilles tendinopathy), this is far less 
common [8]. In recent years, clinical and scientific communities have gained 
abundant yet incomplete knowledge regarding the underlying processes 
involved in the development of tendinopathy.  
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Whilst several models exist proposing to explain the underlying processes 
concerned with tendinopathy, the most commonly cited model is the ‘continuum 
model’ (figure 1.2) [6,9]. The continuum model suggests excessive loading 
causes a loss of tissue homeostasis resulting in a cell mediated reaction in 
absence of an inflammatory reaction [6,9]. Whilst other models disagree and 
suggest the involvement of an inflammatory component [10,11], common to all 
models is the link to the rate of wear being greater than the rate of repair 
[12,13]. Further examination of the current models for tendinopathy is 
undertaken in chapter two, part two.  
 
 
Figure 1.2 The continuum model of tendinopathy [6,9] 
 
Regardless of the pathology underpinning AT, it’s impact on the sufferer is well 
documented. For people with AT, it results in decreased activity participation, 
working ability and quality of life [14]. As will be discussed further in chapters 
14 
 
two and three, factors influencing this impact are poorly understood. Little is 
known about mechanisms driving pain and the response (or lack of) to 
rehabilitation [15–18]. Furthermore, despite structural changes being the focus 
of tendinopathy models [6,9] current evidence suggests that structural changes 
on imaging of tendinopathic tendons do not explain the response to exercise-
led interventions [19]. Whilst recognising that advancements in imaging 
techniques may yet contribute to improved outcome by enhancing 
diagnosis [20], current evidence suggests that clinical outcome for people with 
musculoskeletal conditions is influenced by similar factors across different 
musculoskeletal presentations [21]. Factors such as pain intensity, association 
of psychological distress and high functional disability, appear of key influence 
and the addition of a specific structural diagnosis is not [22,23]. As current 
strategies appear incomplete, the need to investigate factors beyond the 
specific effects of exercise on peripheral tissue appears to be one way of 
potentially optimising outcomes in AT. 
 
1.1 Burden of Achilles Tendinopathy and the Role of Exercise  
There is little doubt that AT is a social burden. AT has an estimated incidence 
rate of 2.35 per 1000 person-years for the general adult population [24,25]. 
Likewise, 52% of top level runners will suffer with AT during their lifetime [26] 
and may contribute to premature retirement in up to 5% of professional athletes 
[27]. AT, however, is not only a problem that impacts sports participation. It 
effects the sedentary population also, negatively affecting the ability to work 
[25]. For anyone with AT, overall quality of life is impacted [25], potentially 
leading to significant physical and psychological burden [28]. 
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Whilst AT can be challenging to manage clinically in some [6], and although 
much uncertainty remains, there is a growing body of evidence advocating an 
exercise-led management approach [29–31]. Current best practice guidelines 
include strength training and load-management as core ingredients [32–34], 
supplemented by additional interventions such as shock wave therapy or laser 
therapy [35,36], although the evidence supporting their addition is lacking 
[36,37]. The principal exercise-based management approach recommended to 
treat AT is eccentric loading [38–40]. Originally described by Alfredson et al 
[41], eccentric  loading for AT comprises of 12 weeks of eccentric heel-drops 
on the injured limb, with the use of the uninjured limb to concentrically return to 
the start position (figure 1.3). Exercises are performed twice daily, for three sets 
of 15 repetitions, both with a straight and bent knee (i.e. 180 repetitions each 
day). Non-disabling pain during the exercises is permitted, and load is added 
gradually in a backpack (in steps of 5 kg) when exercises can be performed 
without pain.  
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Figure 1.3 The Alfredson protocol [41]. From an upright body position and 
standing with all body weight on the forefoot and the ankle joint in plantarflexion 
lifted by the non-injured leg (A), the calf muscle is then loaded eccentrically by 
lowering the heel with the knee straight (B) and with the knee bent (C) 
 
Despite the initial promising results of this intervention demonstrating a 100% 
success rate of returning participants to preinjury levels [41], more recent 
studies have shown  up to 45% of individuals do not respond favourably to 
eccentric loading [42]. Consequently, alternative loading strategies including; 
heavy slow resistance, concentric-eccentric and concentric-eccentric 
progressing to eccentric loading, have been investigated [38,43–46]. Similar to 
eccentric loading, studies into the effects of these interventions have also 
yielded inconsistent findings [33] and the individual response is also variable 
[38]. Such inconsistent and variable findings have led to recommendations that 
clinicians take an approach that enables tolerable repetition volumes to be 
completed, rather than those recommended by strict programmes [39]. Several 
explanations may explain this inconsistency; these may relate to our current 
lack of understanding of the specific and non-specific effects for the optimal 
delivery of the exercise programme. 
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Specific explanations relate to exercise parameters and our current lack of 
knowledge regarding optimal exercise prescription, such as; load magnitude, 
sets, repetitions, frequency and restitution between loading sessions [38]. For 
example, eccentric loading is taught to patients to be performed twice a day 
(morning and evening) yet heavy slow resistance exercises are taught to 
patients to be performed three times a week [38]. The consideration of such 
vastly difference approaches to exercise within research highlights our existing 
lack of understanding of why someone with AT may respond favourably to a 
load-based exercise programme. Most clinical improvement does not 
correspond with the timeframe for structural tendon adaption to occur [47] 
raising the probability of other mechanisms being responsible for clinical 
improvement. To date, such mechanisms that have been considered include; 
changes to tendon length, neurovascular ingrowth, neuro-chemical alterations, 
fluid movement and neuromuscular tissue adaption [15]. Whilst much 
uncertainty remains regarding the specific mechanism of action of exercise on 
tissue for tendinopathy, an alternative explanation might be to investigate other, 
non-specific, influences on the effectiveness of exercise.  
 
Non-specific effects of treatments are multi-factorial, and have been described 
as cognitive and contextual in nature; including the attention of the health care 
provider, the desire to get better and social variables such as a reduction in 
anxiety, increased optimism and improved coping [48]. These factors have 
been considered to significantly influence the success of a range medical 
interventions. For example, Roberts et al [49] reviewed the literature relating to 
five medical interventions that were once considered to be efficacious 
18 
 
(glomectomy for the treatment of asthma; gastric freezing for treatment of 
duodenal ulcers; and levamisole, photodynamic activation, and organic 
solvents for treating herpes simplex virus), but later were shown to have no 
efficacy based on controlled trials. Despite the later evidence that these 
treatments lacked efficacy, prior published clinical trials showed that out of 
6,931 subjects enrolled, 70% of the patients reported good to excellent results 
from these five interventions. Roberts et al [49] concluded that under conditions 
of heightened expectations, the power of non-specific effects far exceeds that 
commonly reported in the literature. Whilst the majority of research indicates 
biological plausibility that there are specific effects of exercise for AT, it is clear 
that further research is required to gain a more informed understanding of these 
processes. Furthermore, given that AT can be resistant to treatment in some 
cases, and the abundant presence of non-specific effects in other medical 
conditions, addressing influences beyond the peripheral tissue is also likely to 
be required [18].  
 
1.2 Rationale Underpinning Further Study  
As presented in this introduction, exercise-led management of AT is justified as 
the first line intervention despite the wide variation in current delivery of this. 
Given that this variation doesn’t appear to significantly impact outcome, with no 
single approach demonstrating superiority over another [33,38], it is paramount 
that in order to optimise outcomes in AT, the mechanisms underpinning this 
require urgent exploration. Although, it is acknowledged that a greater 
understanding of the specific exercise parameters (such as sets, reps and load 
magnitude) and adaptions (such as neuromuscular adaptions and changes to 
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tendon length)  is also required to optimise outcomes for AT, understanding 
influences beyond the peripheral tissue might also help to focus our 
interventions for the benefit of patients [50,51].  
 
In attempt to add significance to this understanding, the thesis is presented as 
follows. Initially, a systematic review investigating the association and 
predictive nature of psychological variables and tendinopathy is presented. 
This review highlights contradictory findings, with conflicting results from high 
quality studies regarding the significance of factors such as depression, anxiety 
and kinesiophobia. A subsequent narrative review is then presented exploring 
possible explanations for this, specifically the cognitive and contextual factors 
which may underpin psychological factors. These factors include 1) self-
efficacy, 2) the relationship between the patient and the therapist, and 3) the 
role of expectations which are considered in full. From this body of work, the 
Managing Achilles Pain (MAP) study was developed. The MAP study was a 
multi-methods study designed to evaluate the feasibility of the protocol for a 
future large longitudinal cohort study that would investigate the association and 
predictive relationship of working alliance, outcome expectations, adherence 
and self-efficacy with clinical outcome in the management of AT. In addition, to 
further inform the design of the MAP study, a critical evaluation of the most 
commonly used patient-reported outcome measure in AT was also undertaken.  
 
 
 
 
 
20 
 
1.2.1 Aim and Objectives 
In the context of further research being required to better understand how to 
optimise exercise-led interventions for people with AT, this thesis aims to 
develop a greater insight by focusing on factors not previously investigated in 
tendinopathy research; cognitive and contextual factors and consider how they 
could contribute to optimising exercise-based interventions.  
 
Underpinning this aim are several objectives: 
i. To systematically review current research evidence to determine if 
there is an association between outcome and psychological 
variables for people with tendinopathy (chapter two, part one) 
ii. To critically review potential underpinning mechanisms of the 
identified variables and consider how they can influence outcome for 
people with tendinopathy (chapter two, part two) 
iii. To critically review the most commonly used patient reported 
outcome measure (PROM) for people with Achilles tendinopathy; the 
VISA-A and determine suitability for the longitudinal cohort study 
(chapter three) 
iv. To evaluate the feasibility of conducting a future large longitudinal 
cohort study utilising an online platform for data collection to 
investigate the association and predictive relationship of working 
alliance, outcome expectations, adherence and self-efficacy with 
outcome in the management of Achilles tendinopathy, exploring 
methodological issues that may underpin future implementation of a 
21 
 
large longitudinal cohort study, reporting both quantitative and 
qualitative perspectives (chapters four, five and six)  
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Chapter 2: Literature Review 
Summary 
This chapter presents two literature reviews. Part One is a systematic review 
which explores the association and prognostic influence of psychological 
variables and tendinopathy. Part Two presents a narrative review, building 
upon the previous systematic review, which discusses potential cognitive and 
contextual factors that may influence the outcome for people receiving 
treatment for tendinopathy. 
 
Part One: The Association of Psychological Variables and 
Outcome in Tendinopathy: A Systematic Review 
Based upon Mallows A, Debenham J, Walker T, et al. Association of psychological variables and 
outcome in tendinopathy: a systematic review. Br J Sports Med 2016; bjsports-2016-096154. 
doi:10.1136/bjsports-2016-096154 (Appendix 1) 
 
2.0 Introduction 
Chapter one discussed the complexities and current gaps in knowledge 
surrounding AT. In addition to these complexities, the chapter also highlights 
common ground; current recommendations for an exercise-led management 
approach through strength training and load-management [32,33]. The 
importance of load management may relate to the role loading history plays in 
the pathogenesis of AT. Significant change in load is considered a major 
contributing factor for the development of tendinopathy [9]. In a Delphi study of 
risk factors for AT, returning to sport following the ‘off-season’ was cited as the 
primary extrinsic risk factor for the development of AT in active individuals and 
trying to get fit as the number one risk factor for sedentary individuals [52]. In 
addition, many non-mechanical factors are considered to modulate load, 
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rendering an individual more or less likely to develop tendinopathy. These 
factors include diabetes mellitus [53], obesity [54,55], high cholesterol [54,56] 
and hypertension [53,57], with such factors considered as influential to the 
tendon’s capacity to repair.  For example, diabetes mellitus may alter the 
glycation of collagen within the tendon, affecting the tendon’s structural integrity 
and therefore reduce the ability of the tendon to tolerate load [58]. Given such 
wide ranging possible influences on a person’s presentation with AT, current 
management programmes need to tailor to individual presentations [6].  
 
Tailoring management strategies to individual presentations has been 
suggested for other conditions which can also be resistant to treatment 
resulting in persistent pain states [59]. Strategies adopted include not only 
addressing physical factors such as loss of muscle strength or co-ordination, 
but also cognitive and psychological factors. Factors such as fear, anxiety, 
depression, stress and catastrophisation are all known to further affect the pain 
experience and disability levels [60]. To date, the association of such 
psychological factors has yet to be established in tendinopathy. Given the 
novelty of the review, initial scoping suggested there was limited primary 
research in this area specifically to AT. As such, as a hypothesis generating 
review, it was decided to expand this review to consider tendinopathy more 
broadly, offering individualised insight where relevant.  
 
The purpose of this review was therefore to determine; 
1) Are psychological variables, such as anxiety, depression and 
kinesiophobia, associated with tendinopathy? 
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2) Are outcomes from non-surgical management of tendinopathy 
associated to the presence of such psychological variables? 
 
2.1 Methods 
2.1.1 Protocol 
A systematic review was performed using a predetermined protocol in 
accordance with the PRISMA statement (appendix 2) [61]. 
 
2.1.2 Data Sources and Search Strategy 
An electronic search of MEDLINE, CiNAHL, SPORTDiscus, EMBASE, 
PsycINFO and PsycARTICLES was undertaken from their inception to April 
2016 by AM. The keywords used are displayed in table 2.1. The electronic 
search was complemented by hand searching the reference lists of the papers 
identified. Citation searching using the identified papers was also carried out 
and recognised experts in the field of tendinopathy were consulted via email in 
an attempt to identify any further published or unpublished studies. The search, 
including the application of the selection criteria, was conducted independently 
by two reviewers (AM & TW – a clinical physiotherapist and named author on 
the published paper) with any discrepancies resolved by discussion with a third 
reviewer (CL).  
Search Terms 
1 Tendin* or tendon* or jumper’s knee or lateral epicondy* or rotator 
cuff or subacromial pain or subacromial impingement or tennis 
elbow 
2 Pyscholog* or fear or depression or emotion* or anxiet* or 
catastroph* or distress 
3 1 & 2 Combined 
Table 2.1 Keywords used in the study selection process 
25 
 
2.1.3 Eligibility Criteria 
2.1.3.1 Population 
Adult participants with a diagnosis of a tendon-related disorder, including 
tendinosis, tendinitis, tendinopathy or synonyms e.g. tennis elbow. In keeping 
with previous reviews, minimal diagnostic criteria of a largely preserved range 
of motion with pain provoked by loading of the tendon was required [62]. 
Studies with mixed or non-specific diagnoses, those concerned with the risk of 
developing tendinopathy or concerned with tendon rupture or post-surgical 
recovery were also excluded. In line with previous reviews [36], studies 
investigating tendinopathy considered to be as a result of an intervention e.g. 
fluoroquinolone and studies using participants with a known specific disease 
present (e.g. spondyloarthropathy) were also excluded.   
 
2.1.3.2 Outcome 
Self-reported psychological measure(s) measuring emotional and cognitive 
variables known to be associated with persistent pain. These were namely; 
depression, anxiety, catastrophisation, fear and distress [60]. Measurements 
of pain and disability, plus any other clinical outcomes were included. 
 
2.1.3.3 Study Design 
Any study design that incorporated measurement of psychological status and 
clinical measures of pain and / or disability. These included case study, case 
series, case-control, cohort, cross sectional, uncontrolled trials, quasi-
experimental studies and randomised controlled trials (RCT). Narrative 
reviews, editorials or other opinion-based publications were excluded.  
26 
 
2.1.3.4 Language 
Studies published in any language were included. 
 
2.1.4 Quality Assessment 
Quality assessment of the included studies was undertaken independently by 
two authors (AM & TW) using the Newcastle-Ottawa Scale (NOS). The NOS is 
a tool designed for cohort and case-control studies, which is reliable and valid 
for assessing quality of non-randomised studies [63]. Criteria evaluate potential 
bias based on selection of participants, comparability of study groups and 
attainment of exposure (case-control studies) or outcome of interest (cohort 
studies) [63]. The NOS uses a star rating system (semi-quantitative) where one 
star is awarded for each criterion of appropriate methods that are reported, with 
the exception of comparability of cohorts where two stars are awarded if a study 
controls for more than one comparison factor [63]. The scale ranges from zero 
to nine stars [64]. Discrepancies in the awarding of a star were resolved by 
discussion with a third reviewer (CL). As the effectiveness of an intervention 
was not of interest to the review, but rather the association of other measures, 
the NOS case-control scale and NOS cohort study scale were also used to 
evaluate included cross-sectional, case-series and intervention studies, 
respectively [65].  
 
2.1.5 Data Extraction 
All data were extracted by a single reviewer (AM) and verified by a second 
reviewer (TW). Data included study characteristics, participant characteristics, 
source, sample size, intervention details, comparison group characteristics and 
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results. Quantitative data relating to psychological measures, pain and 
disability were also extracted. 
 
2.1.6 Data Synthesis 
There was considerable heterogeneity within the included studies with regard 
to study design, patient populations and measures of psychological variables 
[66]. As meta-analysis should only be considered when a group of studies is 
sufficiently homogeneous in terms of participants, interventions and outcomes 
to provide a meaningful summary [67], a qualitative synthesis was deemed the 
most appropriate means to analyse the data. A qualitative synthesis refers to 
synthesis of findings from multiple studies that relies primarily on the use of 
words and text to summarise and explain the findings of the synthesis [68]. As 
threshold scores to differentiate between ‘good’ and ‘poor’ studies using NOS 
have yet to be established [63] the qualitative synthesis of data was informed 
by a scoring system to rate studies included in this review. The score for each 
study was calculated by dividing the number of stars achieved by the number 
of items. For example, if a study was awarded eight stars, this number would 
be divided by nine (the number of items on the NOS) to achieve a score of 0.88. 
Each study was graded as low, moderate or high quality based on this score. 
Cut-off points were designated a priori as: 0.00-0.44 low methodological 
quality, 0.45-0.70 moderate quality, and 0.71-1.00 high quality. Such cut-off 
points are often used to determine reference values for level of association / 
agreement by researchers and have been acknowledged as acceptable by 
experts in research methods [69,70] and utilised by previous reviews [71]. In 
accordance with previous reviews in the tendinopathy field [72], in order for 
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both quality and quantity of the available evidence to be taken into account, a 
rating system for levels of evidence was used to summarise data relating to 
psychological factors, tendinopathy and outcome (table 2.2) [73]. 
 
Strong evidence Consistent findings in high-quality studies (n≥2) 
Moderate evidence Consistent findings among lower-quality studies 
(n>2) and / or one high quality study 
Limited evidence ≤ relevant low quality studies 
Conflicting 
evidence 
Inconsistent findings amongst multiple studies 
No evidence No studies 
Table 2.2 Levels of evidence [73] 
 
2.2 Results 
2.2.1 Study Selection 
Figure 2.1 represents the results of the study identification process. Initially, 
1243 citations were identified once duplications were removed. After screening, 
27 articles were considered for full review. Applying the eligibility criteria, 10 
articles, describing 9 studies were included for quality assessment. No 
identified studies published in a non-English language met the criteria for full 
review and no unpublished studies were identified. 
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Figure 2.1 Study selection flow diagram 
 
2.2.2 Newcastle-Ottawa Scale Assessment 
The results of the quality assessment are shown in table 2.3. From the possible 
nine stars available, five studies were awarded eight stars [74–78] and deemed 
Records identified through 
database searching  
(n = 1566) 
MEDLINE = (n = 791) 
CiNAHL = (n = 159) 
SPORTDiscus = (n = 127) 
PsycARTICLES = (n = 22) 
PsycINFO = (n = 425) 
EMBASE = (n = 42) 
Records after duplicates 
removed 
(n = 1243) 
Records 
excluded 
(inclusion / 
exclusion 
criteria 
applied) 
(n = 1229) 
 
 
n 
 
Full text articles assessed for 
eligibility  
(n = 27) 
Records identified through 
other sources  
(n = 3) 
 
Hand searching = (n =1) 
Citation searching = (n = 1) 
Expert = (n = 1) 
Records screened by title & 
abstract for relevance 
(n = 1243) 
Full text articles assessed for 
eligibility  
(n = 10)  
Full text 
articles 
excluded with 
reasons 
No clear 
diagnosis of 
tendinopathy 
(n = 9) 
No separate 
analysis of 
tendinopathy 
data 
(n=8) 
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of high quality, three studies were awarded seven stars [79–81] and also 
deemed of high quality and two studies were awarded six stars [82,83], deemed 
moderate quality (appendix 3).  
 
 
Author / Year Selection Comparability Exposure / 
Outcome 
Total Stars Quality of 
study 
Alizadehkhaiy
at et al (2007)  
**** * ** 7 HIGH 
Coombes et 
al (2015) 
**** * *** 8 HIGH 
Coombes et 
al (2012) 
**** * *** 8 HIGH 
Engebretsen 
et al (2010) 
**** * ** 7 HIGH 
Garnevall et 
al (2013) 
**** * ** 7 HIGH 
Haahr & 
Andersen 
(2003) 
**** * *** 8 HIGH 
Kromer et al 
(2014) 
**** ** ** 8 HIGH 
Lee et al 
(2014) 
**** * *** 8 HIGH 
Silbernagel et 
al (2011) 
*** * ** 6 MODERATE 
van Wilgen et 
al (2013) 
*** * ** 6 MODERATE 
Table 2.3 Quality assessment using the Newcastle-Ottawa Scale 
 
2.2.3 Study Characteristics 
A summary of the characteristics of the included studies is presented in table 
2.4
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Study characteristics Participants 
characteristic 
(Intervention) Psychological variable & 
outcome measure 
Results 
Alizadehkhaiyat et al (2007) 
 
Case control study to 
evaluate association between 
anxiety and depression and 
tennis elbow 
 
Liverpool, UK 
Cases: 16 participants (50% 
male; mean age = 49 years) 
with tennis elbow recruited 
from an upper limb hospital 
clinic 
  Tennis elbow defined as: 
a. Duration >3/12 
b. Tenderness at the 
lateral epicondyle 
c. Pain with resisted wrist 
and middle finger 
extension 
Control: 16 healthy students 
and staff (56% male; mean 
age = 40 years) 
n/a Anxiety and depression 
measured using Hospital 
Anxiety & Depression Scale 
Hospital Anxiety & Depression 
Scale significantly higher in 
tennis elbow group (sub 
scores P< 0.001;) Anxiety 
subscale showed cases as 
55% ‘probable’, 13% ‘possible’ 
and 31% ‘non-case’. 
Depression subscale showed 
cases as 36% ‘probable’ 31% 
‘possible’ 31% ‘non-case’ 
Coombes et al (2015) 
 
Cohort study to investigate the 
predictive capacity of early 
physical and psychological 
measures on short-term and 
long-term outcomes of pain 
and disability and mechanical 
hyperalgesia at the affected 
(tennis) elbow 
 
Brisbane, Australia 
41 participants from a placebo 
group of a Randomised 
Control Trial (58% male; mean 
age = 49.9 years). 
Tennis elbow defined as: 
a. Duration >6/52 
b. Unilateral 
c. Pain located over 
lateral epicondyle 
d. Severity of at least 
>30 on a 100mm VAS 
e. Provoked by at least 2 
of gripping, palpation, 
resisted wrist or 
middle finger extension, 
or stretching of forearm 
extensors with 
reduced pain free grip 
Placebo group forming the 
cohort all (except 1 whom felt 
had recovered) received a 
single blinded injection of a 
negligible volume saline. 
Kinesiophobia measured using 
Tampa Scale of 
Kinesiophobia. 
 
Anxiety & depression 
measured using Hospital 
Anxiety 
and Depression Scale 
Levels of anxiety, depression 
and kinesiophobia were not 
prognostic of pain and 
disability or mechanical 
hyperalgesia at 2 or 12 
months. 
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Coombes et al (2012) 
 
Cross-sectional study 
evaluating if sensory, motor, 
and psychological factors are 
different in severe lateral 
epicondylalgia compared with 
less severe cases and control 
 
Brisbane, Australia 
Participants taken from a RCT 
 
Cases: 164 participants (62% 
male; mean age = 49.6 years). 
 
LE defined as: 
a. Unilateral elbow pain 
over the lateral 
epicondyle for longer 
than 6/52. 
b. Aggravated by a 
combination of 
palpation, gripping, 
and resisted wrist and 
/ or finger extension. 
 
Control: 62 participants (55% 
male; mean age = 49.6 years) 
n/a Kinesiophobia measured using 
Tampa Scale of Kinesiophobia 
 
Anxiety & depression 
measured using Hospital 
Anxiety 
and Depression Scale 
No significant difference 
between cases and controls 
for levels of anxiety, 
depression, and kinesiophobia 
Engebretsen et al (2010) 
 
Cross sectional study to 
examine influence of 
determinants of Shoulder Pain 
and Disability Index (SPADI). 
 
Oslo, Norway 
200 participants (45.5% male; 
mean age 49.9 years). 
 
Sub acromial shoulder pain 
defined as- dysfunction or pain 
on abduction, normal passive 
gleno-humeral joint ROM, pain 
with 2 of 3 of following: 
Abduction at 0 or 30 degrees, 
external rotation, internal 
rotation. 
n/a Emotional Distress measured 
using the Hopkins Symptom 
Check List 
29 % of variance of SPADI 
explained by combination of 
pain medication, emotional 
distress, flexion and hand- 
behind-back ROM. Emotional 
distress contributes 7.5% of 
total variance of SPADI (p 
<0.01). Emotional distress was 
not significant when the 
variables of pain and function 
were included in the model 
Garnevall et al (2013) 
 
Cross-sectional study 
examining psychosocial / 
personality factors and physical 
measures in tennis elbow 
Cases: 54 participants 
recruited via adverts (30% 
males; mean age = 48.7 
years). 
 
Tennis elbow defined as 2 or 
n/a Anxiety measured by Swedish 
Scales of Personality 
Significant difference was 
found between cases and 
controls for somatic anxiety (P 
= 0.009) 
33 
 
correlating them with Nirschl’s 
classification 
 
Norwegian primary care setting 
 
more of the following 
a. Pain on palpation of 
the epicondyle 
b. Pain on passive 
stretching of the wrist 
extensor muscles 
c. Pain on resisted 
extension of the wrist 
d. Pain on resisted 
finger extension 
 
Controls: 43 recruited from the 
region (42% males; mean age 
= 48.8 years). 
Haahr & Andersen (2003) 
 
RCT performed to determine 
whether minimal intervention 
involving information about the 
disorder, encouragement to 
stay active and instruction in 
graded self-performed 
exercises could enhance the 
prognosis of lateral 
epicondylitis compared with 
usual treatment, to quantify 
workforce factors associated 
with the prognosis, and to 
consider treatments given in 
general practice. 
 
 
Ringkjoebing County, Denmark 
Participants recruited 
consecutively from GP 
practice. 
 
Cases: 141(43% male; 58% 
age >40 years). 
 
Control: 125 (48% male; 65% 
age >40 years). 
 
Tennis elbow defined as: 
a. Pain in the elbow 
region 
       b. Direct and indirect 
tenderness at or within 2cm 
of lateral epicondyle on 
resisted extension of the 
wrist and / or third finger. 
Cases: advised that lateral 
epicondylitis is a self-limiting 
condition with a favourable 
prognosis. Participants were 
informed no specific treatment 
improves the overall long-term 
prognosis. Advice was given to 
avoid total rest, stay active and 
avoid activities that exaggerate 
the pain. Patients were 
encouraged to adjust work 
conditions if possible. 
Instructions were given by an 
ergonomist in performing a 
graded exercise programme. 
 
Control: treatment as preferred 
and agreed upon by the patient 
and the patient’s GP. 
 
No blinding to treatment. 
Distress measured by Setterlind 
two-item symptom scale. 
Continued high pain score 
(and low function) with 
reduction at 1 year of less than 
50% was significantly 
associated with high baseline 
distress (Odds Ratio 1.9, 
Confidence Interval 1.0 - 4.0). 
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Primary outcome assessment 
was done independently. 
Randomisation performed by 
primary investigator according to 
a predetermined random 
sequence of number supplied to 
GP practices in sealed 
envelopes. 
  Kromer et al 2014 
 
Cross-sectional and 
longitudinal study to 
investigate the associations 
among pain, catastrophising, 
fear, and disability and the 
contribution of fear avoidance 
beliefs to disability at baseline 
and at 3 month follow-up (on 
subacromial shoulder pain). 
 
Germany, general practice. 
Data taken from a RCT 
investigating 2 different 
physical therapy interventions 
for participants with 
subacromial pain. 
 
Cases: 46 
Control: 44 
 
Baseline demographics 
presented for group overall 
(49% male; mean age 51 
years). Block randomisation 
process.  
 
Subacromial pain defined as; 
a. Symptoms for at least 
4 weeks 
b. Main complaints in the 
GHJ region or 
proximal segments of 
the arm 
c. Presence of one of the 
following signs; 
Hawkins-Kennedy, 
painful arc with active 
abduction or flexion, 
Both cases and controls: 
received 10 sessions within 5/52 
and continued the home 
exercises for another 7/52 
Supervised stretching and 
strengthening exercises for the 
shoulder, shoulder girdle and 
thoracic spine. 
 
Cases: in addition received; 
 
a. examination-based 
manual mobilisations 
for the shoulder 
complex and cervical 
spine 
b. individualised 
education about the 
pathology 
c. instructions for the 
most provocative ADLs 
to reduce pain events 
during the day. 
Kinesiophobia measured by 
Fear-Avoidance Beliefs 
Questionnaire and 
Catastophisation measured 
by Pain Catastrophizing 
Scale. 
Disability showed significant 
correlations with pain (P<0.1; 
0.401), catastrophizing (P<0.1; 
0.369), and fear-avoidance 
beliefs (P<0.5; 0.237). 
Correlations between pain and 
catastrophizing (P<0.1; 0.318) 
and between catastrophizing 
and fear-avoidance beliefs 
(P<0.1; 0.293) were 
significant. 
 
Hierarchical regression model 
used to show: 
 
Baseline: Fear-avoidance 
beliefs significantly contributed 
to disability at baseline. 
 
3 Months: Fear avoidance and 
scores were not predictive of 
disability at 3 months 
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Neer impingement 
sign 
d. Pain during one of the 
following resistance 
tests; external rotation, 
internal rotation, 
abduction or flexion. 
Lee et al 2014 
 
Cohort study to establish the 
relationship between positive 
and negative phrasing and 
participants’ coping with lateral 
epicondylitis 
 
Seoul, South Korea 
108 consecutive participants 
with isolated lateral 
epicondylitis of less than 6/12 
of symptoms. 91 participated 
at follow up 1 year later (45% 
male; mean age = 54 years 
 
Lateral epicondylitis defined as 
the presence of all 3 of the 
following; 
a. pain located at the 
lateral aspect of the 
elbow 
b. point tenderness over 
the lateral epicondyle 
pain on resisted wrist 
extension with the elbow in 
full extension. 
Wait & see policy; self- 
stretching, counterforce 
bracing, pain medication and 
education that the tendon has 
temporarily weakened and it 
will run its course over 12-18 
months. 
 
All followed up at 4/52 and were 
discharged (n=101) or referred 
for physical therapy, 
corticosteroid injection or 
surgery (n=7 and excluded from 
follow up at this stage). 
Catastrophisation measured 
by Pain Catastrophisation 
Scale. 
Depression measured using 
Patient Health Questionnaire 
Pain Catastrophizing Scale 
used at baseline and 12/12. 
Patient Health Questionnaire 
(depression screening tool) 
was also used at follow up only 
Follow up at 12/12 was 
conducted by telephone and 
participants were asked to 
describe the nature of their 
condition. 
 
At 12/12, those who used 
positive phrasing terms had 
significantly lower 
catastrophisation scores (P = 
0.005) and a larger 
improvement in scores (P = 
0.039).  
 
Multiple analyses showed that 
negative phrasing (P<0.001) 
and depression (P<0.19) were 
independently associated with 
seeking additional treatment 
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van Wilgen et al 2013 
 
Cross-sectional study to 
investigate whether 
somatosensory changes 
represent a plausible 
explanation for pain in 
participants with chronic 
patellar tendinopathies and 
second to investigate if 
psychological comorbidities 
may contribute to pain. 
 
The Netherlands 
Cases: 12 (100% male; mean 
age 23.3 years) athletes. 
Patella tendinopathy defined 
as: 
a. History of knee pain in 
the region related to 
exercise 
b. Tenderness on 
palpation 
c. 6 months duration 
d. Lower than 70 points 
on the Victorian 
Institute of Sports 
Assessment – Patella 
(VISA- P) 
Controls: 20 (100% male; 
mean age 24.7 years) 
recruited from local sports 
clubs via advertising. 
n/a Phobic anxiety, anxiety, 
depression, somatization, 
insufficiency of thinking and 
acting, interpersonal 
sensitivity, hostility, 
and quality of sleep measured 
by Symptom Check List-90. 
Negative mood depression 
(eight 
items), anger (seven items), 
fatigue (six items), positive 
mood 
vigor (five items), and tension 
(six items) measured by Profile 
of Mood States questionnaire. 
The Symptom Check List-90 
and Profile of Mood States 
questionnaires demonstrated 
no significant differences 
between cases and controls. 
Table 2.4 Summary of the characteristics of the included studies
Silbernagel et al 2011 
 
Case series to evaluate the 5 
year outcome of participants 
(with Achilles tendinopathy) 
treated with exercise alone 
and to examine if certain 
characteristics, such as level 
of kinesiophobia, age and sex 
were related to the 
effectiveness of the treatment. 
 
Gothenburg, Sweden 
34 cases (53% male; mean 
age =51 years). Cases were 
originally recruited into a 
randomised study evaluating 
the effect of continuing 
sporting activity compared with 
rest for the initial 6 weeks 
whilst undertaking identical 
exercise programme. 
Achilles tendinopathy defined 
as a combination of; 
a. Achilles tendon pain 
b. Swelling 
c. Impaired 
performance 
Progressive tendon loading 
programme for 12/52 to 6/12 
Kinesiophobia measured by 
Tampa Scale of 
Kinesiophobia 
Significant (P = 0.005) 
negative correlation (-0.590) 
between the level of 
kinesiophobia and heel-rise 
work recovery (a battery of 
tests consisting of 2 jump 
tests, 2 strength tests, and 1 
endurance test). 
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2.2.4 Study Design 
The most frequently used study design was cross sectional (n=5) 
[74,77,80,81,83]. Other study designs were case control (n=1) [79], case series 
(n=1) [82], randomised controlled trial (n=1) [76], and cohort (n=2) [78,84]. 
 
2.2.5 Participants 
Two studies reported data utilising one set of participants [74,84]. Thus, the ten 
articles included for review identified nine studies. The studies included 1108 
participants, 580 women and 528 men. The mean age of the participants was 
48.8 years, ranging from 18 [81] to 82 years [78]. Six studies included 
participants with lateral epicondylalgia (LE)  [74,76,78–80,84], two studies 
included participants with rotator cuff tendinopathy (RT) [77,81], one study 
included participants with Achilles tendinopathy (AT) [82], and one study 
included participants with patella tendinopathy (PT) [83]. 
 
2.2.6 Findings 
2.2.6.1 Psychological Variables (Catastrophisation, Distress, Anxiety 
and Depression and Kinesiophobia) and Tendinopathy 
Overall, there is conflicting evidence relating the presence of psychological 
variables and their association with tendinopathy. Six studies (5 of high quality 
and 1 of moderate quality) support a statistically significant positive association 
between the presence of psychological variables and tendinopathy [76–80,82]. 
Four of these investigated LE, one RT and the other AT. Four studies (3 of high 
quality and 1 of moderate quality) demonstrated no statistically significant 
association between psychological variables and tendinopathy [74,83,84]. Two 
of these investigated LE, one RT and the other PT. 
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2.2.6.2 Catastrophisation 
Two studies investigated the association of catastrophisation and tendinopathy 
[77,78]. One high quality study investigating RT supported a statistically 
significant positive association of the presence of catastrophisation and 
tendinopathy at baseline [77]. The other study investigating LE was also of high 
quality and showed a statistically significant positive relationship between a 
reduction in catastrophisation and a reduction in the need for additional 
treatment [78]. 
 
2.2.6.3 Distress 
Two high quality studies investigated the association of distress and 
tendinopathy [76,81]. One study investigated RT and showed no statistically 
significant association between the presence of distress and pain and function 
associated with tendinopathy [81]. The additional study investigated LE and 
supported a statistically significant positive association of the presence of 
distress and tendinopathy [76]. 
 
2.2.6.4 Anxiety and Depression 
Four studies investigated anxiety in conjunction with depression [74,79,83,84]. 
One study investigated anxiety without depression, but instead included 
aggression and extraversion factors [80]. Two high quality studies [74,84] 
investigating LE and one moderate quality study [83] investigating PT 
demonstrated no statistically significant association between the presence of 
anxiety, depression and tendinopathy. One high quality study investigating LE 
supported a statistically significant positive association between the presence 
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of depression and tendinopathy [79]. Two high quality studies both 
investigating LE supported a statistically significant positive association of the 
presence of anxiety and tendinopathy [79,80]. 
 
2.2.6.5 Kinesiophobia 
Three studies investigated the association of fear-avoidance and tendinopathy 
[74,77,82]. One high quality study investigating LE demonstrated no 
statistically significant association between kinesiophobia and tendinopathy 
[74]. Another high quality study investigating RT supported a statistically 
significant association of the presence of fear-avoidance beliefs and disability 
at baseline [77]. One moderate quality study investigated AT and showed a 
statistically significant negative correlation between levels of kinesiophobia and 
heel-rise work recovery (a battery of tests consisting of two jump tests, two 
strength tests, and one endurance test), suggesting a negative effect on the 
effectiveness of treatment [82]. 
 
2.2.6.6 Psychological Variables (Catastrophisation, Distress, Anxiety 
and Depression and Kinesiophobia) and Prognosis 
Overall, there is conflicting evidence relating the presence of psychological 
variables and their association with outcome in tendinopathy. Three studies (2 
of high quality and 1 of moderate quality), two investigating LE and the other 
AT support a statistically significant positive association [76,78,82]. Two 
studies (both of high quality), one investigating LE and the other RT showed no 
association [77,84].  
 
40 
 
2.2.6.7 Catastrophisation 
Two studies investigated the association of catastrophisation and outcome in 
tendinopathy [77,78]. One high quality study, investigated RT and showed high 
baseline catastrophisation scores were not predictive of disability at three 
months [77]. The other, also of high quality investigated LE and showed a 
statistically significant positive relationship between a reduction in 
catastrophisation and a reduction in the need for additional treatment at twelve 
months [78].  
 
2.2.6.8 Distress 
One high quality study investigated the association of distress and outcome in 
LE [76]. This study showed a statistically significant association with continued 
high pain scores and a less than 50% reduction in pain scores at twelve months 
associated with high baseline distress. 
 
2.2.6.9 Anxiety and Depression 
One high quality study investigated the association of anxiety and depression 
and outcome in LE [84]. This study found no statistically significant association 
between anxiety, depression and pain and disability scores at twelve months. 
One high quality study investigated the association of depression and LE [78]. 
This study showed depression was independently statistically significant for an 
association with seeking additional treatment at twelve months. 
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2.2.6.10 Kinesiophobia 
Three studies investigated the association of fear avoidance and tendinopathy 
[77,82,84]. One high quality study investigated LE and found no statistically 
significant association between kinesiophobia and pain and disability at twelve 
months [84] and another high quality study investigating RT found high baseline 
kinesiophobia scores were not predictive of disability at three months [77]. One 
moderate quality study investigating AT found at five year follow up, increased 
fear of movement was statistically significant for an association with reduced 
heel-rise work recovery [82]. 
 
2.2.6.11 Summary of Key Findings 
2.2.6.12 Lateral Epicondylalgia 
There is conflicting evidence from multiple research studies surrounding the 
association of anxiety, depression and LE [74,78–80,84]. Strong evidence from 
one high quality cross-sectional study and one high quality cohort study, 
suggests kinesiophobia is not associated with LE [74,84]. Moderate evidence 
from one high quality RCT links distress with LE [76]. Moderate evidence from 
one high quality cohort study links catastrophisation with LE [78]. 
 
2.2.6.13 Rotator Cuff Tendinopathy 
There is moderate evidence from one high quality cross-sectional study 
suggesting distress is not associated with RT [81]. There is moderate evidence 
from one high quality cross-sectional and longitudinal study to suggest that 
kinesiophobia and catastrophisation are associated with RT at baseline, but 
are not associated with a suboptimal outcome [77]. 
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2.2.6.14 Patella Tendinopathy 
There is limited evidence from one moderate quality cross-sectional study to 
suggest anxiety and depression are not associated with PT [83]. 
 
2.2.6.15 Achilles Tendinopathy 
There is limited evidence from one moderate quality case series to suggest 
kinesiophobia is associated with AT [82]. 
 
2.3 Discussion 
This systematic review suggests overall there is conflicting high quality 
evidence relating to the association of psychological variables and outcome in 
tendinopathy. Previous systematic reviews considering features of 
tendinopathy have investigated structural changes [19] and central nervous 
system (CNS) changes [85,86], but consideration to psychological variables 
has not been well evaluated in the tendinopathy literature [87,88]. The review 
was undertaken in accordance with published guidelines [61]. Whilst it is 
acknowledged criteria for ‘good’ and ‘poor’ studies have yet to be established 
for the NOS [63], according to the scoring system and cut off points designated 
a priori, the majority of studies were considered to be of a high quality, whilst 
two studies were considered of moderate quality. The conflicting high quality 
evidence as to the association of psychological features in tendinopathy could 
potentially be explained by several factors.  
 
Firstly, the variance in population under investigation. Although most of the 
participants were around the mean age of 50 years, one study [83] had a mean 
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age of 23.3 years. Given that increasing age may be a risk factor for developing 
psychological variables such as depression [89], contrasting results from the 
comparison of such differing study populations may be attributable in part to 
age differences.  Additionally, participants were recruited from various settings 
ranging from specialist hospital settings [79] to university populations [83] and 
general care [76]. Two studies (from three articles) investigated anxiety and 
depression in LE and utilised the Hospital Anxiety and Depression scale 
[74,79,84]. One population [74,84] was recruited via advertising from the 
general population and the other from consecutive attendance at an upper limb 
clinic [79]. While inclusion criteria for both populations were similar, the study 
[79] whose population was taken from attendees at an upper limb clinic found 
a positive association between LE and anxiety and depression whilst the 
population who self-selected for inclusion did not [74,84]. Reasons behind 
these contrasting findings may consequently lie in the population studied. 
Those attending a specialist service may have a longer duration of symptoms 
or failed previous interventions; cross-sectional associations with low mood 
may in part reflect distress that occurs as a consequence of longer-term pain 
[90]. Consequently, this population may represent a separate sub-population 
of LE which appear more vulnerable to associated psychological variables 
alongside tendinopathy. Whilst it is acknowledged the variation in population 
may contribute to discrepancies between the studies, it was considered that 
the inclusion of all study types represents the evidence base as a whole; thus 
allowing the clinician to make their clinical reasoning based on a synthesis of 
all the available evidence [91].  
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The second potential explanation underpinning these findings reflects 
anatomical discrepancies. The majority of studies included in this review 
investigated tendinopathy of the upper limb; six investigated LE [74,76,78–
80,84], two investigated RT [77,81], one PT [83] and one AT [82]. The efficacy 
of treatment, and potential relationship of psychological variables, may be 
viewed as dependent on the specific tendon’s anatomical and biomechanical 
properties [92]. For example, with AT most commonly manifesting in the mid-
portion and LE occurring as an enthesopathy [93,94]. Nonetheless, this review 
has highlighted conflicting findings both within and between upper limb and 
lower limb tendinopathies. For example, kinesiophobia may be associated with 
AT [82], but no psychological variables were associated with PT [83] and the 
conflicting evidence which exists for the association of depression and anxiety 
with LE [74,78–80,84]. As such, considerations beyond the geographical 
location of individual tendon may be useful.  
 
There is growing evidence of changes beyond the tendon exist in people with 
tendinopathy. Such changes have been identified in the CNS and  may 
contribute to pain and disability in tendinopathy [18,95–98]. To date these 
changes have been predominately investigated in the upper limb [85,95], with 
lower  limb data limited [83,98] or even negating [99]. Although more research 
is required, particularly in the lower limb, it appears that there may be an 
association between persistent tendinopathy and sensitisation of the nervous 
system [98]. Changes in the CNS or central sensitisation are much more than 
generalised hypersensitivity to pain and includes increased responsiveness to 
stress, emotions and mental load [100]. Consequently, differing dominant 
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states of sensitivity (peripheral or centrally driven) may have influenced the 
association of psychological variables. A possible area for further study would 
be to investigate this potential influence.    
 
Finally, differing cognitive factors which may underpin the psychological 
variables and their amenability to change could also help explain the conflicting 
results from the high quality studies included in this review. Factors such as 
hope, beliefs, information and expectations have all been shown to influence 
the pain experience [101,102]. The relationship between the patient and the 
practitioner has been shown to be useful in predicting and influencing outcomes 
in other chronic conditions such as low back pain [103,104] and a positive 
alliance is seen to have an overall positive influence on rehabilitation [105]. To 
date, the management models for tendinopathy have not included such factors 
[9,94,106,107]. Whilst it is recognised that for some tendinopathies in 
particular, PT and AT, there are a limited number and quality of studies 
exploring psychological variables and outcome, within the context of the 
conflicting results from multiple high quality studies in other tendinopathies, 
further exploration of cognitive processes connected with psychological 
variables and means of influencing these seems warranted as one avenue of 
further enquiry. Consequently, these factors are the focus of the discussion in 
part two of this chapter. 
 
2.4 Limitations 
Whilst the evidence from this review suggests there may be a statically 
significant association between some psychological variables and the 
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presence of and prognosis of tendinopathy in some, it remains unclear if this is 
clinically meaningful. To understand if a change in psychological status is 
perceived as clinically meaningful it is important to be sure the smallest change 
in the score is beyond measurement error (knowing the minimal detectable 
change of the measure) and whether the smallest change in score is perceived 
as important to patients, clinicians or relevant others (knowing the minimal 
important difference of the measure) [108]. To date, these values are unknown 
in the measures used within a population with tendinopathy. As such, it is 
currently uncertain whether any change in association of a psychological 
variable would be both statistically significant and clinically important. 
 
2.5 Future Directions 
The findings of the current review suggest that taken as a whole, there is 
conflicting evidence as to the significance of psychological variables in 
tendinopathy. However, this conclusion is based on a limited volume of 
research. Specific psychological variables may be associated with 
tendinopathy and suboptimal outcomes from treatment, although the 
uncertainty surrounding this suggestion is clearly recognised.  
 
While a clear explanation for the response of tendinopathy to therapeutic 
exercise is lacking, further studies to identify the underlying mechanism(s) are 
warranted. Theories surrounding the potential influence of the CNS, 
biochemical and myogenic factors have been proposed [18,95,109–111]. 
Whilst acknowledging the likelihood of a multifactorial explanation [112], to date 
psychological response explanations have not been considered and the 
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findings of this review suggest further research is warranted. Currently it is 
unclear how psychological variables might be associated with suboptimal 
outcome, if at all. One possible explanation that has been hypothesised might 
be those with fear of pain could perform less exercise with less intensity [82]. 
Appropriate levels of intensity are likely to be required for the exercise to induce 
a sufficient response from of the proposed mechanisms outlined above and 
reduce associated pain and disability.  
 
2.6 Conclusions 
Conflicting evidence exists surrounding the significance of the association of 
anxiety, depression and LE. However, strong evidence suggests LE is not 
associated with kinesiophobia. Moderate evidence links catastrophisation and 
distress with LE, with distress being associated with a less than 50% reduction 
in pain at twelve months. Conflictingly, moderate evidence suggests distress is 
not associated with RT, but kinesiophobia and catastrophisation are. However, 
this may not lead to a suboptimal outcome. Limited evidence exists linking 
psychological variables and AT and PT, but current evidence suggests PT is 
not associated with anxiety or depression and kinesiophobia may be linked with 
suboptimal outcomes in AT. As such, when a person is suspected to have 
tendinopathy, there may be clinical merit in considering using validated 
screening tools for the presence of psychological variables which may 
contribute to suboptimal outcomes. These include the Tampa Scale of 
Kinesiophobia, Pain Catastrophisation Scale and the Hospital Anxiety and 
Depression Score. These measures may be particularly important when 
considering more invasive procedures such as surgery, as they are associated 
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with negatively influencing outcomes [113–115]. Management to address the 
presence of specific variables might then usefully be incorporated as means of 
addressing these potentially relevant factors in the treatment package. Clearly, 
this is a suggestion that requires validation through further testing but theories 
underpinning this will now be discussed more.  
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Part Two: Cognitive and Contextual Factors to Optimise 
Clinical Outcomes in Tendinopathy 
Based upon Mallows AJ, Debenham JR, Malliaras P, et al Cognitive and contextual factors to 
optimise clinical outcomes in tendinopathy Br J Sports Med Published Online First: 09 October 
2017. doi: 10.1136/bjsports-2017-098064 (Appendix 4) 
 
2.6 Introduction 
Substantial variety has been a feature of the exercise prescription used in 
tendinopathy research to date. However, this variation in exercise does not 
appear to affect the results positively or negatively. Exercise programmes as 
different as a concentric-eccentric heavy slow loading programme performed 
three times per week and eccentric only exercises performed twice daily, seven 
days per week have achieved similar results [38]. Whilst within-group mean 
severity scores improve, individual responses are wide ranging for the same 
exercise programme [38] and success rates vary from 44% failing to improve 
[42] to 100% success [41] for a similar exercise intervention.  
 
It is acknowledged that heterogeneity in the research cohorts (e.g. age, sex, 
chronicity, co-morbidities) [9] or variations in how the exercise programme was 
delivered are likely play a role in explaining these findings. For example, the 
exercise programme may not have been progressed enough or at the correct 
rate; the progression of rehabilitation is related to symptom response to load 
and muscular function, both of which also determine return to full function [106]. 
Alternatively, the person with tendinopathy may continue to perform activities 
which maintain their symptoms, potentially highlighting inaccurate beliefs and 
expectations about pain and the need for appropriate education [106]. 
Additionally, biomechanical requirements, for instance landing with a stiff knee 
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which has been associated with the development of patella tendinopathy [116], 
kinetic chain deficits, such as restricted ankle dorsiflexion [117] or quadriceps 
and hamstring flexibility [118] which can be associated with the development 
of patella tendinopathy, or systemic comorbidities, such as the presence of 
diabetes [11] may have not been adequately addressed; such considerations 
are recommended to form part of a comprehensive programme [106,119]. 
However, in light of the findings from chapter two part one, where conflicting 
evidence was presented relating to the significance of psychological variables 
in tendinopathy, here, an added consideration is provided to offer further 
potential insight into explaining the current equivocal results from vastly 
differing exercise programmes for tendinopathy - cognitive and contextual 
factors that affect each individual therapeutic encounter [120,121].  
 
2.7 Psychosocial Impact 
Beliefs and fears relating to pain and disability have received little attention in 
current tendinopathy management models. For example, local tissue 
pathology-pain models, such as the continuum model of tendon pathology 
[6,9], solely theorise peripheral nociceptive tissue-based (structure and 
function of the tendon) drivers of pain as guidance for management. Whilst the 
identity of the nociceptive driver in tendinopathy remains elusive, the suggested 
interworking of the reactive tendon and dysrepair / degenerative tendon states 
may implicate paracrine signalling (a form of cell-to-cell communication in 
which a cell produces a signal to induce changes in nearby cells, altering the 
behaviour of those cells) by tendon cells (figure 2.2) [17].  
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Figure 2.2 Relationship between structure, function and pain according to the 
continuum model [9] 
 
Whilst the importance of the biologic contribution to tendinopathy is not 
dismissed, such models are confounded by lack of the association between 
pathology and pain [19], and as such fail to recognise the important role of 
mediators beyond the tendon tissue which can affect the painful experience; 
nociception and pain are neither proportionate nor synonymous terms [122].  
 
Littlewood et al [95] suggest pain associated with tendinopathy, that is lasting 
longer than anticipated, be considered within a framework that recognises such 
mediators. Pain is considered as a protective output mechanism of the CNS; 
serving to guard from further threat [122]. However, this output is influenced by 
multiple factors, including a person’s culture, understanding and behaviours; 
this influence may result in a magnification or dampening of the pain, resulting 
in a disproportionate experience to the actual threat (tissue pathology) [123]. 
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For example, a negative perception such as believing pain is a sign of further 
tissue damage, may lead to fear avoidance and consequently a deconditioned 
tendon, placing the person at further risk of recurrence [95]. 
 
Smith et al [124] have recently revisited the Mature Organism Model [123] to 
highlight such complexity and overlapping influences (figure 2.3). This model 
suggests that in addition to pathological and physical status, the clinical status 
of tendinopathy may also be influenced by factors including, but not restricted 
to, psychosocial variables, treatment expectations, recall of prior health and 
pain or health status of the patient at the time of scale administration.  
 
 
Figure 2.3 The overlapping influences which may mitigate and moderate 
musculoskeletal pain. Smith et al [124] 
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Mediation of psychosocial variables may offer another explanation as to the 
response to commonly used loading programmes for the management of 
tendinopathy. A confrontational graded exposure intervention, resembling 
education which aims to address individual cognitive behavioural barriers [125] 
and to influence hope and positive beliefs [102] combined with a progressive 
loading programme may serve to reduce fear, anxiety and catastrophisation 
and consequently enhance performance by reducing pain and disability. Such 
strategies are required to be tested through further research, but this type of 
approach has been utilised successfully in other persistent pain conditions 
[125] where changes in tissue state also do not appear to correlate with 
reductions in pain and disability [19,126].  
 
Underpinning the amenability of mediation to psychosocial variables to 
optimise outcome is the concept of ‘working alliance’. Working alliance, also 
known as ‘therapeutic alliance’ or ‘patient-therapist relationship’, can be 
defined as “the working rapport or positive social connection between the 
patient and the therapist” [127]. Decades of research have consistently linked 
the quality of the alliance between therapist and patient with outcome 
[105,128,129]. The magnitude of this relation appears to be independent of the 
type of therapy and whether the outcome is assessed from the perspective of 
the therapist, client, or observer [128]. Working alliance is positively associated 
with adherence behaviours and rehabilitation outcomes [130–132] and as such 
may help explain why clinicians or researchers achieve different outcomes 
when the prescription of exercises remains the same or similar. Whilst working 
alliance has been shown to positively correlate with treatment adherence, 
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outcomes and satisfaction [130–132], a person’s level of self-efficacy has the 
ability to undermine motivation and enhance dissatisfaction, negatively 
affecting adherence [133,134] and has been shown to be a significant predictor 
of outcome [22]. Self-efficacy may relate to efficacy expectations or outcome 
expectations [135]. Efficacy expectations are beliefs about one’s ability to 
perform the task, and are seen as determinants of whether one attempts the 
task, how persistent one is and ultimately how successful one is [136]. 
Outcome expectation relates to a person’s estimate that a given behaviour will 
lead to certain outcomes [135]. It seems sensible to suggest that if exercise for 
AT is going to be effective then adherence to that exercise programme is 
necessary. Indeed, adherence to therapeutic exercise programmes are 
associated with outcome in other persistent musculoskeletal conditions 
[137,138]. Adherence to exercise programmes has generally received little 
reporting in published studies specifically focusing on tendinopathy [139]. 
Studies which have published adherence rates report wide ranging values; 
27%-92% good adherence (defined as >50% of the exercises performed) 
[38,140–142]. Given the association of adherence to exercise with outcome, 
and, as working alliance and self-efficacy are considered to underpin 
adherence behaviours (figure 2.4), further consideration to these factors in 
tendinopathy appears justified. 
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Figure 2.4 Cognitive and contextual factors which may negatively influence 
clinical outcome 
 
 
2.7.1 Working Alliance   
Working alliance (WA), involves technical skill and the reflective capacity of the 
therapist to respond to the patient, but extends beyond good communication to 
a sense of collaboration, warmth and support [143,144]. The influences on WA 
include a mix of interpersonal skills, practical skills and individualised patient 
centred care [145] and is fundamental to therapeutic process [104].  
 
2.7.2 Developing an Effective Working Alliance 
Ensuring an effective alliance between the clinician and the person with 
tendinopathy would seem central to implementing a successful rehabilitation 
programme for reasons including building trust and adherence. Focusing on a 
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patient-centred interaction style, related to the provision of emotional support 
and allowing patient involvement in the consultation processes have been 
shown to effectively facilitate this [146]. To enable this, a mix of interpersonal, 
clinical, and organisational factors are important [145]. Such interpersonal skills 
may include humour, making time for ordinary conversation, appearing socially 
comparable and giving due attention to the individual [143].  Adopting attitudes 
which appear paternalistic or arrogant, for example giving the impression the 
tendinopathy is the patient’s ‘fault’ because of training errors [106], kinetic chain 
deficits [117,118] or biomechanical variances [116], should be avoided and 
clinicians can demonstrate humility by establishing to the patient that they value 
the importance of both physical and emotional needs [147].  
 
A clinician’s verbal and non-verbal skills have the ability to influence an 
effective WA [121]. Non-verbal skills include the clinician’s own non-verbal 
expressions and the ability to read the patient’s non-verbal body language 
[148]. Affirmative head nodding, forward leaning and suitable body positioning 
are recommended [148,149]. Verbal skills include the use of positive messages 
[150,151]; reassurance around perceived damage may be useful ‘your tendon 
might not look good on imaging, but your outlook is still good’ [19]. Additionally, 
clinicians should avoid interrupting and allow the person with tendinopathy to 
tell their unique story [145]. At this stage, effective active listening skills, 
including paraphrasing, language reciprocity and inviting the patient’s opinion 
are necessary as these can significantly impact on outcomes 
[145,148,152,153]. 
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Further to the establishment of an emotional bond, characterised by liking and 
trust between the clinician and therapist, Bordin [154] set out two additional 
constructs; 1) congruence in relation to the goals and purpose of therapy (goal 
setting) and 2) collaboration on explicit tasks to meet those goals (goal 
attainment). 
 
2.7.3 Goal Setting and Goal Attainment 
For long-term conditions, the use of an individualised programme which is 
based on goal setting, self-monitoring and group support to facilitate 
engagement and effective self-management has demonstrated efficacy in long 
term outcomes [155]. At the initial appointment goals should be set 
collaboratively to enhance a commitment to engage in the tasks required to 
achieve the goals and to facilitate trust and empathy [156,157]. Since change 
in tendon pathology does not appear to be linked with outcome [19] and pain 
intensity does not accurately reflect the state of the tendon tissue [122] 
functional goals may be most appropriate to set. Activities which induce pain 
do not have to be avoided, but acceptable pain responses need to be set, 
including intensity [158] and response over time [106]. Once a meaningful goal 
has been set, preference should be given to exercises that can be easily 
progressed to unilateral work [106]. For example, a meaningful goal for a 
person with patella tendinopathy may be set around jumping ability. Through 
appropriate questioning the clinician should seek to understand the patient’s 
self-rated ability to perform the task in question and then collaboratively set 
attainable goals reflecting set amounts or variations. In this example, should 
the patient rate their ability to perform a task with the stretch-shortening cycle 
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of the tendon requiring fast energy storage and release unacceptable, breaking 
the task down into smaller goals which reduce tendon loading through isotonic 
work (such as leg press, seated knee extension or split squat) might be 
appropriate. Functional ability can then be monitored by the patient and 
clinician, discussed at follow-up appointments and new goals set accordingly.  
Questions aimed at understanding the patient’s experience with rehabilitation, 
hopes for the future and the expected role of exercise have been highlighted 
[28]. 
 
Implementation interventions which spell out the ‘when’, ‘where’ and ‘how’ of 
the exercise programme have been shown to be effective in enabling goal-
attainment, reducing unwanted influences and decreasing disengagement from 
a planned course of action [159]. An appropriate agreement for a person with 
rotator cuff tendinopathy, for example, might be ‘when I am brushing my teeth 
in the bathroom I will use the wall to complete my resisted shoulder rotation 
exercises’ [32]. Here, due consideration needs to be paid to ‘social’ aspect of 
the biopsychosocial framework [160]. Although tendinopathy is often 
considered a sports-related injury, recent research suggested only 29-35% of 
the cases with lower limb tendinopathy described a relationship with sports 
[24,25]. Potential barriers to goal-attainment linked to social needs may be 
transportation problems, child care needs, and work schedules, lack of time, 
family dependents, financial constraints and convenience [161]. Early 
consideration should be given to potential barriers as current strategies to 
enhance adherence to physiotherapist prescribed self-management such as, 
using an activity monitoring and feedback system, providing written exercise 
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instructions, utilising a behavioural exercise programme with booster sessions 
and goal setting require further research before they can be recommended in 
clinical practice [162]. This further highlights the need to examine potential 
influences on adherence and strategies to improve it for people with 
musculoskeletal conditions such as tendinopathy. One possible influence may 
relate to a person’s level of self-efficacy [133,134]. Self-efficacy refers to a 
person’s efficacy expectations or outcome expectations [135], and as such, are 
discussed in detail below. 
 
2.7.4 Efficacy Expectations 
In this PhD thesis, efficacy expectations are referred to as the patient’s beliefs 
about his or her ability to perform the rehabilitation tasks, and to maintain 
control, engagement and persistence when faced with adversity [136]. As such, 
efficacy expectations are key determinants of whether the rehabilitation tasks 
reach their desired outcome [163]. Due consideration must therefore be given 
to the dosage, levels of pain reproduced and complexity of exercises; what may 
be considered best for tissue, may not be optimal in terms of efficacy 
expectations [164]. For example, simple, resistance exercises, completed one 
at a time may appear sub-optimal from the perspective of exercise physiology, 
yet may still yield positive clinical results [32,41]. Exercise prescription should 
promote self-monitoring, and appropriate interpretation of physiological signs 
is essential [163]. In particular, pain response to a load-based exercise 
intervention should be self-monitored and adapted by the individual 
accordingly. Previous guidelines have included using a visual analogue scale 
of no more than 5/10 [158,165]. However, with sufficient efficacy expectations, 
the use of a scale might not be required; patients can determine what pain 
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response is acceptable themselves over time periods that meet their needs, 
including pain response during exercise, pain response immediately after 
exercise, pain response overnight and pain response over 24 hours and 
beyond [32]. This could be judged upon the perceived impact upon sleep, 
activities of daily living or work, for example. This is important because exercise 
that contributes to an unacceptable pain response that disturbs sleep, for 
example, might add a further negative dimension to rehabilitation which serves 
as a barrier to adherence and engagement. 
 
2.7.5 Outcome Expectations 
Outcome expectations relate to a person’s estimate that a given behaviour will 
lead to certain outcomes [135]. Reduced outcome expectations, along with 
negative expectations, such as a fear, concerns and uncertainty surrounding 
potential future damage to the tendon have been identified in people with 
Achilles tendinopathy [28]. Negative outcome expectations might be usefully 
discussed, challenged and reconceptualised, as they might be an important 
determinant of engagement with a load-based exercise programme. For 
example, concerns around the risk of tendon rupture could be explored with the 
clinician highlighting the disparity between painful tendons preceding a rupture 
[17]. Consequently, differentiating between a person’s ideal expectations (what 
he or she wants to occur) and the predicted outcome (what is likely to occur) 
has potential value for directing educational interventions and more appropriate 
goal-setting [166]. Expectations appear to be embedded in both hopes and 
fears, suggesting further attention be paid to cognitive factors when setting 
management plans [167]. 
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2.8 Enhancing Self-Efficacy 
Self-efficacy depends mostly on the way the person interprets their symptoms, 
and to what degree they believe that they can exercise control of the outcome 
of their injury through a series of behavioural choices over time [168]. People 
with high pre-intervention self-efficacy tend to maintain high self-efficacy levels 
through rehabilitation [169] leading to more ambitious goals and a faster 
recovery from setbacks [135]. Consequently, how the patient perceives the 
problem would appear pivotal. A person may consider their problem as highly 
complex, perhaps as a result of imaging or internet searching [170]. This may 
serve as a discourse between the persons’ perceived complex problem and the 
proposed ‘simple’ exercise of loading. Therefore, addressing inaccurate beliefs 
and expectations is essential [106]. The aim of verbal persuasion is to allow 
patients to move beyond their current perceived pain threshold and towards an 
enhanced capability threshold encompassing a mixture of biological, 
psychological and sociological factors. For example, if the clinician provides a 
positive message around the patient’s imaging results to reflect the lack of 
association between structural findings on a scan and pain, it might shift the 
patient’s unhelpful beliefs. For example, from “I shouldn’t do anything that 
hurts” to understanding pain during exercise might be helpful in some situations 
rather than harmful [33]. The choice of words to facilitate this is critical; negative 
perceptions of tissue health from prior imaging or consultation from prior health 
care providers may exist and affect the way information is perceived [171]. It 
may be useful for the clinician to explain pain in terms of sensitivity, ensuring 
the person in pain understands why hurt does not necessarily equal harm [122] 
and why pain during rehabilitation should be acceptable [158]. Special 
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consideration needs to be taken to ensure that experience of the exercises 
confirms the messages the clinician is conveying and provides the patient with 
an experience which solidifies their new-found beliefs via successful 
experiences. In turn, this will expand the patient’s locus of control by gently 
challenging their perceived ability to perform the task without guidance [168]. 
This concept provides a novel perspective for load-based exercises; providing 
experienced control for the person with tendinopathy. Experiencing this control 
will help ‘set up for success’ and ensure an understanding upon which a 
successful partnership can be developed [32]. Understanding should be re-
visited regularly using simple questions such as: “What do you understand is 
the cause of your pain?” “Why could exercises help?" A summary of suggested 
cognitive and contextual considerations to optimise clinical outcomes in 
tendinopathy is offered in figure 2.5.   
 
 
 
Figure 2.5 Summary of suggested cognitive and contextual considerations to 
optimise clinical outcomes in tendinopathy 
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2.9 Conclusion 
In conclusion, load-based exercise is currently advocated for the management 
of tendinopathy. However, given the wide-ranging responses from loading 
exercises in the research, much uncertainty remains. Contextual and cognitive 
factors may help explain some of the variation. Therefore, a greater 
understanding of these factors might enhance our treatment outcomes for our 
patients with tendinopathy. Working alliance and self-efficacy are both 
associated with adherence behaviours and rehabilitation outcome [130,131], 
yet measures of these factors are largely absent from the tendinopathy 
research to date.  As such, these factors might usefully be considered further. 
Based upon this, the next chapter will consider the most suitable primary 
outcome measure for a study designed to investigate contextual and cognitive 
factors and outcome in AT (chapter five)  
 
 
 
 
 
 
 
 
 
 
 
64 
 
Chapter 3: Measuring Clinical Outcomes in People 
with Achilles Tendinopathy 
Based upon Mallows A, Littlewood C, Malliaras P Measuring patient-reported outcomes 
(PROs/PROMs) in people with Achilles tendinopathy: how useful is the VISA-A? Br J Sports 
Med Published Online First: 22 June 2017. doi: 10.1136/bjsports-2017-097531 (Appendix 5) 
 
Summary 
Whilst no current consensus exists regarding the selection of primary outcome 
measures for research investigating AT, the Victorian Institute of Sport- Achilles 
(VISA-A) questionnaire is, to date, the most common outcome measure used. 
The VISA-A is a self-administered questionnaire serving to evaluate the 
severity of Achilles tendon-related disability in relation to impairment (body 
structure and function), activity (activity limitations) and participation 
(participation restrictions) for anyone with AT. As such, the VISA-A would seem 
to make an obvious selection to include when planning research investigating 
AT. However, during the planning stages of the cohort study detailed in chapter 
five, initial inspection of the VISA-A raised concerns over the questionnaire’s 
face validity. Consequently, this chapter goes on to critically examine the ability 
of the VISA-A to inform decision making; although commonly used, the 
development of the questionnaire raises questions over its usefulness. The 
purpose of this examination was to inform the clinical outcome measure 
selected to meet the aim for the cohort study detailed in chapter five. Chapter 
five reports on a feasibility study exploring an online data collection method for 
a longitudinal cohort study investigating the predictive nature of the selected 
variables identified for people with AT that were identified in chapter two. 
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3.0 Introduction 
It is important for clinicians and researchers to measure outcomes. Outcome 
measures are defined as measurement tools that are used to document change 
in one or more constructs over time [172]. Reporting of such outcomes can 
provide benchmarks that assist with interpretation of scores during clinical 
decision making for individual patient care, assist interpretation of results from 
research and inform healthcare policy [173,174].  Achieving routine outcome 
measurement in practice however is challenging [175]. Such challenges 
include familiarity with the tool, ease of use, time consumed using the measure, 
and the amount of equipment involved. These factors have all been identified 
as barriers to measuring clinician-derived outcome measures in physiotherapy 
practice [172]. 
 
Clinician-derived outcome measures in musculoskeletal conditions are 
measures taken by a clinician and typically focus on imaging for pathology (e.g. 
ultrasound scanning of the painful tendon [19]) or measurements of impairment 
(e.g. muscle strength, joint ROM, functional task) [47]. Whilst it is important to 
select an outcome measure with due consideration given to relevant pathology 
and impairments, as previously discussed, these findings do not consistently 
correlate with pain or disability [19]. As such, relying on information from such 
clinician-derived outcome measures to inform clinical decision making can be 
problematic. For example, chapter one discussed the current treatment 
recommendations for AT which focus on load-based exercises, placing 
emphasis on strengthening the plantarflexors of the ankle [34,176]. This 
recommendation is based in part on the premise that weakness in the ankle 
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plantarflexors has been identified as an impairment in runners with AT [177]. 
However, when re-measuring this impairment at long-term follow up, disparity 
has been reported between the clinician-derived measure (plantarflexion 
strength) and the patient’s reported experience (pain and disability) [82]. In a 
five year follow up of participants with AT, now asymptomatic participants who 
were satisfied with their outcome were still found to have a significant decrease 
in concentric plantarflexion strength (p=0.028) [82]. Examples of such disparity 
exists in numerous other musculoskeletal conditions. For example, Dayton et 
al [178] reported that following total hip replacement, performance-based 
function (timed up and go (TUG), 6 minute walk test (6MW) and stair climbing 
test (SCT)) declined compared to baseline, whereas self-reported function 
improved compared with baseline. The results of the correlational analysis from 
one to six months post-operation indicated there was poor correlation between 
change in the Hip and Osteoarthritis Outcome Score – Activities of Daily Living 
subscale and change in TUG (r=.32, p=0.16), SCT (r=.27, p=0.24), and 6MW 
(r=0.34, p=0.13) performance during this time frame. Likewise, similar findings 
were reported by Stevens-Lapsley et al [179] for patients following total knee 
replacement; most self-report measures assessing knee function improved 
from baseline (figure 3.1), whereas the physical performance measures 
declined from baseline (figure 3.2).  
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Figure 3.1 KOOS subscale from preoperatively to 6 months postoperatively. Higher 
scores reflect better outcomes for all subscales. KOOS = Knee Injury and 
Osteoarthritis Outcome Score; TKA = total knee arthroplasty; ADL = activities of daily 
living function; S&R = sport and recreation function; QoL = quality of life; SEM = 
standard error of the mean. *Significant increase in 1 month postoperative score from 
preoperative score. †Significant increase in 3‐ and 6‐month postoperative scores from 
preoperative scores (P < .05). Data are mean ± SEM [179] 
 
 
Figure 3.2 Performance measures (6MW, SCT, TUG and involved quadriceps 
strength) and KOOS ADL percentage change scores preoperatively to 6 months 
postoperatively. Change scores were calculated by using means for each time point 
([initial‐final/initial] × −100) because some individual KOOS values preoperatively were 
zero. 6MW = 6‐minute walk; SCT = stair climbing test; TUG = timed‐up‐and‐go; KOOS 
= Knee Injury and Osteoarthritis Outcome Score; ADL = activity of daily living; SEM = 
standard error of the mean. *Significant increase from preoperative values. 
†Significant decrease from preoperative values (P < .05). Data are mean ± SEM [179] 
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These discrepancies further highlight a) the uncertainty currently surrounding 
the underlying mechanisms of change in response to intervention and b) the 
need for clinicians and researchers to consider additional measures to fully 
understand a patient’s response to treatment.  
 
Capturing patient-reported outcome measures (PROMs) offer such an addition 
[180]. PROMs are questionnaires, which are self-reported and designed to 
attain a person’s perceptions of specified aspects of their health [180]. 
Conceptually, PROMs are designed to obtain the patient’s experience and 
ideally benefit from a service or intervention and as such can be viewed either 
as a ‘tool for evaluation’ or as a ‘mechanism for improvement’ [174].  For 
example, data acquired from a PROM can help a clinician quickly evaluate 
which of their patients experience improvement or deterioration over time and 
thus suggest refinements to care pathways.  
 
Many different PROMs have been utilised by clinicians and researchers as a 
tool for evaluation for individuals with AT. A recent systematic review identified 
eighteen PROMs that have been employed in clinical research for measuring 
pain and disability in AT (table 3.1) [47]. From these eighteen, the most 
frequently utilised was the VISA-A Questionnaire (n=28).  The VISA-A is not 
only a widely-used PROM for AT but is also available in seven different 
languages. Whilst there is no current consensus regarding the selection of 
primary outcomes for research investigating AT [181], the established 
popularity of the VISA-A would seem to make the questionnaire an obvious 
choice. However, initial inspection of the VISA-A raised concerns over the 
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questionnaire’s face validity. Face validity refers to the degree to which the 
items in the questionnaire indeed look as though they are an adequate 
reflection of the construct to be measured [182]. The VISA-A assumes that the 
person completing the questionnaire is an active individual, undertaking 
tendon-loading sports (figure 3.3; questions 7 and 8, for example). As such, the 
VISA-A lacks face validity for measuring disability in a non-active population 
suffering with AT. Given the concern over the VISA-A’s face validity, a more 
detailed examination of ability of the VISA-A to inform decision making was 
undertaken. The purpose of this examination was to subsequently inform the 
choice of the primary outcome measure for the cohort study detailed in chapter 
five. This critical examination will now be discussed in detail.  
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Outcome Measure Number of times used in clinical trials of 
Achilles tendinopathy 
Visual Analogue Scale (VAS) of Pain at 
rest 
6 [44–46,183–185] 
VAS of Pain with various functional 
tasks 
11 [38,41,189,43,44,158,183,184,186–188] 
100mm VAS of Pain with 1KG Squeeze 
of the Achilles Tendon 
3 [44,190,191] 
4 Point Scale of Pain with 1KG Squeeze 
of the Achilles Tendon 
1 [192] 
Numerical Rating Scale (NRS) of Pain 
at Rest 
2 [193,194] 
NRS of Pain over time 5 [140,193–196] 
5 Point Likert Scale of Difficulty in Sport 1 [142] 
Victorian Institute of Sports Assessment 
– Achilles 
28 [38,42,194–203,45,204–
211,82,140,141,158,184,190,193] 
Modified Curwin and Stanish Six Level 
Pain Scale 
2 [212,213] 
Functional Index of Leg and Lower Limb 1 [183] 
American Orthopaedic Foot and Ankle 
Score Hindfoot Scale 
1 [188] 
Short Form-36 2 [188,208] 
EuroQoL 2 [183,206] 
Foot and Ankle Outcome Score 3 [142,185,192] 
Numerical Scale of Physical Activity 1 [142] 
Numerical Scales of Improvement 8 [82,140,191,192,195,196,198,213] 
Treatment Satisfaction 7 [43,45,141,184,199,214,215] 
Patient Global Impression of Change 1 [140] 
Table 3.1 Outcome measures assessing self-reported pain and function in 
Achilles tendinopathy. Adapted Murphy et al [47] 
 
The ability of the VISA-A to improve decision making is determined by its 
reliability, validity and responsiveness to change, as these are essential 
psychometric properties for any measure (box 3.1) [216,217]. Psychometrics is 
the name commonly used for the principles and methods of developing valid 
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and reliable measures of intelligence, attitudes, skills, and other characteristics 
[218]. This approach is considered appropriate to develop instruments that 
measure a single construct using multiple items (e.g. depression or anxiety or 
severity of AT) [219]. Should the measure be directed at measuring multiple 
constructs with a single index then a clinimetric approach may be considered 
more appropriate [219]. Clinimetrics is the term introduced by Alvan R. 
Feinstein in the early 1980s to indicate a domain concerned with indexes, rating 
scales and other expressions that are used to describe or measure symptoms, 
physical signs and other clinical phenomena [220]. Whilst the terms 
psychometrics and clinimetrics have significant overlap (and which term is used 
may depend on the field of application), any perceived differences are less 
obvious when evaluating measurement instruments and the characteristics can 
be considered as clinimetric or psychometric [219].  
 
 
 
 
 
 
 
 
Box 3.1. Definitions of terms [182] 
 
Evidence for an outcome measure’s reliability and validity falls along a 
continuum from no evaluation to full evaluation for the study population; the 
more evidence that the measure is reliably measuring the specific patient 
reported outcome, the more confidence is assured. Thus, both reliability and 
validity are more accurately described as “continuous” rather than 
Reliability - The degree to which the 
measurement is free from measurement error. 
Validity - The degree to which a PROM 
instrument measures the construct(s) it purports 
to measure. 
Responsiveness - The ability of an outcome 
measure to detect change over time in the 
construct to be measured. 
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“dichotomous” psychometric indices and claiming that an outcome measure is 
completely “reliable” or “valid” is inaccurate [217]. The extent of such evidence 
for the VISA-A will now be evaluated. 
 
3.1 Development of the VISA-A Questionnaire 
The methodological framework for developing and evaluating a PROM 
questionnaire is well-described and includes the following steps: (1) 
identification of a specific patient population, (2) item generation, (3) item 
reduction and (4) determination of the validity, reliability and responsiveness 
[221].  A new international consensus for measurement properties for health-
related PROMs has been reached [216] and formulated in a Consensus-based 
Standards for the selection of health Measurement Instruments (COSMIN) 
checklist [222].  The COSMIN initiative aims to improve the selection of 
outcome measurement instruments by developing methodological guidelines 
based on the consensus reached by the international experts [182]. Here a 
critical review of the evidence that exists for the VISA-A questionnaire is 
presented utilising the above methodological framework as a tool for review 
with due consideration given to the recommendations made in the COSMIN 
checklist [222] as evidenced in the development of a recent PROM; The 
Copenhagen Hip and Groin Outcome Score (HAGOS) [221]. The work to 
develop the HAGOS questionnaire [221] by Thorborg et al will be referred to 
as an exemplar for comparison where appropriate.  
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3.1.1 Identification of a Specific Patient Population   
The function of the VISA-A is to evaluate the severity of Achilles tendon-related 
disability in relation to impairment (body structure and function), activity (activity 
limitations) and participation (participation restrictions) for anyone (active or 
sedentary) with AT. The VISA-A is limited in this respect; during the 
development of the VISA-A, an exclusively active population was utilised (i.e. 
cases referred to a sports medicine clinic or awaiting surgery and controls 
representing active individuals from a university population or running club). 
Given that only 29-35% of the general population with Achilles tendinopathy 
may describe a relationship to sports activity [24,25], the VISA-A lacks 
evidence of development and testing not only in non-sporting populations, but 
also a heterogeneous sporting population. 
 
3.1.2 Item Generation 
Item generation refers to the development of the items (questions or 
statements) which may be considered appropriate to be included in the PROM. 
The item generation process for the VISA-A was developed from a template 
designed to measure the severity of patella tendinopathy, supplemented by 
interviewing colleagues, informally interviewing patients about their symptoms, 
and using a focus group of clinicians and subject experts. One further potential 
limitation of the VISA-A is that during item generation, the extent of patient 
inclusion was limited. Patient inclusion at this stage is vital; patients should be 
considered experts when judging the relevance of the items for their population 
[216]. As such, the relevance and comprehensiveness of the items in the VISA-
A for the target population is questionable. To improve the validity of the VISA-
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A further investigation would be required, with additional consideration given to 
reflect current understanding of the multidimensional nature of the condition 
[223]. To contextualise this against a recent exemplar, Thorborg et al [221] 
interviewed a total of 25 patients identified as representative of the identified 
population. Patients were asked to fill out the preliminary version of the HAGOS 
questionnaire while commenting on issues related to questions they felt were 
missing, the questionnaire readability and its ease of comprehension. Data 
were gathered until data saturation was reached. These steps are missing from 
the development of the VISA-A, and as such, questions remain regarding the 
readability and ease of comprehension as these were unexplored. For 
example, is the unconventional nature of the scoring – ten representing no pain 
easily understood? Given an average adult in the United Kingdom (UK) has a 
literacy level comparable to an eleven year-old students [224], these would 
seem important steps to be missing.   
 
3.1.3 Item Reduction and Content Validity 
Item reduction is intimately related to content validity; the degree to which the 
content of the PROM is an adequate reflection of the construct to be measured 
[180,216]. Item reduction refers to the process of reducing the number of items 
included to ensure the PROM is effective, but also as short as possible, 
reducing bias and response in error due to boredom and or fatigue [225]. 
Although Robinson et al [226] report using a focus group of experts to reduce 
items, it remains unclear which items (if any) were removed and the process 
for determining this. Compared again with the exemplar, Thorborg et al [221] 
used a group of experts to reduce items, with a transparent process for 
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identifying items for consideration of removal and a voting process clearly 
described along with a table presenting items removed. The inadequacies in 
the processes of item generation and reduction described above for the VISA-
A raises concerns over its content validity.  
 
3.1.4 Construct Validity 
Construct validity is the degree to which the scores of a PROM are consistent 
with predetermined hypotheses. Construct validity is tested based on the 
assumption that the PROM validly measures the construct intended to be 
measured (severity of AT for the VISA-A). Construct validity is evaluated by 
establishing the degree to which the scores of the PROM are consistent with 
the predetermined hypotheses [180,216], such as relationships to scores from 
other instruments. For example, as the VISA-A is designed to measure the 
severity of AT, scores from the VISA-A would be expected to have higher 
correlations with the Physical Functioning, Role-Physical and Bodily Pain 
subscales of the  Short-Form 36 (a PROM that contains relevant domains for 
assessing physically active patients with reduced physical function and pain 
[227]) than the subscales relating to Mental Health, Vitality, Role-Emotional, 
Social Functioning and General Health [221]. The more hypotheses which are 
tested on whether the data correspond to predetermined hypotheses, the more 
evidence is gathered for construct validity [222]. Whilst Robinson et al [226] 
tested construct validity against two other measures (convergent validity 
testing) and controls (divergent validity testing), the formulation and testing of 
such hypotheses are missing from the VISA-A development, and the potential 
for the VISA-A to be measuring more than one construct has been identified 
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[228]. For instance, the physical activity section of the VISA-A weighs heavily 
in the overall scoring (40 of the 100 points). As such, if a person with AT is 
functioning at a high level despite pain, the construct of the VISA-A may 
indicate, incorrectly, that they are less affected by the condition.  
 
3.1.5 Reliability 
Whilst validity refers to the degree to which a PROM instrument measures the 
construct(s) it purports to measure, reliability refers to the degree to which the 
measurement is free from measurement error [182]. In addition to validity, 
reliability was also tested by Robinson et al [226], measuring test-retest 
reliability at one week. Test-retest reliability showed no significant difference 
between scores taken one week apart (p=0.58). However, this was tested 
exclusively in a sporting population; Robinson et al [226] suggest that the VISA-
A only be used in homogenous populations, and recognise the limitations of its 
use in non-sporting populations. In response to questions 3-7 (figure 3.3) a 
person may never choose to walk more than 30 minutes, use the stairs, perform 
hops or heel lifts nor be participating in sport; as such, a non-active person’s 
symptoms may resolve, yet they might only score 50/100.  As such, people 
may guess what pain response they might feel when performing these tasks 
rather than actually carry out the tasks, reducing accuracy. Consequently, the 
ability of the VISA-A to measure change in a sedentary person with AT is 
uncertain.  
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Figure 3.3 The VISA-A patient reported outcome measure [226] 
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3.1.6 Interpretability 
Interpretability is the degree to which qualitative meaning can be assigned to a 
PROM’s quantitative scores or change in scores [229]. The weighting of the 
scoring of the VISA-A questions the interpretability of the VISA-A. 
Interpretability includes the distribution of total scores and change scores in the 
study sample and in relevant subgroups. As such, estimates of minimal 
important change (MIC) and/or minimal important difference (MID) are key 
considerations. The MIC is the smallest change in score (within a patient) in 
the construct that can be measured that patients still perceive as important 
[229]. The MID is the smallest difference in the construct that can be measured 
(between patients) that is considered important [229]. Ongoing debate exists in 
the literature regarding the best way of establishing either the MIC or MID and 
indeed the COSMIN group failed to reach a consensus on the matter [216]. 
However, it has been shown that under many circumstances, when patients 
with a chronic disease are asked to identify minimal change, the estimates fall 
very close to half a standard deviation [230]. Whilst no MIC has been 
established for the VISA-A and a wide range of estimates have been used in 
research (12-20 points) [231], according to the report by Robinson et al [226], 
the Norman et al [230] rule of thumb estimates a MIC between 9 and 14 points. 
Finally, a MID for the VISA-A has been cautiously suggested to be 6.5 points 
[232], albeit tested in a group of patients with insertional AT. 
 
Another important consideration for interpretability are ‘floor’ and ‘ceiling’ 
effects. Floor and ceiling effects are present if the PROM fails to demonstrate 
a worse score in the patients demonstrating signs of clinical deterioration and 
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an improved score in patients who show clinical improvement as this can be an 
indication that a scale is not sufficiently comprehensive [221]. The two 
examples highlighted above question the comprehensive of the VISA-A as they 
both suggest the PROM has both floor and ceiling effects respectively. Given 
that patients who have Achilles tendinopathy have never reported a score lower 
than 24 in the reported research and those who have recovered rarely score 
higher than 90 [231], this element of interpretability of the VISA-A is one of the 
tools limitations. 
 
3.1.7 Responsiveness 
In addition to the importance of interpretability, responsiveness is also a crucial 
property to inform clinicians and researchers about change in a patient’s status. 
Responsiveness refers to the validity of a change score in a PROM [216]. As 
with evaluating construct validity, a PROM responsiveness is required to be 
tested against hypotheses [216]. Again, this could include testing hypotheses 
against relationships to scores of other instruments. Thorborg et al [221] 
selected the Global Perceived Effect where the patients rate their condition in 
one of seven categories. This relationship (and hypothesis) is then tested at a 
long enough time to allow time for sufficient clinical improvement [221] and is 
a crucial measurement quality; in its absence the ability of the PROM to detect 
when patients are undergoing significant clinical change is missing [233,234]. 
Unfortunately, there is an absence of longitudinal data to inform 
responsiveness of the VISA-A [226]. 
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3.2 Summary 
In summary, the VISA-A was published in 2001, and has now been widely 
used, offering easy comparison between treatments from various clinics and 
research studies. In the absence of an alternative PROM, clinicians and 
researchers might continue to use the VISA-A despite the limited extent of 
evidence concerning the psychometric properties for this PROM. However, 
since the original publication of the VISA-A both our understanding of the 
multidimensional nature of tendinopathy and PROMs have developed, and as 
such the VISA-A requires updating. This critical review has highlighted the need 
for future research into the construct and content validity and responsiveness 
(including interpretability) of the VISA-A. To ensure methodological rigor, this 
should follow the Consensus-based Standards for selection of health 
Measurement Instruments (COSMIN) recommendations for terminology and 
research agenda [216].  
 
3.3 Implications for Future Research 
Whilst no outcome measure can be considered 100% valid, reliable and 
responsive, this chapter has highlighted the extent of evidence which is missing 
for the VISA-A. Given no current consensus exists regarding the selection of 
primary outcome measures for research investigating AT, this work has been 
used to inform the selection of the primary outcome measure for a future 
research study described in chapter five. The future study utilised an online 
platform for data collection which necessitated participants to complete the 
outcome measure without any support from a clinician to clarify a question’s 
meaning. Accurate and reliable data could only be obtained if participants were 
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able to read and understand the questions asked. With an average adult in the 
UK literacy level comparable to eleven year-old students [224], the chosen 
primary outcome measure needed to not only be considered of sufficient 
reliability, validity and responsiveness, but also of sufficient comprehension 
and readability for the average UK population. Notably the VISA-A has an 
absence of evidence regarding readability and comprehension testing and 
coupled with concerns over the validity and responsiveness testing of the VISA-
A, an alternative outcome measure was sought. Although table 3.1 provides 
possible alternatives, only the Foot and Ankle Outcome Score (FAOS) [235] 
was considered in a review of readability  of commonly used PROMs [224]. The 
FAOS is a 42-item questionnaire and the review concluded that it had a 
readability age of between 13-15 years old. Given this finding and the 
potentially burdensome length of the FAOS, a further alternative and more 
succinct PROM was considered. The Lower Extremity Functional Scale (LEFS) 
is a self-report questionnaire designed to measure physical function of people 
with lower extremity dysfunctions, such as AT [232,236–239]. The LEFS is a 
twenty-item questionnaire developed by Binkley et al [240] in 1999 who suggest 
it takes two minutes to complete. Items were generated by reviewing existing 
questionnaires and then surveying thirty-five patients with a variety of lower 
extremity orthopaedic conditions and experienced clinicians [240]. Similar to 
the development of the VISA-A, it is unclear how items were reduced. As with 
the VISA-A, construct validity was tested against the Short-From 36 physical 
function subscale. However, in contrast to the VISA-A, construct validity was 
tested against pre-determined hypotheses. Construct validity was reported as 
(correlations between the LEFS and the Short-Form 36 physical function 
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subscale and physical component score [227]) were r=.80 (95% lower limit 
CI=.73) and r=.64 (95% lower limit CI= .54), respectively [240]. In addition to 
validity, and similarly to Robinson et al [226], Binkley et al [240] describe  
excellent reliability (r=.94 [95% lower limit confidence interval (CI)=.89]) when 
the LEFS questionnaire was repeated 24-48 hours later. Whilst acknowledging 
the limitations above and, as the LEFS was developed in 1999 it was also not 
developed to the methodological rigor of the COSMIN recommendations [216],  
importantly for the online platform of data collection utilised and detailed in 
chapter five, the LEFS has been reported to have a readability age of around 
11-12 years old, meeting the average UK literacy level [241]. As such, whilst, 
in a similar vain to the VISA-A, the LEFS still possesses developmental 
concerns, it was considered more suitable for the research study detailed in 
chapter five.  
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Chapter 4: Research Methodology 
Summary 
This chapter introduces the methodological approach for the primary research 
undertaken for this thesis. Initially, the choice of approach is discussed within 
a relevant paradigm, before justification is offered for the research methods 
chosen for the MAP study presented in the subsequent chapter. 
 
4.0 Introduction and Overview  
The Managing Achilles Pain study (MAP study) was a multi-methods study 
designed to evaluate the feasibility of the protocol for a future large longitudinal 
cohort study. The aim of the future study is to investigate the association and 
predictive relationship of working alliance, outcome expectations, adherence 
and self-efficacy with outcome in the management of Achilles Tendinopathy 
(AT). Two main phases were conducted over time in a sequential nature. In the 
first phase, quantitative methods were employed to determine the recruitment 
& retention rate and to carry out preliminary data analysis of the selected 
variables and clinical outcomes. In the second phase of the study, the 
acceptability of the study procedures was explored from the participants’ 
perspectives.  
 
4.1 Research Paradigm 
This thesis is presented from a post-positivist paradigm. Ontology refers to the 
nature of reality and what there is to know about the world [242]. A post-
positivist paradigm retains the realist ontology of positivism but emphasises 
that reality is interpreted from different perspectives [243]. As such, this 
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approach falls broadly within the school of thought generally known as ‘critical 
realism’ [244]. Ontologically, this means we see reality as something that exists 
independently of those who observe it, but it is only accessible through the 
individuals perceptions and interpretations [242]. Adopting this more holistic 
approach is reflective of how we currently conceptualise health with the 
biopsychosocial model [245]. In relation to AT, this may be seen in 
management of the condition; a person may respond positively to a load-based 
exercise programme, yet the reasons for the positive response may be 
interpreted from multiple perspectives [246]. There is clearly an individual 
aspect which must be considered, which is recognised in the world view of a 
critical realist, where a constructivist epistemological stance is valued. 
Epistemology is concerned with the ways of knowing and learning about the 
world and focuses on issues such as how we can learn about reality and what 
forms the basis of our knowledge [242]. Constructionism emphasises that 
knowledge is actively constructed by human beings, rather than being 
passively received by them. This school of thought focuses on understanding 
the lived experience from the points of view of those who hold it. Consequently, 
researchers should also construct meanings and interpretations based on 
those of participants [242]. From a critical realist perspective, the aim of 
research is therefore to capture the multifaceted and diverse nature of reality 
in all its complexity and depth [242]. To meet these needs, it is clear that 
adopting a solely quantitative or qualitative approach would not fulfil this aim 
and the need for both approaches is warranted. This approach of combining 
approaches is discussed next. 
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4.2 The Design of ‘The Map Study’ 
Whether it is viewed as pragmatism or seen as coherent with a critical realist 
framework, it is argued that it is most important to choose appropriate methods 
to address the specific research questions than to align with a specific 
epistemological stance [242]. Such a view allows qualitative and quantitative 
strategies to be regarded as complementary; viewing the same research 
problem through different lenses [247]. Still, this view is not shared by all 
researchers; combining quantitative and qualitative approaches over recent 
decades has developed a ‘paradigm wars’; it has been argued that these two 
methods are incommensurate in that an objective view of reality need not 
necessarily correspond with that of a subjective experience [248]. However, the 
growing trend of combining approaches suggests this view is diminishing within 
the context of health services research and mixing strategies has become to 
be seen as a ‘good thing’ to enhance our understanding of research problems 
beyond what could be achieved by using either one approach alone [249]. In 
the context of the current literature, this enhanced understanding seems 
important. For example, when randomised controlled trials of interventions for 
AT demonstrate that an intervention is not effective [38], the reasons for this 
typically remain unknown because strategies to investigate this, for example 
qualitative interviews of patient experience, are not undertaken.  
 
Qualitative research may precede quantitative enquiry, accompany it, or may 
be used in some form as a follow up study [242]. Decisions around sequencing 
will largely depend on the role and status of each method respectively [242]. 
Mixed method design refers to the incorporation of various qualitative or 
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quantitative strategies within a single project that may have either qualitative or 
a quantitative theoretical drive, whilst multi-method design is the conduct of two 
or more research methods, each conducted rigorously and complete in itself, 
in one project and the results are then triangulated to form a comprehensive 
whole [250]. Given the feasibility nature of the MAP study, and the aims aligned 
with the nature of such a study, using both quantitative and qualitative 
approaches did not simply provide the opportunity to add depth to data 
collected. Instead, aligned with a multi-method approach, quantitative and 
qualitative methods were utilised to answer different questions about the same 
topic; the feasibility of the MAP study [251]. As such, separate objectives were 
provided for the quantitative study and the qualitative study, whilst the overall 
aim still aligned to evaluate the feasibility of the methods utilised in the study. 
Chapter seven triangulates the quantitative and qualitative approaches to form 
a comprehensive overall understanding. As the nature of the qualitative study 
was reliant on the participants having already completed the quantitative study, 
it was logical to sequence the quantitative prior to the qualitative study (figure 
4.1). 
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Figure 4.1 The sequential nature of a multi-methods approach for evaluating 
feasibility of the MAP study 
 
The following chapter will now report upon the methods selected and the 
development of the protocol for the MAP study. 
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Chapter 5: The MAP Study 
Summary 
This chapter reports the findings from a feasibility study for a multi-centred 
longitudinal cohort study. This study involved the development of a bespoke 
online platform for hosting participant information, data collection and data 
storage. As part of this feasibility study, twenty-four participants with Achilles 
tendinopathy (AT) were recruited over an eleven-month period. Data regarding 
disability from AT, pain, working alliance, outcome expectation, adherence and 
self-efficacy were collected at baseline, six weeks and twelve weeks via the 
online platform.  
 
5.0 Introduction 
Based upon the rationale described in chapter two, the consideration given to 
effectively measuring outcome in AT in chapter three and the methodological 
development described in chapter four of this thesis, this thesis chapter 
describes a study conducted to evaluate the feasibility of a large longitudinal 
cohort study utilising an online platform to investigate the association and 
predictive relationship of working alliance, outcome expectations, adherence 
and self-efficacy with outcome in the management of AT. 
 
Research investigating clinical associations has traditionally been conducted 
through the administration of ‘paper-and-pencil’ based PROMs [252]. However, 
these measures can be burdensome for participants resulting in low completion 
rates [253,254] and lead to the fear of increased workload for the administrator 
[255]. In recent years, electronic data collection has been shown to be an 
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effective alternative [254]. The advantages of using electronic data collection 
for the administration of PROMs, rather than paper-and-pencil administration, 
have been well documented [253]; these include reduction in administrative 
burden, automatic implementation of skip patterns and scoring, avoidance of 
secondary data entry errors, time and date stamped data, and fewer items of 
missing data. In addition, the results from a systematic review and meta-
analysis investigating the equivalence of electronic and paper administration of 
PROMs indicated that electronic and paper PROMs across different modes of 
electronic administration (interactive voice response system, tablet, hand-held 
device or personal computer) produce equivalent scores across a wide range 
of scenarios [256]. This suggests that electronic data administration can 
generally be assumed to be equivalent to paper-and-pencil administration. 
Consequently, to facilitate electronic data collection an online platform was 
constructed which served to host participant information, the selected PROMs 
and to store the data. Further detail is provided in the methods section below. 
 
Whilst an online platform to facilitate electronic data administration would 
appear an appropriate method to employ in a research study, as data collection 
in such a manner was untested for a tendinopathy population, it was uncertain 
whether it could be done. Distinct from pilot studies, a feasibility study focuses 
on conducting research to examine whether the study can be done, whereas 
pilot studies are “smaller versions of the main study used to test whether the 
components of the main study can all work together” [257]. Given the 
magnitude and aim of the future large longitudinal cohort study, it was 
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appropriate to determine if a study designed to utilise an online platform was 
feasible.  
 
5.1 Study Aim and Objectives 
The primary aim of this study was to assess the feasibility of conducting a future 
large longitudinal cohort study utilising an online data collection method to 
investigate the association and predictive relationship of working alliance, 
outcome expectations, adherence and self-efficacy with outcome in the 
management of AT. The objectives were to: 
 
1. To determine the recruitment & retention rate  
2. To carry out preliminary data analysis of the selected variables and 
clinical outcomes 
3. Undertake qualitative interviews to explore the acceptability of the study 
procedures from the patient participants’ perspectives 
4. Undertake qualitative interviews to explore the acceptability of the study 
procedures from the physiotherapists’ perspectives 
 
The study was reported according STROBE guidelines for reporting of 
observational studies (appendix 6) [258].  
 
5.1.1 Ethical Approval 
Ethical approval was sought and granted on 14th September 2017 by London - 
Camden & Kings Cross Research Ethics Committee; REC reference 
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17/LO/1583 and by the Health Research Authority on 15th September 2017; 
IRAS project ID: 219457 (appendix 7). 
 
5.2 Methods / Design 
5.2.1 Study Design 
A multi-centred, longitudinal feasibility cohort study was conducted to meet 
objectives one and two and is reported in this chapter. A process evaluation 
was undertaken to meet objectives three and four and is reported in chapter 
six. 
 
5.2.2 Study Setting 
Potential participants were recruited from physiotherapy services at a large 
NHS Foundation Trust site, two NHS musculoskeletal provider services and 
three private practices within East Anglia from October 2017 to September 
2018.  
 
5.2.3 Eligibility Criteria 
Participants were required to be a minimum of 18 years old, have access to the 
internet, an available email address, proficient with written and spoken English, 
and identified as having AT as determined by the attending physiotherapist 
according to established criteria [32,223]: 
 Local Achilles tendon pain reproduced with load-based activity, 
for example heel raising, for at least ten days duration  
 Tenderness on palpation of the Achilles tendon 
 Range of movement at the ankle within normal limits   
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To minimise confounding variables for recovery participants presenting post-
operatively, or with lumbar spine related disorders which may refer directly to 
the Achilles tendon region were excluded [32,223]. The exclusion criteria were: 
 Tendon rupture  
 Receiving treatment for post-surgical recovery 
 Reproduction of pain in the Achilles region on movements of the spine 
 
5.2.4 Care Pathways and Physiotherapy 
The care pathway for patients recruited into this cohort study did not change 
as a result of study participation; physiotherapy treatment, referral pathways 
and waiting times were unaffected. As discussed in chapter one, treatments 
provided by physiotherapists may be individualised, but generally include 
advice and exercise. Furthermore, treatment may have also included 
supplementary techniques such as manual therapy, electrotherapy or shock 
wave therapy. Possible biomechanical contributing factors may be assessed 
and additional treatments such as exercise targeted at proximal structures or 
orthotics be recommended [259].  
 
5.3 Variables 
Chapter two identified how cognitive and contextual factors may be associated 
with clinical outcome in AT. The potential factors investigated by this study were 
reflective of these: 
 Working Alliance 
 Outcome expectation 
 Adherence 
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 Self-efficacy 
  
Outcome measures used to evaluate these factors were selected based on 
their psychometric properties in similar populations, but also to minimise 
respondent burden. The chosen outcome measures are discussed below. 
 
5.3.1 Working Alliance Inventory Short-Form  
The Working Alliance Inventory- Short Form (WAI-SF) has high reliability, with 
test-retest reliability (r=0.93) [260]. With regard to construct validity, the WAI-
SF correlates well with other therapeutic alliance measures; r = 0.80 with the 
California Psychotherapy Alliance Scale and r = 0.74 with the Helping Alliance 
Questionnaire [261]. It is the most frequently used tool to measure alliance 
within a physical rehabilitation setting [105]. The WAI-SF is a refined 12-item 
measure that assesses three key aspects of the therapeutic alliance: (a) 
agreement on the tasks of therapy, (b) agreement on the goals of therapy and 
(c) development of an affective bond [262]. The WAI-SF requires the participant 
to rate their agreement on a numerical rating scale from 1-7 in twelve domains. 
The total score ranges from 12-84, where a higher score represents a stronger 
therapeutic alliance. 
 
5.3.2 Global Rating of Change for Outcome Expectation  
Global Rating of Change (GRC) scales are utilised to measure a person’s 
response to change with respect to a particular condition over a given time 
[263]. GRC scales have been shown to demonstrate high test-retest reliability 
(intraclass correlation coefficient 0.9) [264]. Construct validity is supported by 
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significant correlations between GRC scales and various construct specific 
measures; disability (Roland Morris Disability Questionnaire r=0.50, Shoulder 
Disability Questionnaire r=0.74) [265,266] and pain (Numerical Rating Scale 
r=0.49) [267]. A numerical rating scale from -5 (very much worse) to +5 (very 
much better) is considered optimal with a change of two or more points 
considered meaningful [263]. As the literature does not support a standardised 
measure of expectation, a single question with clear instructions was provided 
in order to differentiate predicted expectations (what the patient thinks will 
happen, including negative expectations) from ideal expectations (what the 
patient wants to happen) [166]. Consequently, participants were asked to 
‘please indicate what you think will occur, NOT what you want to occur; at the 
end of your treatment, what do you expect the pain associated with your 
Achilles tendon to be?’ [166].  
 
5.3.3 Patient Self-Report Scales of Their Home-Based Rehabilitation 
Adherence  
Currently there is a paucity of reported, validated and reliable self-report 
measures for unsupervised, exercise-based rehabilitation adherence [268]. 
Diary data is unlikely to be highly accurate for a given individual [269] and in 
absence of objectives measures to retrospectively measure adherence, self- 
report scales represent the simplest way of assessing adherence to the home-
based programme [270]. The main limitation of retrospective self-reports is the 
possibility of inaccurate recall, and a bias toward an overestimation of doing 
the home-based activities [271]. While limited, such measures are convenient 
and simple to use. In response to the question, ‘if you have been requested by 
your physiotherapist to do exercises at home, please select the word that 
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overall best indicates the extent you have followed the instruction’, participants 
responded using a 5-item numerical scale from 0 (not at all) to 5 (as advised) 
[272,273].  
 
5.3.4 Pain Self-Efficacy Questionnaire 
Levels of self-efficacy appear to be an important determinant of adherence 
[161], and so this was captured via the Pain Self-Efficacy Questionnaire 
(PSEQ) [274]. The PSEQ is the the most extensively studied tool to measure 
pain self-efficacy [275]. The PSEQ has been shown to have a high degree of 
reliability in a mixed population with persistent pain conditions; test-retest 
(r=0.73 (p<0.001)) from initial assessment to three months later [274]. The 
PSEQ construct validity is reflected in high correlations (in the expected 
directions) with measures of pain-related disability and different coping 
strategies; Pain Belief Questionnaire (r-0.74 p<0.001), Beck Depression 
Inventory (r=-0.59 p<0.001), Coping Strategies Questionnaire subscales 
catastrophisation (r=-0.55 p<0.001), coping statements (r=0.48 p<0.001), 
ignore (r=0.46 p<0.001), increase behaviour (r=0.45 p<0.001) and control pain 
(r=0.56 p<0.001) [274]. The PSEQ requires the participant to state their 
confidence, despite pain, on a numerical rating scale of 0-6 in ten domains; the 
total score ranges from 0-60, where a higher score represents stronger self-
efficacy beliefs [276]. 
 
5.3.5 Clinical Outcome Measures 
As discussed and detailed in chapter three, the primary clinical outcome 
measure was the Lower Extremity Functional Score (LEFS) [240]. The LEFS 
is a self-report questionnaire designed to measure physical function of people 
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with lower extremity dysfunctions, such as AT. Twenty items covering a range 
of lower extremity functional activities are scored on a numerical rating scale 
from zero (extreme difficulty or unable to perform activity) to four (no difficulty). 
This provides maximum scale points of eighty, with zero representing maximum 
dysfunction. To detect both a minimal detectable change and a minimal 
clinically important difference a change of nine scale points is needed [240]. 
One item required the distance to be converted from an American distance of 
‘a block’ to the equivalent in the United Kingdom of 150 metres; participants 
were asked to rate their difficulty in walking 150 metres. 
 
A secondary clinical outcome measure was the Numerical Pain Rating Scale 
(NPRS) [277]. The NPRS for pain is a unidimensional measure of pain intensity 
in adults [278,279]  The NPRS is an 11-point scale designed to measure self-
reported pain intensity on a scale ranging between 0 (no pain at all) and 10 (the 
worst pain ever possible) [280]. High test–retest reliability has been observed 
in both literate and illiterate patients (r = 0.96 and 0.95, respectively) [281]. In 
addition, construct validity has been shown against the Visual Analogue Scale 
with high correlations in a population with mixed pain-related diseases [282]. A 
change on the NPRS of 20% between two time-points of an assessment is 
regarded as clinically significant [277,283]. 
 
5.4 Sample Size 
Feasibility studies typically do not evaluate the clinical outcome of interest 
because they do not undertake hypothesis testing; the sample size is estimated 
to enable evaluation of the key feasibility criteria [284]. To meet the study’s 
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objective of evaluating the recruitment rate and retention, a ‘recruit to time’ 
approach was employed where the recruitment period of eleven months 
duration was pre-specified for this purpose and to align with the timelines of 
this PhD. It is recognised that an a priori sample size can be presented but 
given that the main feasibility criteria were around recruitment, such an 
approach was deemed useful and appropriate for this study.  
  
5.4.1 Participant Selection, Recruitment and Informed Self-Consent 
Potential participants were identified at each site by their treating 
physiotherapist. To minimise burden on the physiotherapist, the 
physiotherapist explained the purpose of the study, the methods involved, and 
then provided a card detailing a website which hosted further information 
(appendix 8). Training in the study processes was provided to the 
physiotherapists in line with Good Clinical Practice (GCP) recommendations 
[285]. Key features of the training included providing background information 
to the MAP study, objectives of the study, eligibility criteria, the design of the 
study and approaching recruitment through a stepped approach (appendix 9). 
The stepped approach encourages clinicians to view recruitment in a six-
stepped process; 1) explain the condition, 2) reassure they will be receiving the 
best treatment, 3) explain there is uncertainty what makes it the best, 4) explain 
the purpose of the study, 5) balance the risks and rewards, 6) explain the 
procedures [286]. 
 
Once identified and provided with a card, potential participants were then able 
to consider whether they would like to participate or not. If potential participants 
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decided not to participate in the study while still in the clinic there was the option 
to provide a reason as to why on the reverse of the card and leave this 
anonymously in a marked box in the reception area. 
On the card, the potential participant was directed to a website, which was 
designed as a part of the bespoke online platform for the purposes of this study. 
The website hosted a landing page and blog post (picture 5.1) containing 
password protected information (the participant information sheet (appendix 
10), consent form (appendix 11) and the outcome measures in the form of an 
online questionnaire). The participant could freely read the participant 
information sheet and consent details without time constraint, and decide to 
participate or not. Participants were free to leave the website without having 
completed the consent form. This information clearly stated that involvement 
was voluntary, participants were free to withdraw at any time and information 
would not be shared with their physiotherapist. It also included contact details 
to provide the opportunity for questions. If the participant consented to take 
part, they were then able to access the online questionnaire.  
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Picture 5.1. The landing page and blog post for the MAP study’s website 
 
5.4.2 Collection of Clinical Outcome Measures and Variables  
Clinical outcome measures (LEFS and NPRS) were collected together with the 
other outcome variables (GRC, PSEQ, WAI-SF and patient self-report scale) 
via the password-protected landing page. Responses from electronic versions 
of the measures in the form of a questionnaire were collected at baseline, and 
then again at six and twelve weeks following completion of the first 
questionnaire. The participant did not have access to the responses they 
provided previously. To maximise response rates, non-responders to follow up 
were sent two email reminders (appendix 12) to encourage them to re-visit the 
website and complete the questionnaire. 
 
5.4.3 Adverse Events 
It was not expected that any adverse events would occur as a result of this 
study. Given its observational nature, any adverse events related to treatment 
were directed to the treating physiotherapist. However, participants were 
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provided the opportunity to contact the author, a supervisor of the study or an 
expert external to the study should they have wished.  
 
5.4.4 Data Management 
Data were collected through a protected online questionnaire provided by 
Qualtrics [287]. Qualtrics host a password-protected website to which only the 
author had the password to for accessing data once participants had completed 
the questionnaire. Although email addresses from participants were collected 
in the questionnaire, Qualtrics itself only collected Internet Protocol addresses 
(IP addresses) by default and made no attempt to identify anyone from these 
and did not save this information within their data set. All data collected from 
participants completing the questionnaire were stored in a single secure 
European data centre. These data were then exported from Qualtrics to a 
Microsoft Excel database on a password protected file store. Handling of all 
personal data was done in compliance with the Data Protection Act [288]. The 
dataset held for an individual participant was pseudo-anonymised meaning that 
a unique identifier linked a participant’s data to their personal details. Personal 
details were required by the author to send follow up questionnaires at six and 
twelve weeks. 
 
5.4.5 Statistical Analysis 
Feasibility outcomes (recruitment and retention rates) were described using 
descriptive statistics. As hypothesis testing is not recommended for this size 
and type of study [284,289], a preliminary correlational analysis only was 
conducted to assess 1) the overall relationship between the variables of 
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working alliance, outcome expectation, adherence and self-efficacy and the 
clinical outcome measures of pain and function and 2) between baseline and 
the twelve week follow-up time point. The value of the correlation coefficient 
was interpreted as small (.10 to .29); medium (.30 to .49); and large (.50 to 1.0) 
[290]. Statistical analysis was undertaken using SPSS (version 25.0, Armonk, 
NY: IBM Corp).  
 
5.5 Patient and Public Involvement  
Patient and public involvement in the research process is critical, with repeated 
calls having been made to engage and involve the public and patients and 
place them at the centre of healthcare [291]. Patient and public involvement 
(PPI) in research has been defined as “experimenting with” as opposed to 
“experimenting on” patients [292] and serves to ensure that patient benefit is 
not simply based on the views and options of research professionals and 
clinicians. It has been suggested that PPI in research can improve the 
relevance and overall quality of research, by ensuring that it focuses on the 
issues of importance to patients [293]. In the UK, the Department of Health’s 
national strategy puts patients at the centre of all National Health Service-
related activity. This national strategy highlights the importance of involving 
patients, carers and the public at all stages of the research process.  
 
Two physiotherapists and two local physiotherapy service users were identified 
through an established working relationship with one recruitment site and 
invited to be involved in the development of the research design and participant 
facing material. The physiotherapists and service users were emailed a digital 
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version of the postcard and a link to the website and asked to review both. The 
aim of this was to maximise recruitment and retention by determining the 
acceptability of the documents and the design and flow of the website and 
questionnaire. Feedback from the physiotherapists and physiotherapy service 
users was provided through email. PPI involvement was reported according to 
the GRIPP 2 short form checklist for reporting of patient and public involvement 
in research (appendix 13) [293]. 
 
One paragraph of the participant information sheet was revised following 
feedback from one physiotherapist; ‘I think you can make this a bit more 
succinct as it is currently a difficult read’. The other physiotherapist provided a 
positive overview; ‘looks good – no problems envisaged’. The postcard was 
amended in response to one service user’s comment; ‘the web site address 
needs to be closer to the first paragraph, the position, as it is looks like it's the 
title line for not doing the survey’. The other service user provided positive 
feedback on the process from visiting the website to completing the 
questionnaire; ‘to be honest, it was pretty straightforward and no issues 
completing it at all’. Both service users were invited to continue to be involved 
in the development of any future revisions of participant facing material, with 
one agreeing but no further revisions were made.  
 
5.6 Results 
5.6.1 Feasibility Analysis - Recruitment and Retention  
The physiotherapists were issued 1100 cards for recruitment of participants. Of 
these, 795 were returned on the completion of the study. One card was 
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returned with a reason given for a potential participant not wishing to take part; 
‘didn’t want to’ was marked. The traffic through the website recorded a total 55 
views of the blog post containing the information about the study. These 55 
views resulted in 24 participants (11 males) consenting to join the study. Table 
5.3 describes the participants’ details. No adverse events were reported by any 
participants. The questionnaire was started 63 times and completed on 60 
separate occasions resulting in a 95% conversation rate from those participants 
who provided initial consent. Full details are listed in table 5.1. All three 
participants who did not complete the questionnaire did so when asked for their 
email address and as such did not consent to join the study. All questionnaires 
were completed fully without any missing data yielding a missing data indicator 
of 0%. Figure 5.1 shows the participants’ journey through the study. 
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Participant Response 1 Response 2 Response 3 
1    
2    
3    
4    
5    
6    
7    
8    
9    
10    
11    
12    
13    
14    
15    
16    
17    
18    
19    
20    
21    
22    
23    
24    
TOTAL 24 20 16 
Retainment 100% 83.3% 66.6% 
Table 5.1 Number of responses from participants 
 
 
Figure 5.1 Participants flow through the MAP study 
 
Inivitation blog post 
viewed 55 times
- Questionnaire 
started (n=27)
- Non-consenting 
(n=3)
- Completion of 1st 
response
(n=24)
- Completion of 
2nd response 
(n=20)
- Total loss to 
follow up (n=4)
- Completion of 3rd 
response (n=16)
- Total loss to 
follow up (n=8)
Analysed (n=16)
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5.6.2 Correlation Analysis 
Initially the data was tested for normality. The results are presented in table 5.2 
and in figure 5.2 and indicate that the data from the WAI-SF, GRC, NPRS and 
Patient Self-Report Scales of Their Home-Based Rehabilitation Adherence 
were not normally distributed as the value of significance is p<0.05 [294]. 
Accordingly, baseline characteristics for all participants shown in table 5.3 
reports median and range values and offers comparison between those who 
returned full data sets (responders) and those who were lost to follow up (non-
responders). As data were not normally distributed a non-parametric test 
(Mann-Whitney Test) was used to assess for differences between the 
responders and non-responders [294]. Statistically significant differences were 
found between the median values of the WAI-SF (p=0.003), the PSEQ 
(p=0.004) and the LEFS (p=0.011). 
 
To describe the strength of the relationship and direction between the variables 
and the clinical outcomes at baseline and twelve weeks, scatterplots were used 
(figures 5.3 and 5.4). Figures 5.5 and 5.6 describe the overall strength of the 
relationship and direction across all time points between the variables and the 
clinical outcomes. 
 
Shapiro-Wilk 
(n) Statistic 
Level of 
significance 
WAI-SF 24 .904 .026* 
GRC 24 .856 .003* 
PSEQ 24 .947 .238 
NPRS 24 .914 .043* 
LEFS 24 .959 .428 
Patient Self-Report Scales of Their 
Home-Based Rehabilitation 
Adherence 
24 .693 <.001* 
Table 5.2 Shapiro-Wilk test for normality of baseline data 
* Indicates non-normal distribution of data (p<0.05) 
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Figure 5.2 Histogram plots of baseline variables and clinical outcome 
measures 
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Baseline Participants 
included in 
analysis: 
responders 
 
(Median) 
Range 
Participants lost to 
follow up: 
non-responders 
 
 
(Median) 
Range 
Overall 
 
 
 
 
(Median) 
Range 
Age range+ (years) 19% 30-39 
25% 40-49 
31% 50-59 
19% 60-69 
06% 70-79 
38% 30-39 
25% 40-49 
25% 50-59 
12% 60-69 
00% 70-79 
25% 30-39 
25% 40-49 
29% 50-59 
17% 60-69 
04% 70-79 
Sex (% female) 
 
56%  50%  54%  
WAI-SF (78.5)  
47-84 
(60)*  
40-70  
(73)   
40-84  
PSEQ (50.5)  
24.8-60.0  
(35)*  
19-45.8  
(45.8)  
19-60  
GRC (3)  
0-5  
(3.5)  
-3-4 
(3)  
-3-5  
LEFS (57)  
21-75  
(43)*  
38-60  
(53.5)  
21-60 
NPRS (45)  
5-71  
(57.5)  
38-81  
(50)  
5-81  
Patient Self-Report 
Scales of Their Home-
Based Rehabilitation 
Adherence 
(5)  
1-5  
(5)  
3-5  
(5)  
1-5  
Table 5.3 Baseline participant characteristics  
WAI_SF- Working Alliance Inventory – Short Form (score ranges from 12-84, where a higher score 
represents a stronger therapeutic alliance). 
PSEQ - Pain Self-Efficacy Questionnaire (score ranges from 0-60, where a higher score represents 
stronger self-efficacy beliefs). 
GRC - Global rating of change for outcome expectation (scale from -5 (very much worse) to +5 (very 
much better)). 
LEFS - Lower Extremity Functional Score (score ranges from 0-80, with 0 representing maximum 
dysfunction). 
NPRS - Numerical Pain Rating Scale (scale ranging between 0 (no pain at all) and 10 (the worst pain 
ever possible)). 
 Patient Self-Report Scales of Their Home-Based Rehabilitation Adherence (5-item numerical scale from 
0 (not at all) to 5 (as advised)) 
* Statistically significant difference (p<0.05) between responders and non-responders using Mann-
Whitney Test 
+ Age range was captured only 
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Figure 5.3 Scatterplots exploring interrelationship between baseline variables 
and clinical outcome (disability) at 12 weeks 
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Figure 5.4 Scatterplots exploring interrelationship between baseline variables 
and clinical outcome (pain) at 12 weeks 
 
 
 
 
 
 
 
 
 
 
112 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5 Scatterplots exploring the overall interrelationship between 
variables and clinical outcome (disability) across all time points 
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Figure 5.6 Scatterplots exploring the overall interrelationship between 
variables and clinical outcome (pain) across all time points  
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Table 5.4 details the results of the overall correlation between variables and 
clinical outcomes across all time points. The relationship was investigated 
using Spearman’s rho correlation coefficient as preliminary analyses (figure 
5.2, table 5.2) indicated there was a violation of normality in distribution of data. 
Overall, the measures of working alliance (WAI-SF) (rho=-.527, p<0.001), and 
pain self-efficacy (PSEQ) (rho=-.580, p<0.001) have a large negative 
correlation with pain measured by the NPRS. Overall, outcome expectation 
measured by the GRC (rho=-.417, p=0.003) has a medium negative correlation 
with NPRS measurement of pain. In addition, the WAI-SF (rho=.551, 
p=<0.001), PSEQ (rho=.800, p=<0.001) and GRC (rho=.507, p=0.001) overall 
all have a large positive correlation with disability measured by the LEFS. 
 
 
  PSEQ GRC Patient Self-
Report Scales of 
Their Home-
Based 
Rehabilitation 
Adherence 
LEFS NPRS 
WAI-SF .669 .634 0.051 .551** -.527** 
PSEQ - .492 0.092 .800** -.580** 
GRC - - 0.005 .507** -.417** 
Patient Self-
Report Scales 
of Their Home-
Based 
Rehabilitation 
Adherence 
- - - 0.121 -0.051 
LEFS - - - - -.677 
Table 5.4 Spearman’s rho correlations between measures of the variables and 
clinical outcome measures across all time points 
** Correlation is statistically significant (p<0.01) 
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Baseline 
Pain self-
efficacy 
Baseline 
GRC 
Baseline 
Patient Self-
Report Scales 
of Their 
Home-Based 
Rehabilitation 
Adherence 
LEFS at 
12 weeks 
NPRS at 
12 weeks 
Baseline WAI-SF .686 .795 .143 .325 -.157 
Baseline PSEQ - .521 .220 .650* -.401 
Baseline GRC - - .160 .146 .078 
Baseline Patient 
Self-Report Scales 
of Their Home-
Based 
Rehabilitation 
Adherence 
- - - .428 .005 
Table 5.5. Spearman’s rho correlations between measures of the baseline 
variables and clinical outcome measures at 12 weeks 
* Correlation is statistically significant (p<0.05) 
 
    
Table 5.5 details the results of the correlation between baseline variables and 
clinical outcomes at 12 weeks. The relationship was investigated using 
Spearman’s rho correlation coefficient as preliminary analyses performed 
(figure 5.2, table 5.2) indicated there was a violation of normality in distribution 
of data. There was a large, positive correlation between baseline pain self-
efficacy as measured by the PSEQ and disability measured by the LEFS at 12 
weeks (rho=.650, p<0.06). There was a medium, positive correlation between 
baseline working alliance measured by the WAI-SF (rho=.325, p<0.219) and 
adherence measured by the Patient Self-Report Scales of Their Home-Based 
Rehabilitation Adherence (rho=.428, p<0.98) and the LEFS at 12 weeks. There 
was a medium, negative correlation between baseline PSEQ and NPRS at 12 
weeks (rho=-.401, p<0.124).  
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5.7 Discussion 
To the author’s knowledge, this is the first study to utilise a protocol 
incorporating an online platform as a data collection method for a longitudinal 
study involving a population with AT. Accordingly, the objectives of this study 
were: 1) to determine the recruitment & retention rate and 2) to carry out 
preliminary data analysis of the selected variables and clinical outcomes. 
 
5.7.1 Feasibility Outcomes - Recruitment and Retention  
Internet-based questionnaires provide an attractive alternative to postal and 
telephone questionnaires, but they raise important technical and 
methodological issues. The major obstacle here is external validity; specifically 
related to how a representative sample and adequate response rate is 
achieved [295]. Such obstacles were seen in this study. Although 305 cards 
were not returned, it is not possible to determine how many of these cards were 
provided to patients. Recruitment difficulties detailed in a subsequent chapter 
(chapter six) suggests many of these non-returned cards may have been lost 
or simply not returned. Over an eleven-month duration, the traffic through the 
website recorded a total 55 views of the blog post containing the information 
about the study. It is not possible to determine how many of the 31 people who 
viewed the blog post but did not take the survey had been directed to the 
website by an invitation card and how many were simply ‘traffic’. On average 
of 2.2 participants were recruited per month. Of these participants 66% were 
retained and completed all three questionnaires. Whilst the difference in the 
attrition rates between feasibility studies and their associated full trial 
demonstrates high variability [296], strategies to maximise retention are 
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explored in chapter six. Utilising the median scores of the non-responders may 
suggest these strategies are especially targeted to those who report a WAI-SF 
score of <60, PSEQ score of <35 or LEFS score of <43. Only three people 
started but did not complete the initial questionnaire resulting in a 95% 
conversion rate. Internet-based questionnaires allow the option of utilising a 
‘forced response’ to a question; the participant is not allowed to submit the 
questionnaire without completing all the required details. This option would 
appear potentially meaningful in facilitating a missing data indicator of 0%. 
 
5.7.2 Correlation Outcomes 
Overall, there was a large positive correlation between the WAI-SF (rho=.551, 
p=<0.001), PSEQ (rho=.800, p=<0.001) and GRC (rho=.507, p=0.001) and the 
LEFS, and a large negative correlation between the WAI-SF (rho=-.527, 
p<0.001), PSEQ (rho=-.580, p<0.001) and the NPRS. These results suggest 
higher levels of perceived working alliance, outcome expectation and pain self-
efficacy were statistically significantly associated with less disability and pain.  
In addition, there was a large positive correlation between baseline pain self-
efficacy measured by the PSEQ and disability measured by the LEFS at 12 
weeks (rho=.650, p<0.06) and a medium positive correlation between baseline 
working alliance measured by the WAI-SF (rho=.325, p<0.219), adherence 
measured by the Patient Self-Report Scales of Their Home-Based 
Rehabilitation Adherence (rho=.428, p<0.98) and disability measured by the 
LEFS at 12 weeks. Finally, there was a medium, negative correlation between 
baseline PSEQ and pain measured by the NPRS at 12 weeks (rho=-.401, 
p<0.124). These results suggest higher levels of pain self-efficacy are 
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statistically signifacntly associated with reduced disability at 12 weeks. Working 
alliance and adherence at baseline are associated with reduced pain and 
disability at 12 weeks, but not at statiscally significant levels. Whilst the level of 
statistical significance does not indicate how strongly variables are associated 
(this is determined by the rho in these results), it instead indicates how much 
confidence can be placed in the results obtained [294]. In addition, the 
significance of the rho is strongly influenced by the sample size. A small sample 
size, such as n=16, will increase the data variability, lowering the probability of 
replication and as such data may be unusual simply by chance. Whilst, the 
statistical method of imputation could have been utilised to replace the missing 
the data from the ‘non-responders’ with values created by the statistical 
package [297], the resultant increase would still leave a small sample size 
(n=24) and given the preliminary nature of the analysis this was decided 
against. Consequently, these findings should be interpreted cautiously and a 
future study will require a larger sample size. Tabachnick and Fidell [298] 
provide a formula for calculating sample size requirements by taking into 
account the number of independent variables that will be used: N>50 + 8m (m= 
number of independent variables). Utilising the number of independent 
variables investigated in this feasibility study (n=4; working alliance, outcome 
expectation, adherence, self-efficacy), the sample size required for a future 
study which would allow for determining prediction in addition to correlation 
would be 50+(8x4)= n>82.  
 
As the data were not normally distributed, non-parametric testing for correlation 
was performed and it should be noted that non-parametric tests tend to be less 
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sensitive, potentially failing to detect relationships that do actually exist [294]. 
Whilst this appears not to be the case for the results presented here (although 
alternative explanations have been presented and caution urged with their 
interpretation), this requires further consideration for planning of a future fully 
powered study. Because parametric testing requires a minimum level of interval 
data, the Patient Self-Report Scale of Their Home-Based Rehabilitation 
Adherence provides ordinal level of data and therefore would not have met 
assumptions for parametric testing [294]. Furthermore, potential problems of 
assuming that ordinal level ratings (e.g. Likert scales such as NPRS and the 
GRC) approximate interval level scaling are increasingly being recognised. As 
such, further consideration is required to the level of data produced by the 
responses in the questionnaire to ensure matching with the planned statistical 
tests [294]. 
 
5.8 Limitations 
This feasibility study has some limitations. Firstly, the design of the study did 
not allow for all feasibility data to provide complete answers; it remains 
uncertain how many patients were given cards and how many landed on the 
blog page and then decided not to participate. Secondly, all recruitment sites 
were within the UK. The online platform allows for future studies to include 
international collaboration to improve generalisability. Whilst the current study 
would, however, inform the documentation of standard operating procedures in 
terms of recruitment and data collection, potential recruitment and retention 
obstacles from international collaboration remain unknown.  
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5.9 Conclusion 
Feasibility studies ask the question ‘can this be done’? Based on the data from 
recruitment and rates and exploratory correlation analysis a future study can 
be done; this previously untested online platform appears feasible. Future 
consideration is required to ensure the level of data produced from the 
responses to the questionnaire matches with the statistical technique required 
to meet the aim of the study. Additional consideration is needed to enhance 
recruitment strategies and reduce attrition rates; these strategies are 
investigated and discussed in chapter six of this thesis. 
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Chapter 6: The Process Evaluation 
Based upon Mallows A, Littlewood C, Jackson J, Debenham J Managing Achilles Pain (the MAP 
study) – a process evaluation of data collection methods. Musculoskeletal Science and Practice 
2019; doi.org/10.1016/j.msksp.2019.04.008 (Appendix 14) 
 
Summary 
This chapter describes the process evaluation from a sample of patient 
participants (n=7) and physiotherapists (n=6) exploring the acceptability of the 
study from their perspective. Semi-structured interviews were used to obtain 
the data and analysed using the Framework Approach. 
 
6.0 Introduction  
Process evaluations explore the way in which the outcome from a study is 
implemented and can provide valuable insight into why a failure happens or 
unexpected consequences, or why a success occurs and how this can be 
optimised [299]. High quality evaluation is crucial in allowing policy-makers, 
practitioners and researchers to identify outcomes that are effective, and learn 
how to improve those that are not [300]. The online platform used for collection 
methods was untested and as such it was important to identify outcomes from 
using this method and explore these from the perspectives all of those involved 
in the study. Hence, this aspect of the study provides complementary data to 
the findings of the feasibility cohort study and identifies factors that might 
present as obstacles or facilitate successful wider implementation. Whilst this 
process evaluation refers to the feasibility of the MAP study, the data generated 
can provide guidance to researchers developing study protocols for similar 
studies.   
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The Medical Research Council (MRC) process evaluation framework [300] sets 
out guidance which emphasises the relations between implementation, 
mechanisms, and context (box 6.1). For example, figure 6.1 highlights the 
success of data collection could be affected by design of the website and the 
questionnaire (implementation); the motivation of the participants to complete 
repeated questionnaires (mechanism of impact); and the perceived effort to 
take part (context). 
 
 
 
 
  
 
 
 
 
Box 6.1 Definitions of terms [300] 
 
 
 
 
Figure 6.1 Key functions of a process evaluation and relationships amongst 
them [300] 
 Implementation: the structures, resources and processes through 
which delivery is achieved, and the quantity and quality of what is 
delivered 
 Mechanisms of impact: how intervention activities, and 
participants’ interactions with them, trigger change 
 Context: how external factors influence the delivery and 
functioning of interventions 
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Utilising the guidance from the MRC [300], the purpose of the process 
evaluation was to meet predetermined objectives three and four of the MAP 
study; to explore the acceptability of the study procedures from the patient 
participants’ and physiotherapists’ perspectives respectively. The process 
sought to discover what worked (and did not), for whom, how, why and in what 
circumstances. The process evaluation is reported according to the COREQ 
checklist for research using interviews and focus groups (appendix 15). 
 
6.1 Methodological Approach  
As discussed in chapter four, the qualitative component reported here took a 
‘critical realist’ perspective; to evaluate participant perspectives to realise the 
critical importance of participants’ own interpretations of the issues researched, 
believing that the varying vantage points of different participants would yield 
different types of understanding [242]. This perspective was adopted to ensure 
data collection methods and analytical strategies best met the objectives of the 
process evaluation [301–303] and focused on accurately describing 
participants’ experiences, staying close to the data, and ensuring subsequent 
interpretations are transparent [304,305]. 
 
6.2 Methods 
Guidance in the literature exists for conducting a process evaluation. At the 
feasibility and piloting stage, Moore et al [300] recommend basic quantitative 
measures of implementation be combined with in-depth qualitative data to 
provide detailed understandings of outcome functioning on a small scale. To 
achieve this, the same authors [300] propose combining quantitative data on 
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key process variables from all sites or participants with in-depth qualitative data 
from samples purposively selected along dimensions expected to influence the 
functioning of the outcome. 
 
To generate such in-depth qualitative data, semi-structured interviews were 
utilised. Such interviews are a powerful method for generating description and 
interpretation of people’s social worlds; researchers talk to those who have 
knowledge of or lived experience with the problem of interest. Through 
exploration of experiences, motives, and opinions, the researcher may learn to 
view the world from another perspective other than their own [242]. Silverman 
[247] outlines three models of interviewing, each underpinned by a different 
epistemological standpoint; positivism, naturalism and constructionism (table 
6.1). According to positivism, interview data have the potential to give accurate 
and reliable ‘facts’ about what is being explored; a standardised interview 
through a set of questions is used to ‘mine’ for data which participants already 
hold independent of the research. However, this model ignores the desire to 
understand the meaning behind the data generated. To achieve this, more 
open-ended interviews are required to allow the researcher to ‘travel’ with the 
interviewee; therefore, both naturalism and constructionism models require 
analysis. Naturalism is concerned with eliciting authentic accounts of a 
subjective experience. 
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Table 6.1 Differing models of interviewing [247] 
 
Given that the interviewer wants to access the lived experience of the 
interviewee, emotions are central to this model. However, the interview itself is 
not acknowledged as a contextual and interactive component of shaping this 
experience, potentially limiting the validity of the data uncovered. 
Constructionism views the process of the interview itself as a recognised part 
of the representation of that which it seeks to explore; constructionists are 
concerned with how interview participants actively create meaning. However, 
this has led to criticism of  a narrow view; ‘it would seem to deny the value of 
treating interview data as saying anything about any other reality than the 
interview itself’ [247]. Consequently, although a constructionist approach was 
undertaken to interview the two separate stakeholder groups (physiotherapists 
and patient participants), given the critique of the models discussed above, it 
was important to not only interpret the interview data, but also the way it was 
collected. Such considerations are discussed in the strengths and limitations 
section of this chapter. 
 
 
 Status of Data Methods 
Positivism Facts about behaviour 
and attitudes 
Random samples 
Standardised questions 
Tabulations 
Naturalism Authentic experiences Unstructured, open-
ended interviews 
Constructionism Mutually constructed Close study of how 
participants produce 
sense in any research 
data 
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6.2.1 Patient Participant Selection and Recruitment 
To gain maximum variation in terms of age, gender and clinical outcome, as 
determined by change in LEFS and NRS from baseline to twelve weeks follow-
up, all patient participants were invited from the MAP cohort study described in 
chapter five. Patient participants were contacted by email; sent the participant 
information sheet, and consent form (appendices 16-18), then provided the 
opportunity to ask questions and invited to respond. Once any questions were 
answered, the patient participant was invited to participate in an individual 
interview at their convenience. Consent to take part in the interviews was audio 
recorded prior to commencing the interview. To reduce recall bias, selection 
and recruitment were completed within one month of the patient participant 
completing the cohort study. 
 
6.2.2 Physiotherapist Selection and Recruitment 
An invitation by email (appendix 19) along with a participant information sheet 
and consent form (appendices 20 and 21) was sent to the Lead Physiotherapist 
at each site. Lead Physiotherapists were asked to share this email with all 
physiotherapists who have taken part in recruitment for the study. 
Physiotherapists considering volunteering replied to the email and were then 
provided the opportunity to ask questions; once any questions were answered, 
the physiotherapist was invited to participate in an individual interview at their 
convenience. Consent to take part in the interviews was audio recorded prior 
to commencing the interview. 
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6.2.3 Data Collection 
Face to face interviews have traditionally been the preferred mode of conduct 
for this type of data collection. However, recent research has highlighted that 
face to face interviews are not inherently superior over telephone interviews 
[306]. Consequently, to minimise burden on the patient participant, or 
physiotherapist respectively, one-on-one interviews were conducted via 
telephone. There was a pre-existing professional relationship with the 
physiotherapists from the provision of the training, consequently, the 
physiotherapists were aware of the reasons for carrying out the research and 
the author’s interest in the research topic. There was no established 
relationship with the patient participants. Semi-structured interviews were 
directed by a topic guide (appendix 22) and were recorded at the University of 
Essex using a digital voice recorder and transcribed verbatim. Training, 
provided by the University of Essex, in conducting interviews was undertaken 
prior to data collection and practice interviews were carried out to pilot the topic 
guide with feedback provided by one of the PhD supervisors (CL).  
 
6.2.4 Data Analysis  
The data were analysed using the Framework Approach [242]. To facilitate this 
a computer-assisted analysis software (CAQDS) programme was used; QSR 
International's NVivo 12 (NVivo Version 12, QSR International, Melbourne, 
Australia). The Framework Approach has been developed specifically for 
applied research in which the objectives of the investigation are set a priori 
[307]. The Framework Approach is an analytic tool that supports key steps in 
the data management process, including the indexing and sorting tasks 
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common across many different approaches, but adds one further step; data 
summary and display (figure 6.2) [242]. The framework can be used for 
indexing, but its distinctive feature is that it forms the basis of a thematic matrix, 
in which every participant is allocated a row and each column denotes a 
separate theme. Data are then summarised by case and by theme and the 
summary entered in the appropriate cell. The thematic matrix was then 
triangulated with interview notes and sent to all participants to verify source 
interpretation. Whilst some debate amongst qualitative researchers exists 
about the extent to which triangulation is in fact useful in checking the validity 
of data, triangulation during data analysis has been advocated to not only 
provide diverse ways of looking at the same phenomenon but to also add 
creditability by strengthening confidence in whatever conclusions are drawn 
[302]. Different forms of triangulation are advocated based on a 
conceptualisation from Denzin listed below [308].  
 
 Methods triangulation: comparing data generated by different methods 
(e.g. qualitative and quantitative) 
 Triangulation of sources: comparing data from different qualitative 
methods (e.g. observations, interviews, documented accounts) 
 Triangulation through multiple analysis: using different observers, 
interviewers, analysts to compare and check data collection and 
interpretation 
 Theory triangulation: looking at data from different theoretical 
perspectives 
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This process evaluation utilised triangulation of sources through comparison of 
interview notes and interview data and source triangulation by taking the 
research evidence back to the research participants. 
 
 
Figure 6.2. The five stages of data analysis associated with the Framework 
Approach  
 
Given that not all researchers embarking using the Framework Approach go 
through each of the steps detailed above in figure 6.2 (researchers may need 
Familiarisation
• identifying the key themes
Identifying an 
initial thematic 
framework 
• identifying all key issues, concepts and themes by which the data can be 
examined
Indexing and 
sorting 
•application of the thematic framework to all the data
Charting
•organisation and refinement of the data according to the defined 
thematic framework to which they produce coherent groupings
Mapping and 
interpretation 
•before moving on to the more interpretive stage of analysis, this final 
task in data management is writing a precis for each theme and each 
person in the study. These summaries are then entered and displayed –
by theme and by participant – in a framework matrix.
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to adapt the process within the context of any particular study [242]), a detailed 
description of the steps taken in the analytic process is given below. 
 
6.2.4.1 Familiarisation 
Familiarisation of the data began early on with the undertaking of all telephone 
interviews and notes were made of the interviewees’ responses during each 
interview. Once all interviews were transcribed, recurrent topics of interest were 
identified and cross referenced against the notes made and topic guide to 
ensure the list was exhaustive and against the research objectives to confirm 
their relevance. Whilst the preparatory stage of this was completed using pen 
and paper, by the end of this stage the themes that were used to label, sort and 
compare the data were determined and entered into the CAQDAS programme. 
This can be viewed as the initial thematic framework. The initial thematic 
framework from data provided by the physiotherapists can be seen in picture 
6.1 below.   
 
6.2.4.2 Identifying an Initial Thematic Framework  
Themes were sorted and grouped in a hierarchal arrangement of themes and 
subthemes so that an overall structure could be viewed. This served to ensure 
no obvious areas of overlap or omission were evident. 
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Picture 6.1 Initial thematic framework 
 
6.2.4.3 Indexing and Sorting 
In this step the thematic framework was applied to the data in order to locate 
where particular topics were being discussed. Indexing shows which theme or 
subtheme is being referred to within a particular section of the data, in much 
the same way that a subject index in the back of a book works [242]. Each 
sentence was read and then determined to which part or parts of the framework 
it applied. Using the CAQDAS programme this is achieved by highlighting the 
text to be indexed and ‘dragging and dropping’ into the desired section of the 
framework. Once indexing has been completed sorting reassembles the 
‘fractured’ data. Using the CAQDAS programme this was straightforward by 
viewing the data which have grouped together under one theme. An example 
from the theme ‘participants’ motivation’ is provided in the picture 6.2 below. 
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Picture 6.2 Sorting of the theme ‘participants’ motivation’ 
 
6.2.4.4 Charting 
After the data have been indexed and sorted the data extracts were re-read to 
gauge the coherency and establish if any important themes were missing from 
the framework. The final indexed themes are provided in picture 6.3 below. 
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Picture 6.3 Final refinement of indexed themes 
 
6.2.4.5 Mapping and Interpretation 
This final stage of data management served to reduce the data to a more 
manageable level by distilling the essence of the data for representation. Each 
theme has its own matrix in which each subtheme was allocated a column. The 
first column describes the physiotherapist / patient participant number. Each 
physiotherapist / patient participant was then assigned a row so that 
comparisons can be made across physiotherapists / participants. If a subtheme 
did not emerge from the discussion with physiotherapist / patient participant 
then this was recorded as ‘not discussed’. A framework matrix displaying a 
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summary for physiotherapists’ and patient participants’ data are detailed below 
in tables 6.2 and 6.3 respectively.  
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Table 6.2 Framework matrix for physiotherapists’ data 
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Table 6.3 Framework matrix for patient participants’ data 
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6.3 Findings 
Data from seven patient participants and six physiotherapists were analysed. 
Three patient participants declined to be interviewed without stating a reason, 
and no response was received from fourteen patient participants. It is unknown 
how many physiotherapists participated in the MAP cohort study and therefore 
how many did not respond. Interviews lasted up to 30 minutes. Patient 
participant and physiotherapist characteristics are given in tables 6.4 and 6.5 
respectively.  
 
Patient Participant Age range* Gender 
1 30-39 years  Male 
2 60-69 years Female 
3 40-49 years Male 
4 50-59 years Male 
5 40-49 years Female 
6 40-49 years Male 
7 60-69 years Female 
Table 6.4 Patient participants’ characteristics. *Only age range was recorded 
 
Physiothera
pist 
 Years 
Qualified 
Years of 
speciality in 
MSK 
Sex Private or 
NHS 
provider 
1 7 6 Male NHS 
2 4 3 Male Private 
3 4 4 Male NHS 
4 18 16 Male Private 
5 15 12 Female NHS 
6 3 3 Male NHS 
Table 6.5 of physiotherapists’ characteristics 
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6.3.1 Acceptability of The MAP Study Procedures from The 
Physiotherapists’ Perspectives 
Figure 6.3 details the initial thematic map developed from the physiotherapists’ 
data. Through indexing, sorting and charting a final thematic map was 
constructed (figure 6.4). 
 
 
 
 
Figure 6.3. Initial thematic map from the physiotherapists’ perspectives 
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experience
Recall
Time
Training
Motivation
Simplicity
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Figure 6.4 Final thematic map from the physiotherapists’ perspectives 
 
6.3.1.1 Key Themes 
To meet the aim of the process evaluation and interpret acceptability, two main 
themes were sought from the data after transcription; obstacles and enablers. 
From these 2 themes a further 8 subthemes were identified; (1) access to 
participants; (2) recall; (3) visibility; (4) time; (5) training; (6) motivation; (7) 
incentives; (8) simplicity.  
 
6.3.1.2 Obstacles 
6.3.1.2.1 Theme 1: Access to Participants 
Difficulties in accessing the target population for the MAP study was often 
referred in many of the interviews. Potential reasons for this varied. Two 
physiotherapists felt this was simply serendipitous. 
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“The main issue seemed to be that all my Achilles tendon patients seemed to 
disappear.” Physiotherapist 4. 
 
“I noticed was that in my particular caseload, I don't have a lot of Achilles 
tendinopathy patients.” Physiotherapist 1. 
 
Whilst two other physiotherapists felt part of the problem lay with a telephone 
triage system operated at their place of work. 
 
“We do telephone triage, and a lot of that emphasis is to give the patient the 
option of self-management with some exercises, and with tendinopathy despite 
the complexity that I've mentioned, might be deemed something that actually, 
you can start someone off with simple exercises. So, there's a possibility that 
some patients might not have had the opportunity to be recruited.” 
Physiotherapist 2. 
 
“I think because whether those patients get better on the phone or not, it 
definitely means that less of Achilles pain comes through to eventually see in 
a clinic.” Physiotherapist 3. 
 
6.3.1.2.2 Theme 2: Recall 
A common theme reported by the physiotherapists in the study related to 
difficulties in remembering to recruit potential participants. Some 
physiotherapists related this to their workload. 
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“In a busy clinic remembering to provide them with the information in the first 
place.” Physiotherapist 1. 
 
“Everybody's got lots of different pressures in clinic generally, lots of different 
things to think about. It definitely would be easy to have an Achilles 
tendinopathy patient and just forget and not hand it out to the patient.” 
Physiotherapist 3. 
 
“If you're seeing sometimes 18 patients in a day, and you get a couple of 
Achilles ones within that, if that, then is it going to be the thing that you're going 
to remember? Probably unlikely.” Physiotherapist 5. 
 
Other physiotherapists felt that the infrequency of seeing people with Achilles 
tendinopathy was a contributing factor. 
 
“But yeah, other clinicians have definitely said that they forgot, and part of the 
reason for that, I guess, is if you see an Achilles tendinopathy one week and 
then, two or three weeks later, you see your next new patient.” Physiotherapist 
2.  
 
“Some of our part-time staff or people that run classes or hydrotherapy and 
don't have a massive case load, they're not going to see one very often and it 
might not be at the forefront of their mind.” Physiotherapist 6. 
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Although training was provided, and a staff meeting was attended one month 
following to discuss any recruitment queries and then monthly email reminders 
were sent to the Lead Physiotherapist at each site, physiotherapists were keen 
to be contacted directly to be reminded of recruitment.  
 
“To kind of set up a group email and just ping it across because that's just one 
level of communication that you can then take out where it could fall down if 
said manager doesn't pass it on.” Physiotherapist 3. 
 
“You might receive six or seven or eight emails from the manager, and there 
might be potential to only skim-read that, whereas if there was an email from a 
different source that you don't normally see in your email box, that might prompt 
you to pay more attention.” Physiotherapist 1. 
 
“An automated email that - although that might be received as slightly irritating, 
to have an email every week saying the same thing, equally it may also prompt 
individuals - if something's repeated on a weekly basis, they're probably going 
to be more likely to remember.” Physiotherapist 6. 
 
6.3.1.2.3 Theme 3: Visibility 
Participating physiotherapists outlined a common theme of needing to improve 
the visibility of the study to aid with recruitment. Some felt using posters to 
inform patients that the study was recruiting participants would be useful. 
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“A poster or some visualisation of the study. Maybe something to put in the 
waiting room that a patient may have some preconceptions, pre-information 
about the study so that it's not completely something that's maybe sprung on 
them out of the blue if you like.” Physiotherapist 1 
 
“If the information's there for them, the patient, they might actually start that 
conversation off, kind of like what you just said, rather than the other way 
around.” Physiotherapist 2. 
 
“I don't know whether things like posters and stuff doesn't always work in 
clinical setting at times because when you've been working in an environment 
for a period of time, you tend to start to phase out what's around you, I suppose, 
on a visual side of things, whereas if you're a patient and you're waiting, you're 
more likely to take in that type of information, perhaps.” Physiotherapist 4. 
 
Some physiotherapists felt that it was them would benefit from an increased 
visualisation of the study. 
 
“Put the information there so it's in plain sight so that, again, from a jogging 
your memory” Physiotherapist 2. 
 
“Whether you have left some out in the area, or some kind of handouts for the 
physio just as a reminder, more like a poster that we could have popped up in 
the staffroom just to remind people to keep doing it.” Physiotherapist 1. 
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“There's lots to sort of do and think about every day at work, and it's very easy 
to get quickly engrossed in what the patient's needs are and what they're telling 
you and maybe forget that there's a bunch of cards there with a study on it that 
to talk about. So I think the more sort of handy reminders, the better.” 
Physiotherapist 5. 
 
6.3.1.2.4 Theme 4: Time 
Time as an obstacle was often cited by the physiotherapists. Some felt a lack 
of time with the patient impacted on the success of recruitment. 
 
“If you got half an hour to get a patient in, treat them, manage them, and 
document, and then you starting thinking there are other things on top 
sometimes. So that is then pushed to the less of a priority and such.” 
Physiotherapist 1. 
“It would be good to have an extra five minutes at the end of the consultation 
to say, on a complete side note to this, one of our colleagues at the university 
is doing this, this is what it entails. But it always felt a bit more rushed than that 
and difficult to really give out the information that was needed alongside.” 
Physiotherapist 4. 
“We're pushed for time. So if you're running short on time in an appointment 
session and then had to go and explain everything that could have been 
difficult.” Physiotherapist 6. 
Physiotherapists viewed time as a precious commodity; something that they 
valued with their patients. Two physiotherapists felt that they would have 
145 
 
benefitted from more reassurance that recruiting patients shouldn’t impact 
greatly upon this. 
“Yeah, I guess it's always going to be valuable, isn't it, to know that it's not going 
to take much time.” Physiotherapist 2 
“I guess, kind of how long would it take? Again, I guess, with physio you don't 
want to lose time.” Physiotherapist 6.  
6.3.1.3 Enablers 
6.3.1.3.1 Theme 5: Training 
A common them reported by the physiotherapists referred to the recruitment 
training which was provided for them. The training served to provide clarity on 
the role of the physiotherapists and installed a sense of confidence in the 
procedures which were described. 
“I felt very confident and capable of recruiting participants after that session 
itself and the information given across from that.” Physiotherapist 5 
“From my point of view I think the information that was delivered was 
appropriate and enabled me to have a clear understanding of what I needed to 
do.” Physiotherapist 3. 
“I think all the information was there. I think it was well laid out from the 
beginning to finish.” Physiotherapist 6. 
“As far as I was concerned, my role was simply to identify patients that were 
appropriate for the study and give them the information, give them the handout 
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that I was given for them to then look at the website and participate if they 
chose to, or not.” Physiotherapist 2. 
The training enabled physiotherapists to answer questions from the 
participants. 
“Yes, I could answer most of it for them and just direct them towards the website 
if they have any other queries before getting involved.” Physiotherapist 1. 
6.3.1.3.2 Theme 6: Motivation 
Motivation to be involved in the MAP study was commonly referred to by the 
physiotherapists interviewed. Some physiotherapists felt that the impact this 
might have on their care of patients was an important motivating factor. 
“I think the study was very much with the patient's interest at the forefront.” 
Physiotherapist 4. 
“We treat Achilles tendinopathy. So the more information eventually we can get 
from research, it better shapes our care.” Physiotherapist 3.  
“I certainly think the aim of what was being looked at is probably useful for all 
other physiotherapy intentions, although it won't be able to be generalized that 
easily.” Physiotherapist 1. 
Physiotherapists were also motivated by the opportunity to be involved in a 
research project. 
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“It's always interesting to get involved with any research or the data collection 
side of things that may turn up for our department. And it's important, I think, 
from a physio side of things to engage with that.” Physiotherapist 4. 
“I think it's just if you're aware of a research project or anything from that side 
of things going on, you tend to want to engage with that as much as you can.” 
Physiotherapist 5. 
“It's something that I'm interested in, research and evidence, so if in any way I 
can help with that, even if it's in a small way, then I'm normally more than happy 
to do so.” Physiotherapist 2. 
6.3.1.3.3 Theme 7: Incentives 
Physiotherapists discussed the potential need for incentivising the MAP study. 
Some physiotherapists felt a reward for the efforts of the physiotherapists might 
be warranted, although they were not sure what that could be. 
“I think incentives always helps, doesn't it? And I don't think it really should be 
necessary for it. And like I said people always like to think they are getting 
something from it, but I wouldn't have any suggestions on what.” 
Physiotherapist 1. 
“Whether you give out 10, 20 cards to appropriate patients, then you're-- not 
get a reward, that sounds wrong, but you're more likely to be able to-- I don't 
know. It encourages clinicians to do more from that side of things.” 
Physiotherapist 3. 
148 
 
“But then, how do you incentivise clinicians about effecting or influencing 
results around that?” Physiotherapist 5. 
It was also highlighted that the non-onerous nature of the recruitment task be 
more clearly made.  
“But I guess you could highlight it, or emphasize how simple it is, or how little 
time it actually takes. It may help with the physios doing it”. Physiotherapist 1. 
Questions were also raised with regard how participants felt incentivised. Some 
physiotherapists felt the answer lay in the opportunity to help others who are 
experiencing what they are.   
“It's difficult to know whether patients thought that was a worthwhile reason for 
completing the study.” Physiotherapist 1.  
“There's always the question of the patient thinking, "What am I getting out of 
doing this?"” Physiotherapist 3. 
“And eventually, treat people that were suffering with what they've been 
suffering with. That seemed to be quite a key thing that people were interested 
in.” Physiotherapist 4. 
6.3.1.3.4 Theme 8: Simplicity 
A common theme discussed during the interviews with the physiotherapists 
was the simplicity of the MAP study. Most felt this was a key issue to raise to 
the potential participants in order to maximise recruitment. 
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“I think it was quite clear and that seemed to be the case when speaking to 
patients, they weren't too fazed by the simplicity and the process they're about 
to undertake.” Physiotherapist 4. 
 “If someone has to go through something that takes them half an hour, then 
they're going to, generally speaking, not really want to fill that out or complete 
it. So if they know it's going to be fairly quick and easy to do, then most people 
will try to engage.” Physiotherapist 5. 
“The ease or speed of which they can complete it because – it turns people 
off.” Physiotherapist 2. 
Others highlighted how, overall, straightforward they found being involved in 
the MAP study. 
“It wasn't difficult as all of that actually sounded. I thought it was quite easy to 
do. There were just, if I would say, small bumps in the road along the way, 
rather than any big barriers to actually putting the study into action. So it might- 
there's quite a few negative points there, but it wasn't like that in reality.” 
Physiotherapist 6. 
“I don't suppose I think there are too many barriers to the study, I think it's an 
easy enough one to get involved in or get the data you need from.” 
Physiotherapist 3. 
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6.3.2 Acceptability of The MAP Study Procedures from The Patient 
Participants ’ Perspectives 
Figure 6.5 details the initial thematic map developed from the patient 
participants’ data. Through indexing, sorting and charting a final thematic map 
was constructed (figure 6.6). 
 
Figure 6.5 Initial thematic map from patient participants’ experience  
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Figure 6.6 Final thematic map from patient participants’ experience  
 
6.3.2.1 Key Themes 
To meet the aim of the process evaluation and interpret acceptability, three 
main themes were sought from the data after transcription; consequences, 
obstacles and enablers. From these 3 themes a further 6 subthemes were 
identified; (1) information from the physiotherapist; (2) follow up; (3) motivation; 
(4) website; (5) questionnaire; (6) positive experience. 
 
6.3.2.2 Obstacles 
6.3.2.2.1 Theme 1: Information from The Physiotherapist  
The patient participants interviewed often referred to the need for more quality 
verbal information from the physiotherapists at the time of recruitment. 
 
“If I hadn't been quite so spontaneously happy to do it, I might have benefitted 
with a little bit more explanation as to what they were trying to get out of it.” 
Patient participant 1. 
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“He didn't really say anything. He was quite neutral about it.” Patient participant 
3. 
 
“I think he gave me a card and asked me how I felt about being part of the 
study, but we didn't talk about it at all.” Patient participant 2. 
 
“She said that you required someone for the study and would I be prepared to 
do it, to which I said I would, and at that point I took the card. And I think that 
was pretty much it really. We didn't go into too much detail at that stage.” 
Patient participant 4. 
 
Some of the patient participants felt more information would be helpful to 
prepare potential participants about the question topics. 
“It would have been perhaps nice just to have discussed it through a bit what 
kinds of things were being done.” Patient participant 5. 
 
“Just give me a bit of a heads up about what the questions were going to be 
about. That would have been interesting, I think. I wasn't sure what the 
questions were going to be about.” Patient participant 6. 
 
Most patient participants viewed the postcard as a positive tool, enhancing 
engagement in the study. 
 
“Had she just told me about it, chances are I would have forgotten about it, 
even though I was very eager to do it. But I think it was a business card, or like 
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a little flyer that she gave me, but I then found later. So obviously, that was 
really helpful in kind of jogging my memory to actually doing it.” Patient 
participant 6. 
 
“Eager though, I was to do it when my physiotherapist told me about it. It's one 
of those things that I probably would have forgotten about had I not had the 
postcard and thought, "Oh, I was going to do that. I need to do that."” Patient 
participant 4. 
 
“It's quite colourful. I was experiencing pain in the very area that was indicated 
at the time. I think that struck a chord.” Patient participant 2. 
 
6.3.2.2.2 Theme 2: Follow Up 
Some patient participants expressed confusion around the process of being 
invited to complete the questionnaire for a second or third time. 
 
“In my head it just seemed like I'd done that bit. So it wasn't until I went on and 
looked at my emails on the laptop that I actually found it. It might be helpful if it 
were headed up second of the doc and then third and final of the doc.” Patient 
participant 7. 
 
“I got a bit confused and I thought I'd already filled that one out.” Patient 
participant 5. 
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“I think the problem lies with the amount of rubbish we all receive over email. 
And I'm sure you're exactly the same as the rest of us. Sometimes more 
important things do get lost amongst the dross really, there's just so much of 
it.” Patient participant 3. 
 
Patient participants offered ways of improving communication, including the 
suggestion of adding a text message reminder and ensuring communications 
were clearly headed as to which number survey the correspondence was 
referring to. 
 
“I suppose before you answered the first one, you should be absolutely clear 
that you're going to have to answer a few more afterwards, and that they're all 
going to be the same questions and the one variable is the time lapse between 
them.” Patient participant 7. 
 
“Heading them up and making it clear at the start that there were going to be 
three and heading them up two and three, I think that would be very helpful.” 
Patient participant 5. 
 
“I think for a lot of people they wouldn't mind a text reminder.” Patient participant 
3. 
 
“I don't think for future people taking part it would be that much of an extra step 
to give their phone number for this service as well.” Patient participant 2. 
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6.3.2.3 Enablers 
6.3.2.3.1 Theme 3: Motivation 
Almost all the patient participants outlined their motivation for involving 
themselves in the MAP study. Motivation appeared to be largely altruistic in 
nature. 
 
“If it helps other people who have hurt themselves and moves things forward 
and all that, then that should be what you should do.” Patient participant 7. 
 
“Advancing research on such issues is beneficial for everyone, isn't it? So it's 
something one should do rather than not.” Patient participant 2. 
 
“I've had various surveys that have come through about my diabetes condition, 
and I've done one on aorta, and things like that. So, you know, I've done a few 
surveys before so, I don't mind contributing because I know research into 
health-related matters is important for society these days.” Patient participant 
1. 
 
“Recognizing that here's something that I'm benefitting other people's research 
into physio and Achilles pain.” Patient participant 4. 
 
Two patient participants suggested that the relationship that they had with the 
physiotherapist motivated them to participate. 
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“Probably just that the trust that I had in my physiotherapist, after the 
disappointment of what I had from me GP, and the fact that he was giving me 
good treatment that was improving the situation, puts you in a good frame of 
mind.” Patient participant 3. 
 
“The fact that he was asking me, made me much more likely to fill it in than if 
he just sent me a mailshot.” Patient participant 6. 
 
6.3.2.3.2 Theme 4: Website 
A positive experience from using the website was expressed from most of the 
patient participants. This ranged from providing information which was missed 
by the recruiting physiotherapist to the ease of navigating the webpage.  
 
“Once I got to the website page, it gave me all the information I needed.” Patient 
participant 3. 
 
“I don't recall being frustrated by anything. I'm easily frustrated on the Internet.” 
Patient participant 4. 
 
“It was easy to navigate. It was clearly laid out, and it was all quite 
straightforward. So it wasn't an arduous task at all.” Patient participant 1. 
 
“That was very straightforward. I didn't have any problems at all.” Patient 
participant 6. 
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6.3.2.3.3 Theme 5: Questionnaire 
A positive engagement with the questionnaire was often cited by the patient 
participants. Particular reference was made to the simplicity and short duration 
of the questionnaire. 
 
“For most people now, because everyone seems to lead very busy lives, I think 
it was very helpful that it was just literally quick. And I think it kind of made it 
more intuitive as well, I suppose, because you haven't got to sit down and think 
about, "What am I going to write? What am I going to say?" When you just see 
the questions, it's kind of like your mind I suppose immediately goes to, "Well, 
that's an eight. That's a three. That's a seven." You know?” Patient participant 
1. 
  
“We've all had questionnaires of customer feedback where they ask you to write 
so much detail, you give up because it's too painful. So it wasn't like that, which 
is really good.” Patient participant 3. 
 
“I think it was so straightforward. I'm not sure, but I don't think anybody would 
have a problem completing any of it. And as I said, it's all very-- like I said, it's 
all so simple. And I mean, I think it says that it will take about 15 minutes, but I 
think it probably takes less than that. I'm not sure what else there is that could 
be done to actually encourage people more.” Patient participant 6. 
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“If you'd ask me to fill in a 58-page paper form, I might have been asking a fine 
to keep doing it every time, particularly if they're the same questions.” Patient 
participant 4. 
 
“It was all very, kind of, reassuring. And I found the actual website, and the 
logging on, and the actual questionnaire itself is all very, very simple. I found it 
very simple to use. It's really good.” Patient participant 2. 
 
6.3.2.4 Consequences  
6.3.2.4.1 Theme 6: Positive Experience 
Many patient participants stated that their involvement in the MAP study 
resulted in a positive experience; it made them reconsider their condition and 
treatment and how they engaged with their physiotherapist. 
 
“It has made me think actually - maybe asking, this is not making as much 
progress as we were making. Should we try something different and I've started 
to think about that actually.” Patient participant 5. 
 
“It made me think actually, it's not half bad because I can do all this stuff. There 
must be people who can't do all those things and therefore, I'm in a pretty good 
state. So I shouldn't worry or complain too much about the fact that I can't run 
and play hockey.” Patient participant 2. 
 
“Being more interactive rather than just submissive if that's the phrase for in 
this context.” Patient participant 3.  
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“It made me very aware of all the things we just discussed. The fact that if you 
don't have a relationship shall we say, a positive relationship, with your 
physiotherapist, I can see that you may not get the end result that I've been 
fortunate in the second case to achieve.” Patient participant 4. 
 
“It made me take it a bit more seriously really and feel a bit more as though, I 
wasn't on my own. There were other people obviously who were going through 
the same kind of problem. So maybe it validated it a bit more, I think, for me, 
which was good.” Patient participant 7. 
 
6.4 Discussion 
The purpose of the process evaluation was to meet objectives three and four 
of this thesis; to explore the acceptability of the study procedures from the 
patient participants’ and physiotherapists’ perspectives respectively. The online 
data collection method was newly developed and as such it was important to 
evaluate the processes involved. Likewise, it was important to explore these 
methods from the perspectives all of those involved in the study. As such, this 
aspect of the study provided complementary data to the findings of the cohort 
study and identifies factors that might present as obstacles or facilitate 
successful wider implementation. From the physiotherapists’ perspective four 
themes were identified which related to obstacles; (1) access to participants; 
(2) recall; (3) visibility; (4) time, and four themes were identified which related 
to facilitating success; (1) training; (2) motivation; (3) incentives; (4) simplicity. 
From the patient participants’ perspective two themes were identified which 
160 
 
related to obstacles; (1) information from the physiotherapist; (2) follow up, 
three themes were identified which related to facilitating success; (1) 
motivation; (2) website; (3) questionnaire, and one theme which related to 
unintended consequences of participating in the study; positive experience. 
 
The NHS Constitution for England pledges to inform all patients about 
opportunities for involvement with suitable research studies [309]. In this 
context healthcare professionals play a vital role in clinical research, linking 
researchers and patients. A variety of challenges may exist in recruiting 
participants from specialist healthcare services, such as physiotherapy, into 
cohort studies and little formal research has investigated these challenges 
[310]. Frayne et al (figure 6.7) have conceptualised a process by which a 
patient may be referred to a research study when the initial invitation to 
participate is delivered by a healthcare professional in the clinical setting (rather 
than being invited by a healthcare provider who has responsibilities and 
involvement in the whole trial) [311]. 
 
 
Figure 6.7 Process of a patient being referred to a research study by a clinician 
(adapted from Frayne et al. [311]) 
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In order to contextualise the findings from this process evaluation with previous 
research and consider implications for future studies, the discussion is framed 
by the conceptual process outlined in figure 6.7. 
 
6.4.1 Involvement with the Study 
Motivation to be involved in research was a theme identified from patient 
participants and physiotherapists alike. From the patient participants’ 
perspective, the motivation was largely altruistic in nature; the chance to ‘give 
back’, and from the physiotherapists’ perspective the drive was the opportunity 
to be involved in research which was considered to directly influence patient 
care. Motivation as a driving factor for recruitment wasn’t considered in the 
training provided for the physiotherapists prior to commencing recruitment. 
Although the training was considered by the physiotherapists as facilitatory for 
recruitment, the training focused on how to recruit [286] rather than serving to 
motivate recruitment. Nevertheless, this focus did have benefits; the 
physiotherapists understood what they were required to do, were happy to 
answer questions from patients and felt confident in carrying out the 
recruitment. For example, Cvijovic et al [312] highlighted that pharmacists were 
reluctant to invite patients when they felt this could prompt questions they could 
not answer. However, valuing the research has been seen as a key driver of 
engagement of recruiting healthcare providers previously [313] and as such, 
training would benefit from tailoring to ensure the physiotherapists not only 
understood what to do and how to do it, but also developed attitudes towards 
the research which were as positive as possible. For example, the training 
could emphasise the positive experience (and absence of negative experience) 
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which the participants have described from being involved in the study. 
The Research changed my life [314] campaign within the NHS is a further 
example, where patients across England share stories of how their lives were 
positively transformed by clinical research. Allowing the physiotherapists to 
better understand this might serve to act as an incentive, something which the 
physiotherapists felt was important. Incentivising patients to participate was not 
possible as the study was unfunded. However, a £10 gift voucher has been 
shown to more than triple a response rate to an internet-based recruitment 
system and as such could be considered in future funded studies though 
automatic email delivery by a voucher supplier [315]. Whilst, the provision of 
such training has been shown to modify some aspects of recruiters' behaviour, 
this may still result in clinicians not sufficiently restructuring their recruitment 
consultations [316]. As such, a process of monitoring and further visits, where 
necessary, from the researcher to the recruitment sites to ensure recruiters are 
clear how participation in research varies from clinical practice might be a 
useful strategy [317]. At this stage, the focus might turn to communication skills 
facilitated by role play scenarios to highlight common obstacles to recruitment 
[318].  
 
6.4.2 Inviting a Patient 
Pragmatic issues rather than ‘gate keeping’ concerns [319,320] largely 
influenced whether a patient was invited to be involved in the study or not. Two 
main pragmatic issues were identified; remembering to recruit participants and 
the visibility of the study. Reasons for not remembering to invite a participant 
ranged from other work pressures to the infrequency of seeing people with 
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Achilles tendinopathy. French et al [321] identified the clinical work setting as 
an influence on recruitment; an organisation which has developed a positive 
research culture is an important facilitator to inviting patients to participate. It 
was unknown what the research culture was like at each recruitment site prior 
to commencing recruitment. Fenlon et al [322] utilised a careful pre-screening 
and selection of participating centres. Although the nature of pre-screening 
sites and the decisions to work with sites varies according to the given study, it 
is a useful way to initiate relationships and potentially identify sites at risk of low 
recruitment [322]. Recognising this complexity, formal methods of evaluation 
have been developed that identify problems with recruitment and informed 
consent and develop action plans to address them while recruitment is 
underway [323]. Increasingly such methods, evaluating processes, need to be 
integrated into the pilot phases of research work to maximise the chance of 
success. 
 
To address the second pragmatic issue, physiotherapists suggested 
recruitment for the study might be enhanced if the study was visualised in some 
way, such as posters in the waiting room and staff room to act as a reminder 
to staff and to encourage questions from potential participants. This would incur 
only a small increase in cost, and also provide a further opportunity to share 
the positive experience which participants can have from being involved in 
research [314]. A positive experience from this study was found from the use 
of the postcard to invite patients to become participants; the design resonated 
with participants and it served as a tangible reminder to take part. Contrastingly, 
the use of a follow up via email was sub-optimal. Using email and text message 
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reminders to encourage questionnaire completion amongst participants 
appears to be a viable strategy; following two email reminders, a text message 
reminder appeared to be more effective than another email reminder in a study 
also utilising an online questionnaire [315].  
 
6.4.3 Discussing the Study 
Reporting lack of time as an obstacle to recruiting participants would appear 
significant. This was also reflected by the participants expressing they were 
given minimal verbal information by the physiotherapists during the invitation 
process. Limited time for recruitment resulting in clinicians not prioritising 
research activities has been seen in previous studies [310,313].  Resources 
are critical and lack of resources have been seen to negatively influence 
recruitment at all stages [322]. The absence of dedicated resources, such as 
clinical time, not only constrains the capacity of clinicians to undertake research 
activity but can also undermine their belief in the research and lose a sense 
that their roles are respected [313]. Consequently, research resources must be 
seen to make a difference. Here, effective communication is considered central 
to promote respect, reciprocity and maximise recruitment [313,322]. Ensuring 
that the right information reaches the right people in a timely manner, and that 
clinicians are provided with progress reports and study findings, is essential 
[313]. Improved communication from the researcher directly to the 
physiotherapists involved in recruiting was a finding from this study. To address 
this, future studies should consider providing progress reports and  developing 
a newsletter which includes ‘frequently asked questions’ and tips from research 
sites that have good recruitment rates [322].   
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6.4.4 Willingness to be Involved 
The minimal burden of the study design appeared to be key to both 
physiotherapists’ and participants’ willingness to be involved in the study. As 
previously discussed, time is a precious commodity to physiotherapists. The 
simplicity of the MAP study was referred to as an enabler to engaging 
physiotherapists and that this simplicity needed to be highlighted more 
effectively in the training to provide reassurance on the minimal impact of time 
to the physiotherapists. Participants described a positive engagement with the 
website; it appeared to enhance patients’ willingness to participate by being 
easy to navigate and ensuring it gave them all the information they required. In 
addition, the short duration of the questionnaire appeared a significant factor 
for participants to be willing to be involved. Previous research shows 
participants appear to start abandoning questionnaires after around 9 minutes, 
regardless of whether they are told the survey would take 8-10 minutes or 20 
minutes [324]. 
   
6.5 Strengths and Limitations  
This study included physiotherapists from all but one recruitment site and this 
ensured that the views expressed were as representative as possible of the 
sites involved. However, the self-selecting nature of recruitment may result in 
‘volunteer bias’; for example, physiotherapists largely expressed an interest in 
research, meaning perceptions of physiotherapists who felt negatively or 
ambivalent towards research were not recruited. Nevertheless, those taking 
part offered both positive and negative comments towards the MAP study. In 
addition, five of the six physiotherapists who volunteered were male which, 
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depending on the gender balance at each site, suggests female 
physiotherapists’ views might be underrepresented.   
 
Whilst those patient participants who dropped out, but had agreed to be 
contacted for interview, were invited for interview no responses were received. 
Again, this may have resulted in ‘volunteer bias’ and therefore alternative views 
were not captured. While this is a limitation, several of the insights offered by 
this study relate to facilitators brought about by positive attitudes, affording the 
opportunity to examine facilitators in more depth. 
 
The prior established professional relationship with the physiotherapists 
through the provision of training, could have inhibited physiotherapists and 
discussing negative opinions about the study. Although efforts to reduce this 
were made through prior training and interview practise with feedback from one 
PhD supervisor (CL), this could have led to a degree of interviewer bias. 
 
6.6 Conclusion 
This process evaluation has highlighted some important factors for researchers 
to consider when planning future research studies. Although clinicians are 
enthused to be involved in research, organisational factors, such as time, 
appear to be key drivers of levels of engagement. Publicising the study to all 
involved; optimising verbal recruitment strategies between the physiotherapists 
and potential participants; and ensuring clarity in communication to recruiting 
physiotherapists and the participants all appear key to optimising the potential 
success of a study. 
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Chapter 7: Discussion, Contributions, Strengths and 
Limitations and Recommendations for Future 
Research 
Summary 
This chapter returns to the aim and objectives stated in chapter one and 
discusses the extent to which each has been met. Consideration is then given 
to the implications and impact of the work that has been conducted in relation 
to each objective. Through triangulation of the results from chapters five and 
six, the degree to which new knowledge has been generated is discussed 
alongside suggestions for further research in this field. 
 
7.0 Aim of This Thesis  
In the context of further research being required to better understand how 
to optimise exercise-led interventions for people with Achilles 
tendinopathy, this thesis aimed to develop new knowledge by focusing 
on factors not previously investigated in tendinopathy research – 
cognitive and contextual factors and consider how they could contribute 
to optimising exercise-based interventions. It is suggested this has been 
met through the enhanced understanding generated from the feasibility study 
reported in chapters five and six. The study has provided a robust, previously 
untested, approach to investigating the selected variables generated from the 
two reviews presented in chapter two. Underpinning this aim were several 
objectives. The extent to which each one of these has been met and the impact 
of the work will now be considered in turn. 
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7.0.1 Objective One 
The first objective of this thesis was to systematically review the current 
evidence-base to determine the association and link to outcome between 
psychological variables and people with tendinopathy. This objective was 
met in chapter two, part one. This was the first systematic review to consider 
this link. Reported in accordance with the PRISMA statement [61], the review 
reported the overall conflicting high quality evidence relating to the association 
of psychological variables and outcome in tendinopathy. The review 
recognised the limited number and quality of studies regarding Achilles 
tendinopathy. However, within the context of the conflicting results from 
multiple high-quality studies in other tendinopathies, it was highlighted that 
differing cognitive factors which might underpin the psychological variables and 
their amenability to change, were worthy of further investigation. 
 
7.0.2 Objective Two  
The second objective of this thesis was to critically review potential 
underpinning mechanisms of psychological variables and consider how 
they might influence prognosis for people with tendinopathy. This 
objective was met in chapter two, part two. Here a novel consideration was 
discussed which had received little attention in current tendinopathy 
management models -cognitive and contextual factors. The review discussed 
how these factors may help explain some of the variation in results from 
exercise-led interventions and also present a novel perspective to target for 
interventions. These key variables were then utilised to inform the variables for 
the future cohort study. 
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7.0.3 Objective Three  
The third objective of this thesis was to critically review the most 
commonly used patient reported outcome measure (PROM) for people 
with Achilles tendinopathy; the VISA-A and determine its suitability for 
use within the future study. This objective was met in chapter three. This 
review highlighted the extent of evidence which was missing from the 
development for the VISA-A. This was then used to inform the selection of the 
primary outcome measure for the future cohort study. Given the future cohort 
study required participants to complete an online version of the primary 
outcome measure in isolation from any support of a clinician to clarify a 
question’s meaning, the chosen primary outcome measure required to not only 
be considered of sufficient reliability, validity and responsiveness, but also be 
considered of easy readability and comprehension. Notably the VISA-A had an 
absence of evidence regarding readability and comprehension testing and, 
coupled with concerns over the validity and responsiveness testing of the VISA-
A, an alternative outcome measure was utilised (the LEFS) which met the 
current literacy standards within the UK. 
 
7.0.4 Objective Four  
The fourth objective of this thesis was to conduct and complete a cohort 
study and report feasibility from both quantitative and qualitative 
perspectives. This objective was met in chapters four, five and six. 
Triangulating the results from the quantitative and qualitative findings, a future 
large cohort study appears feasible, but with certain caveats. The results from 
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the quantitative component suggested further consideration was required to 
ensure the level of data produced from the responses to the questionnaire 
matches with the statistical technique required to meet the aim of the study. 
Additional consideration was needed to enhance recruitment strategies and 
reduce attrition rates. Such considerations were explored in the qualitative 
aspect of the study; the process evaluation. The findings from the process 
evaluation highlighted clinicians were enthused to be involved in research, 
however organisational factors, such as time, appeared to be key drivers of 
levels of engagement. In addition, future studies should ensure the study is 
publicised to all involved and ensure clarity in communication to recruiting 
physiotherapists and the participants.  
 
7.1 Strengths and Limitations  
This thesis presents several strengths. Firstly, wherever appropriate the 
reporting of the research undertaken has been in accordance with the 
appropriate reporting guideline. A reporting guideline is a tool which provides a 
minimum list of information needed to ensure a manuscript can be; understood 
by a reader; replicated by a researcher; used by a health professional to make 
a clinical decision; and included in a systematic review [325]. The use of such 
guidelines have been shown to increase the completeness and transparency 
of health research published in journals [326]. In addition, four of the chapters 
have been shaped from external peer review through publication. This process 
has also added robustness and rigour to the thesis. Chapters five and six have 
highlighted some limitations within both the quantitative and qualitative 
approaches to feasibility. Firstly, the study did not allow for all feasibility data to 
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provide complete answers; it remains uncertain how many patients were given 
cards and how many landed on the blog page and then decided not to 
participate. Secondly, all recruitment sites were within the UK. As will be 
discussed below, a strength of the online platform is the ease of transition to 
international collaboration to improve generalisability. 
   
7.2 Recommendations for Future Research  
There are a number of areas for future research that could be proposed based 
upon the focus of the preceding thesis. Chapter three has demonstrated the 
need for a robustly developed patient-reported outcome measure for people 
with Achilles tendinopathy. Our knowledge of the condition and outcome 
measures has evolved significantly since the VISA-A was developed and a 
newly constructed measure to reflect this is warranted. 
 
Prognostic factors for people with Achilles tendinopathy remain poorly 
understood but are critically important to informing patient management. The 
current evidence base however suggests these prognostic factors are unlikely 
to be reflective of the state of the tissue alone. The triangulation from the 
quantitative and qualitative investigations into the feasibility of the MAP study, 
indicate a future large cohort study is feasible to investigate the association and 
predictive nature of cognitive and contextual factors. The online platform design 
of the protocol should facilitate potential international collaboration and future 
studies should consider this to maximise generalisability and recruitment. 
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Chapter 8: Conclusion 
This PhD thesis has offered new insight into novel considerations to optimise 
the outcome for Achilles Tendinopathy. Using robust methods, the thesis has 
explored variables which have previously received little attention in 
tendinopathy research. Acknowledging the limiting factors discussed above, 
the high-quality feasibility study suggests a future large cohort study is 
warranted and feasible. In many respects this thesis leaves as many questions 
as it provides answers, however, importantly it has provided a platform from 
which those questions can begin to be answered. 
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APPENDIX 2 – PRISMA Checklist 
Section/topic  # Checklist item  
Reported 
on page 
#  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  19 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility 
criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; 
conclusions and implications of key findings; systematic review registration number.  
- 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  20 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
20 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, 
provide registration information including registration number.  
- 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years 
considered, language, publication status) used as criteria for eligibility, giving rationale.  
22 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
21 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could 
be repeated.  
21 
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Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if 
applicable, included in the meta-analysis).  
21 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators.  
24 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions 
and simplifications made.  
24 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this 
was done at the study or outcome level), and how this information is to be used in any data synthesis.  
23 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  24 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (e.g., I2) for each meta-analysis.  
- 
 
Page 1 of 2  
Section/topic  # Checklist item  
Reported 
on page 
#  
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, 
selective reporting within studies).  
- 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, 
indicating which were pre-specified.  
- 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for 
exclusions at each stage, ideally with a flow diagram.  
26 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up 
period) and provide the citations.  
28-33 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  27 
206 
 
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
- 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  - 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  - 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 
16]).  
- 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their 
relevance to key groups (e.g., healthcare providers, users, and policy makers).  
38 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval 
of identified research, reporting bias).  
39-43 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future 
research.  
43 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders 
for the systematic review.  
- 
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(6): 
e1000097. doi:10.1371/journal.pmed1000097  
For more information, visit: www.prisma-statement.org.  
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APPENDIX 3 – Newcastle Ottawa Assessment 
(Alizadehkhaiyat et al 2007) 
NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE -CASE CONTROL 
STUDIES – 
 
Note: A study can be awarded a maximum of one star for each numbered item within the 
Selection and Exposure categories. A maximum of two stars can be given for Comparability. 
 
Selection 
1) Is the case definition adequate? 
a) yes, with independent validation Orthopaedic surgeon made diagnosis + 
previous diagnosis made separately i.e. taken from a list diagnosed with TE. 
b) yes, eg record linkage or based on self reports 
c) no description 
2) Representativeness of the cases 
a) consecutive or obviously representative series of cases  Consecutively identified 
from hospital records 
b) potential for selection biases or not stated 
3) Selection of Controls 
a) community controls     Students and University staff 
b) hospital controls 
c) no description 
4) Definition of Controls 
a) no history of disease (endpoint)  
b) no description of source 
Comparability 
1) Comparability of cases and controls on the basis of the design or analysis 
a) study controls for ____GENDER_________  (Select the most important factor.)   
b) study controls for any additional factor   (This criteria could be modified to indicate 
specific                   control for a second important factor.) Age range too spread in controls. 
Weight & height (?significance of these factors to TE) 
 
Exposure 
1) Ascertainment of exposure 
a) secure record (eg surgical records)  
b) structured interview where blind to case/control status  
c) interview not blinded to case/control status 
d) written self report or medical record only   Questionnaires completed by participants 
e) no description 
2) Same method of ascertainment for cases and controls 
a) yes  
b) no 
3) Non-Response rate 
a) same rate for both groups  
b) non respondents described 
c) rate different and no designation 
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 (Coombes et al 2012) 
NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE -COHORT STUDIES 
 
Note: A study can be awarded a maximum of one star for each numbered item within the 
Selection and Outcome categories. A maximum of two stars can be given for Comparability 
Selection 
1) Representativeness of the exposed cohort 
a) truly representative of the average _TENNIS ELBOW (describe) in the community 
 tennis elbow clearly defined )  
 
b) somewhat representative of the average ______________ in the community  
c) selected group of users eg nurses, volunteers 
d) no description of the derivation of the cohort 
2) Selection of the non exposed cohort 
a) drawn from the same community as the exposed cohort  No non-exposed cohort 
b) drawn from a different source 
c) no description of the derivation of the non exposed cohort  
3) Ascertainment of exposure 
a) secure record (eg surgical records)  Ascertained from a placebo arm of a RCT 
b) structured interview  
c) written self report 
d) no description 
4) Demonstration that outcome of interest was not present at start of study 
a) yes   outcome of interest (pain & disability) were present (as they needed to be) at 
start 
b) no 
Comparability 
1) Comparability of cohorts on the basis of the design or analysis 
a) study controls for _____________ (select the most important factor)  
b) study controls for any additional factor   (This criteria could be modified to indicate 
specific                   control for a second important factor.)  
Outcome 
1) Assessment of outcome  
a) independent blind assessment   blinded outcome assessor used to complete all 
questionnaires and assessments 
b) record linkage  
c) self report  
d) no description 
2) Was follow-up long enough for outcomes to occur 
a) yes (select an adequate follow up period for outcome of interest)  
b) no 
3) Adequacy of follow up of cohorts 
a) complete follow up - all subjects accounted for   
b) subjects lost to follow up unlikely to introduce bias - small number lost - > __2__ % 
(select an                     adequate %) follow up, or description provided of those lost)  
     c) follow up rate < ____% (select an adequate %) and no description of those lost 
d) no statement 
 
209 
 
(Coombes et al 2015) 
NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE -COHORT STUDIES 
 
Note: A study can be awarded a maximum of one star for each numbered item within the 
Selection and Outcome categories. A maximum of two stars can be given for Comparability 
Selection 
1) Representativeness of the exposed cohort 
a) truly representative of the average _TENNIS ELBOW (describe) in the community  
tennis elbow clearly defined.  
b) somewhat representative of the average ______________ in the community  
c) selected group of users eg nurses, volunteers 
d) no description of the derivation of the cohort 
2) Selection of the non exposed cohort 
a) drawn from the same community as the exposed cohort  No non-exposed cohort 
b) drawn from a different source 
c) no description of the derivation of the non exposed cohort  
3) Ascertainment of exposure 
a) secure record (eg surgical records)  Ascertained from a placebo arm of a RCT 
b) structured interview  
c) written self report 
d) no description 
4) Demonstration that outcome of interest was not present at start of study 
a) yes  Prospective study, so outcome of interest (pain & disability) were present (as 
they needed to be) at start 
b) no 
Comparability 
1) Comparability of cohorts on the basis of the design or analysis 
a) study controls for _____________ (select the most important factor)  
b) study controls for any additional factor   (This criteria could be modified to indicate 
specific                   control for a second important factor.)  
Outcome 
1) Assessment of outcome  
a) independent blind assessment   blinded outcome assessor used to complete all 
questionnaires and assessments 
b) record linkage  
c) self report  
d) no description 
2) Was follow-up long enough for outcomes to occur 
a) yes (select an adequate follow up period for outcome of interest) 1 year follow 
up adequate to see change in dependant variables (pain and disability) as measured by 
Patient-rated Tennis Elbow Evaluation (PRTEE) 
b) no 
3) Adequacy of follow up of cohorts 
a) complete follow up - all subjects accounted for   
b) subjects lost to follow up unlikely to introduce bias - small number lost - > __2__ % 
(select an                     adequate %) follow up, or description provided of those lost) 
40/41 subjects able to be contacted at 1 year 
     c) follow up rate < ____% (select an adequate %) and no description of those lost 
d) no statement 
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(Engebretsen et al 2010) 
NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE -COHORT STUDIES 
 
Note: A study can be awarded a maximum of one star for each numbered item within the 
Selection and Outcome categories. A maximum of two stars can be given for Comparability 
Selection 
1) Representativeness of the exposed cohort 
a) truly representative of the average _Rotator cuff (describe) in the community  
diagnostic criteria clearly defined )  
b) somewhat representative of the average ______________ in the community  
c) selected group of users eg nurses, volunteers 
d) no description of the derivation of the cohort 
2) Selection of the non exposed cohort 
a) drawn from the same community as the exposed cohort  No non-exposed cohort 
b) drawn from a different source 
c) no description of the derivation of the non exposed cohort  
3) Ascertainment of exposure 
a) secure record (eg surgical records)  Ascertained from a clinical trial 
b) structured interview  
c) written self report 
d) no description 
4) Demonstration that outcome of interest was not present at start of study 
a) yes   outcome of interest (pain & disability) were present (as they needed to be) at 
start 
b) no 
Comparability 
1) Comparability of cohorts on the basis of the design or analysis 
a) study controls for _____________ (select the most important factor)  
b) study controls for any additional factor   (This criteria could be modified to indicate 
specific control for a second important factor.)  
Outcome 
1) Assessment of outcome  
a) independent blind assessment   
b) record linkage  
c) self report  SPADI and HSCL. 
d) no description 
2) Was follow-up long enough for outcomes to occur 
a) yes (select an adequate follow up period for outcome of interest)  
b) no 
3) Adequacy of follow up of cohorts 
a) complete follow up - all subjects accounted for   
b) subjects lost to follow up unlikely to introduce bias - small number lost - > __2__ % 
(select an                     adequate %) follow up, or description provided of those lost)  
     c) follow up rate < ____% (select an adequate %) and no description of those lost 
d) no statement 
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(Garnevall et al 2013) 
NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE -COHORT STUDIES 
 
Note: A study can be awarded a maximum of one star for each numbered item within the 
Selection and Outcome categories. A maximum of two stars can be given for Comparability 
Selection 
1) Representativeness of the exposed cohort 
a) truly representative of the average _tennis elbow  (describe) in the community 
 tennis elbow clearly defined )  
 
b) somewhat representative of the average ______________ in the community  
c) selected group of users eg nurses, volunteers 
d) no description of the derivation of the cohort 
2) Selection of the non exposed cohort 
a) drawn from the same community as the exposed cohort  primary care 
b) drawn from a different source 
c) no description of the derivation of the non exposed cohort  
3) Ascertainment of exposure 
a) secure record (eg surgical records)  
b) structured interview  by lead author 
c) written self report 
d) no description 
4) Demonstration that outcome of interest was not present at start of study 
a) yes   outcome of interest (pain & disability) were present (as they needed to be) at 
start 
b) no 
Comparability 
1) Comparability of cohorts on the basis of the design or analysis 
a) study controls for __gender_________ (select the most important factor)  
b) study controls for any additional factor   (This criteria could be modified to indicate 
specific                   control for a second important factor.)    
Outcome 
1) Assessment of outcome  
a) independent blind assessment   
b) record linkage  
c) self report  
d) no description 
2) Was follow-up long enough for outcomes to occur 
a) yes (select an adequate follow up period for outcome of interest)  
b) no 
3) Adequacy of follow up of cohorts 
a) complete follow up - all subjects accounted for   
b) subjects lost to follow up unlikely to introduce bias - small number lost - > ____ % 
(select an                     adequate %) follow up, or description provided of those lost)  
     c) follow up rate < ____% (select an adequate %) and no description of those lost 
d) no statement 
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(Kromer et al 2014) 
NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE -COHORT STUDIES 
 
Note: A study can be awarded a maximum of one star for each numbered item within the 
Selection and Outcome categories. A maximum of two stars can be given for Comparability 
Selection 
1) Representativeness of the exposed cohort 
a) truly representative of the average _rotator cuff  (describe) in the community  
sub acromial pain clearly defined )  
 
b) somewhat representative of the average ______________ in the community  
c) selected group of users eg nurses, volunteers 
d) no description of the derivation of the cohort 
2) Selection of the non exposed cohort 
a) drawn from the same community as the exposed cohort  No non-exposed cohort 
b) drawn from a different source 
c) no description of the derivation of the non exposed cohort  
3) Ascertainment of exposure 
a) secure record (eg surgical records)  Ascertained from a RCT 
b) structured interview  
c) written self report 
d) no description 
4) Demonstration that outcome of interest was not present at start of study 
a) yes   outcome of interest (pain & disability) were present (as they needed to be) at 
start 
b) no 
Comparability 
1) Comparability of cohorts on the basis of the design or analysis 
a) study controls for _____________ (select the most important factor)  
b) study controls for any additional factor   (This criteria could be modified to indicate 
specific                   control for a second important factor.)    
Outcome 
1) Assessment of outcome  
a) independent blind assessment   
b) record linkage  
c) self report  
d) no description 
2) Was follow-up long enough for outcomes to occur 
a) yes (select an adequate follow up period for outcome of interest)  
b) no 
3) Adequacy of follow up of cohorts 
a) complete follow up - all subjects accounted for   
b) subjects lost to follow up unlikely to introduce bias - small number lost - > __2__ % 
(select an                     adequate %) follow up, or description provided of those lost)  
     c) follow up rate < ____% (select an adequate %) and no description of those lost 
d) no statement 
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(Haahr & Andersen 2003) 
NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE -COHORT STUDIES 
 
Note: A study can be awarded a maximum of one star for each numbered item within the 
Selection and Outcome categories. A maximum of two stars can be given for Comparability 
 
Selection 
1) Representativeness of the exposed cohort 
a) truly representative of the average _TENNIS ELBOW______ (describe) in the 
community   tennis elbow clearly defined. 289 consecutively diagnosed cases utilised. 
b) somewhat representative of the average ______________ in the community  
c) selected group of users eg nurses, volunteers 
d) no description of the derivation of the cohort 
2) Selection of the non exposed cohort 
a) drawn from the same community as the exposed cohort  
b) drawn from a different source 
c) no description of the derivation of the non exposed cohort  
3) Ascertainment of exposure 
a) secure record (eg surgical records) consulted GP 
b) structured interview  
c) written self report 
d) no description 
4) Demonstration that outcome of interest was not present at start of study 
a) yes All had pain and disability present 
b) no 
Comparability 
1) Comparability of cohorts on the basis of the design or analysis 
a) study controls for _____________ (select the most important factor)  
b) study controls for any additional factor   (This criteria could be modified to indicate 
specific                   control for a second important factor.)  
Outcome 
1) Assessment of outcome  
a) independent blind assessment   primary outcome assessment was done 
independently, based on patient self-reports in follow up questinnnares 
b) record linkage  
c) self report  
d) no description 
2) Was follow-up long enough for outcomes to occur 
a) yes (select an adequate follow up period for outcome of interest)  1 year follow up 
to assess pain and disability 
b) no 
3) Adequacy of follow up of cohorts 
a) complete follow up - all subjects accounted for   
b) subjects lost to follow up unlikely to introduce bias - small number lost - > ____ % 
(select an                     adequate %) follow up, or description provided of those lost) 
227 o238 followed up  
c) follow up rate < ____% (select an adequate %) and no description of those lost 
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(Lee et al 2014) 
NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE -COHORT STUDIES 
 
Note: A study can be awarded a maximum of one star for each numbered item within the 
Selection and Outcome categories. A maximum of two stars can be given for Comparability 
 
Selection 
1) Representativeness of the exposed cohort 
a) truly representative of the average _TENNIS ELBOW______ (describe) in the 
community   tennis elbow clearly defined. 108 consecutive patients utilised. 
b) somewhat representative of the average ______________ in the community  
c) selected group of users eg nurses, volunteers 
d) no description of the derivation of the cohort 
2) Selection of the non exposed cohort 
a) drawn from the same community as the exposed cohort  
b) drawn from a different source 
c) no description of the derivation of the non exposed cohort  
3) Ascertainment of exposure 
a) secure record (eg surgical records)  
b) structured interview  
c) written self report 
d) no description 
4) Demonstration that outcome of interest was not present at start of study 
a) yes All had pain and disability present 
b) no 
Comparability 
1) Comparability of cohorts on the basis of the design or analysis 
a) study controls for _____________ (select the most important factor)  
b) study controls for any additional factor   (This criteria could be modified to indicate 
specific                   control for a second important factor.)  
Outcome 
1) Assessment of outcome  
a) independent blind assessment   2 researchers blinded to patient data or survey 
results 
b) record linkage  
c) self report  
d) no description 
2) Was follow-up long enough for outcomes to occur 
a) yes (select an adequate follow up period for outcome of interest)  1 year follow up 
to assess pain and disability 
b) no 
3) Adequacy of follow up of cohorts 
a) complete follow up - all subjects accounted for   
b) subjects lost to follow up unlikely to introduce bias - small number lost - > ____ % 
(select an                     adequate %) follow up, or description provided of those lost) 
91 of 108 followed up  
c) follow up rate < ____% (select an adequate %) and no description of those lost 
d) no statement 
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(Silbernagel et al 2011) 
NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE -COHORT STUDIES 
 
Note: A study can be awarded a maximum of one star for each numbered item within the 
Selection and Outcome categories. A maximum of two stars can be given for Comparability 
 
Selection 
1) Representativeness of the exposed cohort 
a) truly representative of the average ____ (describe) in the community   
b) somewhat representative of the average ______________ in the community  
Achilles tendinopathy clearly described. Cohort derived from a RCT ( small representative 
sample n=31) 
c) selected group of users eg nurses, volunteers 
d) no description of the derivation of the cohort 
2) Selection of the non exposed cohort 
a) drawn from the same community as the exposed cohort  
b) drawn from a different source 
c) no description of the derivation of the non exposed cohort  
3) Ascertainment of exposure 
a) secure record (eg surgical records)  
b) structured interview  
c) written self report 
d) no description 
4) Demonstration that outcome of interest was not present at start of study 
a) yes All had pain and disability present 
b) no 
Comparability 
1) Comparability of cohorts on the basis of the design or analysis 
a) study controls for __AGE___________ (select the most important factor)  
b) study controls for any additional factor   (This criteria could be modified to indicate 
specific                   control for a second important factor.)  
Outcome 
1) Assessment of outcome  
a) independent blind assessment   
b) record linkage  
c) self report  VISA-A, TSK & PAS 
d) no description 
2) Was follow-up long enough for outcomes to occur 
a) yes (select an adequate follow up period for outcome of interest)  5 year follow up 
to assess pain and disability 
b) no 
3) Adequacy of follow up of cohorts 
a) complete follow up - all subjects accounted for   
b) subjects lost to follow up unlikely to introduce bias - small number lost - > ____ % 
(select an                     adequate %) follow up, or description provided of those lost) 
90% followed up  
c) follow up rate < ____% (select an adequate %) and no description of those lost 
d) no statement 
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(Van Wilgen et al 2013) 
NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE -COHORT STUDIES 
 
Note: A study can be awarded a maximum of one star for each numbered item within the 
Selection and Outcome categories. A maximum of two stars can be given for Comparability 
Selection 
1) Representativeness of the exposed cohort 
a) truly representative of the average (describe) in the community   
b) somewhat representative of the average ______________ in the community  
c) selected group of users eg nurses, volunteers Only male subjects asked to participate.  
d) no description of the derivation of the cohort 
2) Selection of the non exposed cohort 
a) drawn from the same community as the exposed cohort  male sports population 
b) drawn from a different source 
c) no description of the derivation of the non exposed cohort  
3) Ascertainment of exposure 
a) secure record (eg surgical records)   from attending physician 
b) structured interview  
c) written self report 
d) no description 
4) Demonstration that outcome of interest was not present at start of study 
a) yes   outcome of interest (pain & disability) were present (as they needed to be) at 
start 
b) no 
Comparability 
1) Comparability of cohorts on the basis of the design or analysis 
a) study controls for _____________ (select the most important factor)  
b) study controls for any additional factor   (This criteria could be modified to indicate 
specific                   control for a second important factor.)  
Outcome 
1) Assessment of outcome  
a) independent blind assessment    
b) record linkage  
c) self report  
d) no description no blinding evident 
2) Was follow-up long enough for outcomes to occur 
a) yes (select an adequate follow up period for outcome of interest)  
b) no 
3) Adequacy of follow up of cohorts 
a) complete follow up - all subjects accounted for   
b) subjects lost to follow up unlikely to introduce bias - small number lost - > __2__ % 
(select an                     adequate %) follow up, or description provided of those lost)  
     c) follow up rate < ____% (select an adequate %) and no description of those lost 
d) no statement 
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APPENDIX 4 – Published Narrative Review 
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APPENDIX 5 – Published Narrative Review  
 
 
 
 
 
 
 
220 
 
 
 
 
 
 
 
 
221 
 
 APPENDIX 6 – STROBE Checklist 
STROBE Statement—Checklist of items that should be included in reports of cohort studies  
 
 
Item 
No Recommendation 
Page No 
Title and abstract 1 (a) Indicate the study’s design with a commonly 
used term in the title or the abstract 
86 
(b) Provide in the abstract an informative and 
balanced summary of what was done and what 
was found 
- 
Introduction 
Background/rationale 2 Explain the scientific background and rationale 
for the investigation being reported 
86-87 
Objectives 3 State specific objectives, including any 
prespecified hypotheses 
88 
Methods 
Study design 4 Present key elements of study design early in 
the paper 
89 
Setting 5 Describe the setting, locations, and relevant 
dates, including periods of recruitment, 
exposure, follow-up, and data collection 
89 
Participants 6 (a) Give the eligibility criteria, and the sources 
and methods of selection of participants. 
Describe methods of follow-up 
89 
(b) For matched studies, give matching criteria 
and number of exposed and unexposed 
- 
Variables 7 Clearly define all outcomes, exposures, 
predictors, potential confounders, and effect 
modifiers. Give diagnostic criteria, if applicable 
91 
Data sources/ 
measurement 
8*  For each variable of interest, give sources of 
data and details of methods of assessment 
(measurement). Describe comparability of 
assessment methods if there is more than one 
group 
91-95 
Bias 9 Describe any efforts to address potential 
sources of bias 
90 
Study size 10 Explain how the study size was arrived at 95 
Quantitative variables 11 Explain how quantitative variables were 
handled in the analyses. If applicable, describe 
which groupings were chosen and why 
99 
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Statistical methods 12 (a) Describe all statistical methods, including 
those used to control for confounding 
99 
(b) Describe any methods used to examine 
subgroups and interactions 
- 
(c) Explain how missing data were addressed 101 
(d) If applicable, explain how loss to follow-up 
was addressed 
102 
(e) Describe any sensitivity analyses - 
Results 
 
Participants 13* (a) Report numbers of individuals at each stage 
of study—eg numbers potentially eligible, 
examined for eligibility, confirmed eligible, 
included in the study, completing follow-up, 
and analysed 
102 
(b) Give reasons for non-participation at each 
stage 
101 
(c) Consider use of a flow diagram 102 
Descriptive data 14* (a) Give characteristics of study participants (eg 
demographic, clinical, social) and information 
on exposures and potential confounders 
105 
(b) Indicate number of participants with 
missing data for each variable of interest 
105 
(c) Summarise follow-up time (eg, average and 
total amount) 
111 
Outcome data 15* Report numbers of outcome events or 
summary measures over time 
110-11 
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 APPENDIX 7 – HRA Ethical Approval Letter 
  
  
Mr Adrian J Mallows    
Lecturer in Physiotherapy & PhD Student  Email: hra.approval@nhs.net  
University of Essex  
School of Sport, Rehabilitation and Exercise Sciences  
Wivenhoe Park  
Essex  
CO4 3SQ  
  
15 September 2017  
  
Dear Mr Mallows    
  
Letter of HRA Approval  
  
Study title:  The association of working alliance, outcome expectation, 
adherence and self-efficacy with clinical outcomes for 
Achilles tendon-related pain: protocol for a pilot cohort 
study (the MAP study)                 
IRAS project ID:  219457   
REC reference:  17/LO/1583    
Sponsor  University of Essex  
  
I am pleased to confirm that HRA Approval has been given for the above referenced study, on the basis 
described in the application form, protocol, supporting documentation and any clarifications noted in this 
letter.   
  
Participation of NHS Organisations in England   
The sponsor should now provide a copy of this letter to all participating NHS organisations in England.   
  
Appendix B provides important information for sponsors and participating NHS organisations in England 
for arranging and confirming capacity and capability. Please read Appendix B carefully, in particular 
the following sections:  
• Participating NHS organisations in England – this clarifies the types of participating 
organisations in the study and whether or not all organisations will be undertaking the same 
activities  
• Confirmation of capacity and capability - this confirms whether or not each type of 
participating NHS organisation in England is expected to give formal confirmation of capacity 
and capability. Where formal confirmation is not expected, the section also provides details on 
the time limit given to participating organisations to opt out of the study, or request additional 
time, before their participation is assumed.  
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• Allocation of responsibilities and rights are agreed and documented (4.1 of HRA 
assessment criteria) - this provides detail on the form of agreement to be used in the study to 
confirm capacity and capability, where applicable.  
Page 1 of 8  
Further information on funding, HR processes, and compliance with HRA criteria and standards is also 
provided.  
  
It is critical that you involve both the research management function (e.g. R&D office) supporting each 
organisation and the local research team (where there is one) in setting up your study. Contact details and 
further information about working with the research management function for each organisation can be 
accessed from www.hra.nhs.uk/hra-approval.   
  
Appendices  
The HRA Approval letter contains the following appendices:  
• A – List of documents reviewed during HRA assessment  
• B – Summary of HRA assessment  
  
After HRA Approval  
The document “After Ethical Review – guidance for sponsors and investigators”, issued with your 
REC favourable opinion, gives detailed guidance on reporting expectations for studies, including:   
• Registration of research  
• Notifying amendments  
• Notifying the end of the study  
The HRA website also provides guidance on these topics, and is updated in the light of changes in reporting 
expectations or procedures.  
  
In addition to the guidance in the above, please note the following:  
• HRA Approval applies for the duration of your REC favourable opinion, unless otherwise 
notified in writing by the HRA.  
• Substantial amendments should be submitted directly to the Research Ethics Committee, as 
detailed in the After Ethical Review document. Non-substantial amendments should be 
submitted for review by the HRA using the form provided on the HRA website, and emailed to 
hra.amendments@nhs.net.   
• The HRA will categorise amendments (substantial and non-substantial) and issue confirmation of 
continued HRA Approval. Further details can be found on the HRA website.  
  
Scope   
HRA Approval provides an approval for research involving patients or staff in NHS organisations in 
England.   
  
If your study involves NHS organisations in other countries in the UK, please contact the relevant national 
coordinating functions for support and advice. Further information can be found at 
http://www.hra.nhs.uk/resources/applying-for-reviews/nhs-hsc-rd-review/.  
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If there are participating non-NHS organisations, local agreement should be obtained in accordance with 
the procedures of the local participating non-NHS organisation.  
  
User Feedback  
The Health Research Authority is continually striving to provide a high quality service to all applicants and 
sponsors. You are invited to give your view of the service you have received and the application procedure. 
If you wish to make your views known please use the feedback form available on the HRA website: 
http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance/.  
  
HRA Training  
We are pleased to welcome researchers and research management staff at our training days – see details at 
http://www.hra.nhs.uk/hra-training/   
  
Your IRAS project ID is 219457. Please quote this on all correspondence.  
  
Yours sincerely  
  
Kelly Rowe  
Assessor  
  
Email: hra.approval@nhs.net    
  
  
  
Copy to:  Ms Sarah Manning-Press, University of Essex, Sponsor Representative     
Craig Mackerness, Southend University Hospital NHS Foundation Trust, 
Lead NHS R&D contact     
      
      
      
  
    
Appendix A - List of Documents  
  
The final document set assessed and approved by HRA Approval is listed below.    
  
 Document    Version    Date    
Copies of advertisement materials for research participants [Card 
given to potential participants]   
2.0   18 July 2017   
Covering letter on headed paper [Covering letter explaining changes 
which have been made]   
    02 August 2017   
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Evidence of Sponsor insurance or indemnity (non NHS Sponsors 
only)   
   15 July 2017   
HRA Schedule of Events [Validated SOE]   1.0   15 September 2017  
HRA Statement of Activities [Validated SOA]   1.0   15 September 2017  
Interview schedules or topic guides for participants   2.0   18 July 2017   
IRAS Application Form [IRAS_Form_29082017]      29 August 2017   
Letter from sponsor      17 August 2017   
Letters of invitation to participant [Email invitation for participation 
in the follow up interview]   
1.0   02 August 2017   
Non-validated questionnaire [The questionnaire is compiled of 
validated outcome measures ]   
2.0   18 July 2017   
Other [CV for collaborator]   2.0   18 July 2017   
Other [CV for 2nd collaborator]   2.0   18 July 2017   
Other [Interview consent form]   1.0   18 July 2017   
Other [Letter from private site]   1.0   02 August 2017   
Other [REC letter]   NA   13 July 2017   
Other [Email invitation to complete questionnaire for 2nd time]   1.0   13 September 2017  
Other [Email invitation to complete questionnaire for 3rd time]   1.0   13 September 2017  
Other [response to Camden and Kings Cross PR Sub-Committee]   1.0   13 September 2017  
Participant consent form [Online consent form]   2.0   18 July 2017   
Participant information sheet (PIS) [Changes are highlighted]   2.0   18 July 2017   
Research protocol or project proposal [Changes are highlighted in 
response to London Central REC and track changes used in 
response to PR Sub-Committee from Camden]   
3.0   13 September 2017  
Summary CV for Chief Investigator (CI)      18 July 2017   
Summary CV for student      18 July 2017   
Summary CV for supervisor (student research)      18 July 2017   
      
Appendix B - Summary of HRA Assessment  
  
This appendix provides assurance to you, the sponsor and the NHS in England that the study, as reviewed 
for HRA Approval, is compliant with relevant standards. It also provides information and clarification, 
where appropriate, to participating NHS organisations in England to assist in assessing and arranging 
capacity and capability.  
For information on how the sponsor should be working with participating NHS organisations in  
England, please refer to the, participating NHS organisations, capacity and capability 
and Allocation of responsibilities and rights are agreed and documented (4.1 of HRA 
assessment criteria) sections in this appendix.   
The following person is the sponsor contact for the purpose of addressing participating organisation 
questions relating to the study:  
  
Name: Ms Sarah Manning-Press  
Tel: 01206873561  
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Email: sarahm@essex.ac.uk   
  
HRA assessment criteria   
Section  HRA Assessment 
Criteria  
Compliant 
with 
Standards  
Comments  
1.1  IRAS application completed 
correctly  
Yes  NHS involvement will be through PIC 
activity.   
        
2.1  Participant 
information/consent 
documents and consent 
process  
Yes  No comments  
        
3.1  Protocol assessment  Yes  No comments  
        
4.1  Allocation of responsibilities 
and rights are agreed and 
documented   
Yes  The statement of activities will act as 
agreement of an NHS organisation to 
participate.   
No further agreements expected   
  
Although formal confirmation of 
capacity and capability is not expected 
of all or some organisations 
participating in this study (see  
Confirmation of Capacity and 
Capability section for full details), and 
such  
 
Section  HRA Assessment 
Criteria  
Compliant 
with 
Standards  
Comments  
   organisations would therefore be 
assumed to have confirmed their 
capacity and capability should they not 
respond to the contrary, we would ask 
that these organisations pro-actively 
engage with the sponsor in order to 
confirm at as early a date as possible.  
Confirmation in such cases should be 
by email to the CI and Sponsor 
confirming participation based on the 
relevant Statement of Activities and 
information within this Appendix B.  
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4.2  Insurance/indemnity 
arrangements assessed  
Yes  Where applicable, independent 
contractors (e.g. General Practitioners) 
should ensure that the professional 
indemnity provided by their medical 
defence organisation covers the 
activities expected of them for this 
research study  
4.3  Financial arrangements 
assessed   
Yes  No external application for funding has 
been made, study will be undertaken as 
part of a PhD   
The statement of activities confirms that 
there is no funding available to sites 
from the sponsor.  
        
5.1  Compliance with the Data 
Protection Act and data 
security issues assessed  
Yes  No comments  
5.2  CTIMPS – Arrangements for 
compliance with the Clinical 
Trials Regulations assessed  
Not Applicable  No comments  
5.3  Compliance with any 
applicable laws or regulations  
Yes  No comments  
        
6.1  NHS Research Ethics  
Committee favourable opinion 
received for applicable studies  
Yes  
  
REC FO dated 14/09/2017  
6.2  CTIMPS – Clinical Trials 
Authorisation (CTA) letter  
Not Applicable  No comments  
Section  HRA Assessment 
Criteria  
Compliant 
with 
Standards  
Comments  
 received    
6.3  Devices – MHRA notice of no 
objection received  
Not Applicable  No comments  
6.4  Other regulatory approvals 
and authorisations received  
Not Applicable  No comments  
  
Participating NHS Organisations in England  
This provides detail on the types of participating NHS organisations in the study and a statement as 
to whether the activities at all organisations are the same or different.   
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There is one site type; participating NHS organisations will be Participant Identification Centres (PIC).  
An information card is to be given to potential eligible patients by their treating physiotherapist.  
Patient will then access the website for further information of their own free will. 
Researcher will conduct interviews with participants via telephone or Skype.  
   
The Chief Investigator or sponsor should share relevant study documents with participating NHS 
organisations in England in order to put arrangements in place to deliver the study. The documents 
should be sent to both the local study team, where applicable, and the office providing the research 
management function at the participating organisation. For NIHR CRN Portfolio studies, the Local 
LCRN contact should also be copied into this correspondence.  For further guidance on working with 
participating NHS organisations please see the HRA website.  
  
If chief investigators, sponsors or principal investigators are asked to complete site level forms for 
participating NHS organisations in England which are not provided in IRAS or on the HRA website, 
the chief investigator, sponsor or principal investigator should notify the HRA immediately at 
hra.approval@nhs.net. The HRA will work with these organisations to achieve a consistent approach to 
information provision.   
  
Confirmation of Capacity and Capability   
This describes whether formal confirmation of capacity and capability is expected from participating 
NHS organisations in England.  
The HRA has determined that participating NHS organisations in England (PIC Sites) are not 
expected to formally confirm their capacity and capability to host this research, 
because of their limited involvement in this study.   
• The HRA has informed the relevant research management offices that you intend to undertake 
the research at their organisation. However, you should still support and liaise with these 
organisations as necessary.  
• Following issue of the HRA Approval letter, and subject to the two conditions below, it is 
expected that these organisations will become participating NHS organisations 35 days after issue 
of this Letter of HRA Approval (no later than 20/10/2017):  
 o You may not include the NHS organisation if they provide justification to the sponsor 
and the HRA as to why the organisation cannot participate  
o You may not include the NHS organisation if they request additional time to confirm, 
until they notify you that the considerations have been satisfactorily completed..  
  You may include NHS organisations in this study in advance of the deadline above where the 
organisation confirms by email to the CI and sponsor that the research may proceed.   
  The document “Collaborative working between sponsors and NHS organisations in England 
for HRA Approval studies, where no formal confirmation of capacity and capability is 
expected” provides further information for the sponsor and NHS organisations on working 
with NHS organisations in England where no formal confirmation of capacity and capability is 
expectations, and the processes involved in adding new organisations. Further study specific 
details are provided the Participating NHS Organisations and Allocation of 
responsibilities and rights are agreed and documented (4.1 of HRA assessment 
criteria) sections of this Appendix.  
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Principal Investigator Suitability  
This confirms whether the sponsor position on whether a PI, LC or neither should be in place is 
correct for each type of participating NHS organisation in England and the minimum expectations for 
education, training and experience that PIs should meet (where applicable).  
A local collaborator is expected at participants NHS organisations. CI will provide guidance on the 
eligibility criteria to the local collaborator.  
  
GCP training is not a generic training expectation, in line with the HRA statement on training 
expectations.  
  
HR Good Practice Resource Pack Expectations  
This confirms the HR Good Practice Resource Pack expectations for the study and the pre-
engagement checks that should and should not be undertaken  
It is anticipated that participant identification will be completed by local staff with existing contractual 
arrangements with the participating NHS organisation. No further HR good practice arrangements 
expected.  
  
Other Information to Aid Study Set-up   
This details any other information that may be helpful to sponsors and participating NHS organisations 
in England to aid study set-up.  
The applicant has indicated that they do not intend to apply for inclusion on the NIHR CRN Portfolio.  
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APPENDIX 8 - Postcard 
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APPENDIX 9 – Physiotherapists’ Training  
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APPENDIX 10 – Participant Information Sheet 
Participant Information Sheet 
 
Managing Achilles Pain – a pilot study 
 
Adrian Mallows, PhD Student and Chief Investigator 
Professor Jo Jackson, Academic Supervisor 
 
We would like to invite you to take part in our research study. Before you decide, we would like you to understand 
why the research is being done and what it would involve for you. Please take time to read the following 
information carefully. Talk to others about the study if you wish. Please ask us if there is anything that is not 
clear. 
 
Background to the study 
Having a painful Achilles tendon is fairly common. Recent research suggests how treatment is 
delivered may be influential on the success of treatment.  Based on previous work, we think a 
person’s expectations, beliefs and who delivers the treatment to them may be important. 
 
What is the purpose of the study? 
Exploring these factors has yet to be investigated, and in order to do so we have designed this ‘pilot 
study’ to help us develop a larger study. 
 
Why have I been invited? 
You have been invited because you are currently undergoing treatment for a painful Achilles tendon. 
 
Do I have to take part? 
No, it is up to you to decide to join the study. You can change your mind at any time and decide not to participate. 
The treatment and standard of care you receive will not be affected in any way if you decide not to take part 
now or if you withdraw from the study later. We are happy to answer any questions you may have before 
deciding whether you wish to take part in this study. 
 
What will I have to do? 
We are asking people to complete a questionnaire 3 times over a 3 month period. You will be contacted by 
email to remind you to take the follow up questionnaires. You may then be invited to participate in a follow 
up interview about your experience of the study. This interview will take place using a video call over the 
internet or simply by telephone. The interviews will be audio recorded and transcribed by the Chief 
Investigator, Adrian Mallows. 
 
Expenses and payments 
There are no expenses or payments for your participation. 
 
What are the possible disadvantages and risks of taking part? 
The questionnaire will take around 15 minutes to complete each time. A follow up interview will last around 
30 minutes. There are no anticipated risks associated with your participation. 
 
 
 
What are the possible benefits of taking part? 
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There are no direct benefits to you, but we hope the information derived from this study will help improve 
the future treatment of people with painful Achilles tendons. 
 
What will happen if I don’t want to carry on with the study? 
All information collected prior to your withdrawal with your permission will be used, but no further data 
will be collected. 
 
What if there is a problem? 
If you have any concerns about any aspect of this study, please contact the Chief Investigator, Adrian 
Mallows. You can do this by email amallows@essex.ac.uk or telephone 01206 873847. Alternatively, you 
can contact his PhD supervisor Professor Jo Jackson at the University of Essex. You can do this by email 
jo.jackson@essex.ac.uk or by telephone 01206 874230. They will do his best to answer your questions, 
however, if you remain unhappy and wish to provide any feedback, or formally complain you can do this by 
contacting Sarah Manning-Press, the Research Governance and Planning Manager, Research Office, 
University of Essex, Wivenhoe Park, Colchester, CO4 3SQ or by emailing: sarahm@essex.ac.uk. 
 
Will my taking part in this study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will be handled in confidence 
and will not be shared with anyone, including your physiotherapist. The questionnaire will not collect any 
personally identifiable data, but will ask you for your email address so that you can be reminded to take the 
follow up questionnaires and potentially be invited for a follow up interview. All data storage will comply 
with EU data protection regulation. The data collected are stored on a secure, encrypted website called 
Qualtrics. The website is password protected with only the Chief Investigator having access to the survey’s 
data. If you participate in a follow up interview, the audio recordings will not collect any personally 
identifiable data and will be stored on a secure computer at the University of Essex. Direct quotes may be 
used from the recordings and these will be anonymised. Only the Chief Investigator and his academic 
supervisors will listen to the recordings, and these will be destroyed after they have been transcribed. This 
transcription will then be stored for 5 years.  
 
What will happen to the results of the research study? 
It is anticipated the results from the study will be published and presented at scientific meetings. There is no 
formal plan to make the results available to participants, however if you would like to obtain a copy please 
contact Adrian Mallows by email amallows@essex.ac.uk or by telephone 01206 873847. 
 
Who is organising and funding the research? 
The study is being organised by Adrian Mallows as a part of his PhD at The University of Essex. There is 
no external funding. 
 
Who has reviewed the study? 
The NHS Health Research Authority have reviewed the study and given approval for the conduct of the 
research (IRAS ID: 219457). 
 
Further information and contact details 
For further information, please contact Adrian Mallows by email amallows@essex.ac.uk or by telephone 
01206 873847. 
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APPENDIX 11 – Participant Consent Form 
CONSENT FORM 
1.     I confirm that I have read the information sheet dated 19th May 2017(version 1:1) for the 
above study. I have had the opportunity to consider the information, ask questions and have 
had these answered satisfactorily. 
 I agree 
2.     I understand that my participation is voluntary and that I am free to withdraw at any time, without 
giving any reason, without my medical care or legal rights being affected. 
 
 I agree 
3.    I understand that the information collected about me will be used to support 
other research in the future, and may be shared anonymously with other researchers. 
 
 I agree 
4.   I agree to providing an email address in order for the researchers to send me the 2 further questionnaires 
 
  
 I agree 
6.  I am willing to be invited by email to participate in a follow-up study. 
 I agree 
 I do not agree 
If I participate in a follow-up study, I agree for the interview to be audio-recorded and transcribed by the 
chief investigator. I am aware that this recording will be listened to by the chief investigator and academic 
supervisors. I am aware this recording will be kept on a secure computer on University premises and will be 
destroyed after 5 years.  
 I agree 
 I do not agree 
I consent to direct quotes being used from the recording of my interview 
 I agree 
 I do not agree 
7.    If I choose to withdraw from the study, I understand all information collected prior to my 
withdrawal will be used, but no further data will be collected. 
 I agree 
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 I do not agree 
I understand that relevant sections of data collected during the study, may be looked at by individuals from 
the University of Essex, from regulatory authorities or from the NHS Trust, where it is relevant to my taking 
part in this research. I give permission for these individuals to have access to my records“ 
 I agree 
 I do not agree 
5.    I agree to take part in the study. 
 I agree 
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APPENDIX 12 – Emails for Follow Up 
Dear XXXX 
 
Thank you for taking part in the Managing Achilles Pain study and completing the questionnaire for the first 
time.  
 
As we are measuring change over time, I would like to ask you to complete the questionnaire for a second 
time. Here is the link to the website hosting the questionnaire https://managing-achilles-pain.com/. The 
password is essex. Just to remind you, all your answers are kept confidential and are helpful to progressing 
the future treatment for people with painful Achilles tendons. 
 
If you have any questions please let me know. 
 
Best Wishes 
 
Adrian 
 
Adrian Mallows  
Lecturer in Physiotherapy 
MSc (pre-reg) Physiotherapy Programme Lead 
School of Sport, Rehabilitaion and Exercise Sciences 
University of Essex 
Room 2S2.5.22 
 
T +44 (0)1206 873847 
E amallows@essex.ac.uk 
►https://www1.essex.ac.uk/sres/  
 
WE ARE ESSEX 
TOP 20 FOR RESEARCH EXCELLENCE 
TEF GOLD 2017 
 
 
  
259 
 
Dear XXXX 
 
Thank you for taking part in the Managing Achilles Pain study and completing the questionnaire for the 
second time.  
 
As we are measuring change over time, I would like to ask you to complete the questionnaire for the third 
and final time. Here is the link to the website hosting the questionnaire https://managing-achilles-
pain.com/. The password is ‘essex’. Just to remind you, all your answers are kept confidential and are helpful 
to progressing the future treatment for people with painful Achilles tendons. 
 
If you have any questions please let me know. 
 
Best Wishes 
 
Adrian 
 
Adrian Mallows  
Lecturer in Physiotherapy 
MSc (pre-reg) Physiotherapy Programme Lead 
School of Sport, Rehabilitaion and Exercise Sciences 
University of Essex 
Room 2S2.5.22 
 
T +44 (0)1206 873847 
E amallows@essex.ac.uk 
►https://www1.essex.ac.uk/sres/  
 
WE ARE ESSEX 
TOP 20 FOR RESEARCH EXCELLENCE 
TEF GOLD 2017 
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APPENDIX 13 – GRIPP 2 Checklist 
 
 
 
Section and topic Item Reported 
on page No 
1: Aim Report the aim of PPI in the study  100 
2: Methods Provide a clear description of the methods 
used for PPI in the study 
 100 
3: Study results Outcomes—Report the results of PPI in 
the study, including both positive and 
negative outcomes 
 100 
4: Discussion and 
conclusions 
Outcomes—Comment on the extent to 
which PPI influenced the study overall. 
Describe positive and negative effects 
 100 
5: Reflections/critical 
perspective 
Comment critically on the study, 
reflecting on the things that went well and 
those that did not, so others can learn from 
this experience 
 100 
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APPENDIX 14 – Published Process Evaluation 
Managing Achilles Pain (the MAP study) – a process evaluation of data collection methods 
 
Introduction  
The Managing Achilles Pain study (MAP study) had the primary aim of assessing the feasibility of the 
protocol for a future large longitudinal cohort study that would investigate the association and predictive 
relationship of contextual influences (self-efficacy, working alliance and expectations) with outcome in the 
management of Achilles tendinopathy (AT) (see supplementary file 1 for full protocol). In recent times, such 
factors have been highlighted as potentially relevant factors that would benefit from investigation in 
tendinopathy [16,327].  The MAP study enrolled twenty-four participants with Achilles tendinopathy; 
participants were directed to an internet-based data collection method by their treating physiotherapist. 
Participants completed the same internet-based questionnaire relating to the contextual factors discussed 
previously, and the pain and disability relating to their AT at three data collection points over a three month 
period. Such a data collection method was untested, therefore, to understand more about how the data 
collection worked, we undertook a process evaluation. Process evaluations explore the way in which a study 
was conducted and can provide valuable insight into why studies work well or fail as a basis for a future large 
study [299]. The Medical Research Council (MRC) has provided a framework for process evaluation, arguing 
that process evaluation can have a vital role in understanding the feasibility and optimising its design and 
evaluation [300]. The aim of the process evaluation reported here was to investigate factors affecting the 
implementation, context and mechanisms of impact on the data collection process described above (figure 
1). These factors were considered from both the participants’ and physiotherapists’ perspectives. Whilst this 
process evaluation refers to the data collection methods of the MAP study, the data generated can provide 
guidance to researchers developing study protocols for similar studies.   
 
 
Figure 1. Key functions of a process evaluation and relationships amongst them. Blue boxes represent 
components of process evaluation, which are informed by the causal assumptions of the intervention, and 
inform the interpretation of outcomes [300]. 
 
Ethical Approval 
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Ethical approval was sought and granted on 14th September 2017 (IRAS project ID: 219457, REC reference 
17/LO/1583). 
 
Methodological Approach 
To realise the critical importance of participants’ own interpretations of the issues researched, our process 
evaluation took a ‘critical realist’ perspective to evaluate participant perspectives, believing that the varying 
vantage points of different participants would yield different types of understanding [242]. This perspective 
was adopted to ensure data collection methods and analytical strategies best met the objectives of the process 
evaluation [301–303] and focused on accurately describing participants’ experiences, staying close to the 
data, and ensuring subsequent interpretations are transparent [304,305]. The consolidated criteria for 
reporting qualitative research (COREQ) checklist provided guidance during the reporting of this study [328]. 
 
Methods 
We utilised the MRC framework outlined in figure 1 to meet the predetermined aim; data was sought to 
determine factors influencing insights into factors affecting the implementation, context and mechanisms of 
impact from the data collection procedures during the MAP study [300]. The process sought to discover 
what worked (and did not), for whom, how, why and in what circumstances.   
 
Data collection 
Whilst traditionally face to face interviews have been the preferred mode of conduct, recent research has 
highlighted that  face to face interviews are not inherently superior to telephone interviews [306]. 
Consequently, to minimise burden on the interviewee (participant or physiotherapist), one-on-one 
interviews were conducted remotely by the lead author, a PhD candidate, via telephone. To gain maximum 
variation in responses, all participants who enrolled in the MAP study and all physiotherapists who had taken 
part in recruitment for the study, were invited to take part in this process evaluation. Participants and lead 
physiotherapists at each recruitment site were contacted by email and sent the participant information sheet 
and consent form. Lead physiotherapists were asked to share the email with all physiotherapists who had 
taken part in recruitment. Anyone considering volunteering then emailed the lead author. Both 
physiotherapists and participants were provided with the opportunity to ask questions and once any 
questions were answered, were invited to take part in one-to-one individual interviews at their convenience. 
Consent to take part in the interviews was audio recorded prior to commencing the interview. To reduce 
recall bias, selection and recruitment were completed within one month of the participant completing the 
cohort study. During the interviews the lead author took notes as needed. The lead author was unknown to 
participants but had provided recruitment training to the physiotherapists prior; consequently, the 
physiotherapists were aware of the reasons for carrying out the research and the author’s interest in the 
research topic. Semi-structured interviews were directed by a topic guide and were recorded at the University 
of Essex using a digital voice recorder and transcribed verbatim. The lead author undertook training in 
conducting interviews prior to data collection and carried out practice interviews to pilot the topic guide 
with feedback provided by one co-author (CL). 
 
Data analysis  
The data was analysed by one author (AM) using the Framework Approach. To facilitate this, a computer-
assisted analysis software (CAQDS) programme was used (NVivo Version 12, QSR International, 
Melbourne, Australia). The Framework Approach has been developed specifically for applied research in 
which the objectives of the investigation are set a priori [307]. Framework Approach is an analytic tool that 
supports key steps in the data management process, including the indexing and sorting tasks common across 
many different approaches, but adds one further step; data summary and display [242]. The framework can 
be used for indexing, but its distinctive feature is that it forms the basis of a thematic matrix, in which every 
participant is allocated a row and each column denotes a separate theme (Supplementary File 2). The 
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thematic matrix was then triangulated with interview notes and sent to all participants to verify source 
interpretation. 
 
Findings 
Data from seven participants and six physiotherapists were analysed. Three participants declined to be 
interviewed without stating a reason, and no response was received from fourteen participants. It is unknown 
how many physiotherapists participated and therefore how many did not respond. Interviews lasted up to 
30 minutes.  
 
Participant Age range* Gender 
1 30-39 years  Male 
2 60-69 years Female 
3 40-49 years Male 
4 50-59 years Male 
5 40-49 years Female 
6 40-49 years Male 
7 60-69 years Female 
Table 1. Participants’ characteristics. *Only age range was collected from participants 
 
Physiotherapist  Years Qualified Years of 
speciality in 
MSK 
Gender Private or NHS 
provider 
1 7 6 Male NHS 
2 4 3 Male Private 
3 4 4 Male NHS 
4 18 16 Male Private 
5 15 12 Female NHS 
6 3 3 Male NHS 
Table 2. Physiotherapists’ characteristics 
Physiotherapists’ perspectives of the study procedures  
Key themes 
To meet the aim of the process evaluation, two main themes were sought from the data after transcription; 
obstacles and enablers. From these two themes a further eight subthemes were identified; (1) access to 
participants; (2) recall; (3) visibility; (4) time; (5) training; (6) motivation; (7) incentives; (8) simplicity.  
 
Obstacles 
Theme 1: Access to participants 
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Difficulties in accessing the target population for the MAP study was often referred to in many of the 
interviews. Potential reasons for this varied from the serendipitous to a telephone triage system. 
“The main issue seemed to be that all my Achilles tendon patients seemed to disappear.” Physiotherapist 4. 
“I think because whether those patients get better on the phone or not, it definitely means that less of Achilles pain comes through 
to eventually see in a clinic.” Physiotherapist 3. 
 
Theme 2: Recall 
A common theme reported by the physiotherapists in the study related to difficulties in remembering to 
recruit potential participants. Some physiotherapists related this to their workload. 
“In a busy clinic remembering to provide them with the information in the first place.” Physiotherapist 1. 
 
Other physiotherapists felt that the infrequency of seeing people with Achilles tendinopathy was a 
contributing factor. 
“But yeah, other clinicians have definitely said that they forgot, and part of the reason for that, I guess, is if you see an Achilles 
tendinopathy one week and then, two or three weeks later, you see your next new patient.” Physiotherapist 2.  
 
Although training was provided, and a staff meeting was attended one month later to discuss any recruitment 
queries followed by monthly email reminders sent to the Lead Physiotherapist at each site, physiotherapists 
were keen to be contacted directly to be reminded of recruitment.  
“You might receive six or seven or eight emails from the manager, and there might be potential to only skim-read that, whereas 
if there was an email from a different source that you don't normally see in your email box, that might prompt you to pay more 
attention.” Physiotherapist 1. 
 
Theme 3: Visibility 
Participating physiotherapists outlined a common theme of needing to improve the visibility of the study to 
aid with recruitment. Some felt using posters to inform patients that the study was recruiting participants 
would be useful. Others felt it would benefit the physiotherapists. 
“If the information's there for them, the patient, they might actually start that conversation off, kind of like what you just said, 
rather than the other way around.” Physiotherapist 2. 
 
Theme 4: Time 
Time as an obstacle was often cited by the physiotherapists. Some felt a lack of time with the patient 
impacted on the success of recruitment. 
“If you got half an hour to get a patient in, treat them, manage them, and document, and then you starting thinking there are 
other things on top sometimes. So that is then pushed to the less of a priority and such.” Physiotherapist 1. 
 
Enablers 
Theme 5: Training 
A common them reported by the physiotherapists referred to the recruitment training which was provided 
for them. The training served to provide clarity on the role of the physiotherapists and installed a sense of 
confidence in the procedures which were described. 
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“I felt very confident and capable of recruiting participants after that session itself and the information given across from that.” 
Physiotherapist 5 
 
Theme 6: Motivation 
Motivation to be involved in the MAP study was commonly referred to by the physiotherapists interviewed. 
Some physiotherapists felt that the impact this might have on their care of patients was an important 
motivating factor. 
“I think the study was very much with the patient's interest at the forefront.” Physiotherapist 4. 
Physiotherapists were also motivated by the opportunity to be involved in a research project. 
“It's always interesting to get involved with any research or the data collection side of things that may turn up for our department. 
And it's important, I think, from a physio side of things to engage with that.” Physiotherapist 4. 
 
Theme 7: Incentives 
Physiotherapists discussed the potential need for incentivising the MAP study. Some physiotherapists felt a 
reward for the efforts of the physiotherapists might be warranted, although they were not sure what that 
could be. 
 “Whether you give out 10, 20 cards to appropriate patients, then you're-- not get a reward, that sounds wrong, but you're more 
likely to be able to-- I don't know. It encourages clinicians to do more from that side of things.” Physiotherapist 3. 
 
Questions were also raised with regard how participants felt incentivised. Some physiotherapists felt the 
answer laid in the opportunity to help others who are experiencing what they are.   
“And eventually, treat people that were suffering with what they've been suffering with. That seemed to be quite a key thing that 
people were interested in.” Physiotherapist 4. 
 
Theme 8: Simplicity 
A common theme discussed during the interviews with the physiotherapists was the simplicity of the MAP 
study. Most felt this was a key issue to raise to the potential participants in order to maximise recruitment. 
 “If someone has to go through something that takes them half an hour, then they're going to, generally speaking, not really want 
to fill that out or complete it. So if they know it's going to be fairly quick and easy to do, then most people will try to engage.” 
Physiotherapist 5. 
 
Participants’ perspectives of the study procedures  
Key themes 
To meet the aim of the process evaluation, three main themes were sought from the data after transcription; 
consequences, obstacles and enablers. From these three themes a further six subthemes were identified; (1) 
information from the physiotherapist; (2) follow up; (3) motivation; (4) website; (5) questionnaire; (6) 
positive experience.  
 
Obstacles 
Theme 1: Information from the physiotherapist 
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The participants interviewed often referred to the need for more quality verbal information from the 
physiotherapists at the time of recruitment. 
“If I hadn't been quite so spontaneously happy to do it, I might have benefitted with a little bit more explanation as to what 
they were trying to get out of it.” Participant 1. 
 
Most participants viewed the postcard as a positive tool, enhancing engagement in the study. 
“Eager though, I was to do it when my physiotherapist told me about it. It's one of those things that I probably would have 
forgotten about had I not had the postcard and thought, "Oh, I was going to do that. I need to do that."” Participant 4. 
 
Theme 2: Follow up 
Some participants expressed confusion around the process of being invited to complete the questionnaire 
for a second or third time. 
“I think the problem lies with the amount of rubbish we all receive over email. And I'm sure you're exactly the same as the rest 
of us. Sometimes more important things do get lost amongst the dross really, there's just so much of it.” Participant 3. 
 
Participants offered ways of improving communication, including the suggestion of adding a text message 
reminder and ensuring communications were clearly headed as to which number survey the correspondence 
was referring to. 
“Heading them up and making it clear at the start that there were going to be three and heading them up two and three, I think 
that would be very helpful.” Participant 5. 
“I don't think for future people taking part it would be that much of an extra step to give their phone number for this service 
as well.” Participant 2. 
 
Enablers 
Theme 3: Motivation 
Almost all the participants outlined their motivation for involving themselves in the MAP study. Motivation 
appeared to be largely altruistic in nature. 
 “Advancing research on such issues is beneficial for everyone, isn't it? So it's something one should do rather than not.” 
Participant 2. 
 
Theme 4: Website 
A positive experience from using the website was expressed from most of the participants. This ranged from 
providing information which was missed by the recruiting physiotherapist to the ease of navigating the 
webpage.  
“Once I got to the website page, it gave me all the information I needed.” Participant 3. 
“I don't recall being frustrated by anything. I'm easily frustrated on the Internet.” Participant 4. 
 
Theme 5: Questionnaire 
A positive engagement with the questionnaire was often cited by the participants. Particular reference was 
made to the simplicity and short duration of the questionnaire. 
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“We've all had questionnaires of customer feedback where they ask you to write so much detail, you give up because it's too 
painful. So it wasn't like that, which is really good.” Participant 3. 
 
Consequences  
Theme 6: Positive experience 
Many participants stated that their involvement in the MAP study resulted in a positive experience; it made 
them reconsider their condition and treatment and how they engaged with their physiotherapist. 
“It made me take it a bit more seriously really and feel a bit more as though, I wasn't on my own. There were other people 
obviously who were going through the same kind of problem. So maybe it validated it a bit more, I think, for me, which was 
good.” Participant 7. 
 
Discussion 
The purpose of this process evaluation was to explore the MAP study procedures from the participants’ and 
physiotherapists’ perspectives respectively. From the physiotherapists’ perspective four themes were 
identified which related to obstacles; (1) access to participants; (2) recall; (3) visibility; (4) time, and four themes 
were identified which related to facilitating success; (1) training; (2) motivation; (3) incentives; (4) simplicity. From 
the participants’ perspective two themes were identified which related to obstacles; (1) information from the 
physiotherapist; (2) follow up, three themes were identified which related to facilitating success; (1) motivation; (2) 
website; (3) questionnaire, and one theme which related to unintended consequences of participating in the 
study; positive experience. 
The NHS Constitution for England pledges to inform all patients about opportunities for involvement with 
suitable research studies [309]. In this context healthcare professionals play a vital role in clinical research, 
linking researchers and patients. A variety of challenges may exist in recruiting participants from specialist 
healthcare services, such as physiotherapy, into cohort studies and little formal research has investigated 
these challenges [310]. Frayne et al (Figure 2) have conceptualised a process by which a patient may be 
referred to a research study when the initial invitation to participate is delivered by a healthcare professional 
in the clinical setting (rather than being invited by a healthcare provider who has responsibilities and 
involvement in the whole trial) [311]. 
 
 
Figure 2. Process of a patient being referred to a research study by a clinician (adapted from Frayne et al 
[311].) 
In order to contextualise the findings from this process evaluation with previous research and consider 
implications for future studies, the discussion is framed by the conceptual process outlined in figure 2. 
 
Involvement with the study 
Motivation to be involved in research was a theme identified from participants and physiotherapists alike. 
From the participants’ perspectives, the motivation was largely altruistic in nature; the chance to ‘give back’, 
clinician 
agrees to 
involvement 
with the 
study
clinician 
decides to 
invite an 
individual 
patient
clinician 
discussed 
study with 
the patient
patient is 
willing to be 
involved in 
the study
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and from the physiotherapists’ perspectives the drive was the opportunity to be involved in research which 
was considered to directly influence patient care. Motivation as a driving factor for recruitment wasn’t 
considered in the training provided. Although the training was considered by the physiotherapists as 
facilitatory for recruitment, the training focused on how to recruit [286] rather than serving to motivate 
recruitment. Nevertheless, this focus did have benefits; the physiotherapists understood what they were 
required to do, were happy to answer questions from patients and felt confident in carrying out the 
recruitment. Cvijovic et al [312] highlighted that pharmacists were reluctant to invite patients when they felt 
this could prompt questions they could not answer. However, valuing the research has been seen as a key 
driver of engagement of recruiting healthcare providers previously [313] and as such, training would benefit 
from tailoring to ensure the physiotherapists not only understood what to do and how to do it, but also 
developed attitudes towards the research which were as positive as possible. For example, future training 
could emphasise the positive experience (and absence of negative experience) which the participants have 
described from being involved in the study. Whilst, the provision of such training has been shown to modify 
some aspects of recruiters' behaviour, this may still result in clinicians not sufficiently restructuring their 
recruitment consultations [316]. As such, a process of monitoring and further visits, where necessary, from 
the researcher to the recruitment sites to ensure recruiters are clear how participation in research varies from 
clinical practice might be a useful strategy [317]. At this stage, the focus might turn to communication skills 
facilitated by role play scenarios to highlight common obstacles to recruitment [318]. 
 
Inviting a patient 
Pragmatic issues rather than ‘gate keeping’ concerns [319,320] largely influenced whether a patient was 
invited to be involved in the study or not. Two main pragmatic issues were identified; remembering to recruit 
participants and the visibility of the study. Reasons for not remembering to invite a participant ranged from 
other work pressures to the infrequency of seeing people with Achilles tendinopathy. French et al [321] 
identified the clinical work setting as an influence on recruitment; an organisation which has developed a 
positive research culture is an important facilitator to inviting patients to participate. It was unknown what 
the research culture was like at each recruitment site prior to commencing recruitment. Fenlon et al [322] 
utilised a careful pre-screening and selection of participating centres. Although the nature of pre-screening 
sites and the decisions to work with sites varies according to the given study, it is a useful way to initiate 
relationships and potentially identify sites at risk of low recruitment [322]. Recognising this complexity, 
formal methods of evaluation have been developed that identify problems with recruitment and informed 
consent and develop action plans to address them while recruitment is underway [323]. Increasingly such 
methods, evaluating processes, need to be integrated in to the pilot phases of research work to maximise the 
chance of success.  
To address the second pragmatic issue relating to the visibility of the study, physiotherapists suggested 
recruitment for the study might be enhanced if the study was visualised in some way, such as posters in the 
waiting room and staff room to act as a reminder to staff and to encourage questions from potential 
participants. This would incur only a small increase in cost, and also provide a further opportunity to share 
the positive experience which participants can have from being involved in research [314]. A positive 
experience from this study was found from the use of the postcard to invite patients to become participants; 
the design resonated with participants and it served as a tangible reminder to take part. Contrastingly, the 
use of a follow up via email was sub-optimal. Using email and text message reminders to encourage 
questionnaire completion amongst participants appears to be a viable strategy; following two email 
reminders, a text message reminder appeared to be more effective than another email reminder in a study 
also utilising an online questionnaire [315].  
 
Discussing the study 
Reporting lack of time as an obstacle to recruiting participants would appear significant. This was also 
reflected by the participants expressing they were given minimal verbal information by the physiotherapists 
during the invitation process. Limited time for recruitment resulting in clinicians not prioritising research 
activities has been seen in previous studies [310,313].  Resources are critical and lack of resources have been 
seen to negatively influence recruitment at all stages [322]. The absence of dedicated resources, such as 
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clinical time, not only constrains the capacity of clinicians to undertake research activity but can also 
undermine their belief in the research and lose a sense that their roles are respected [313]. Consequently, 
research resources must be seen to make a difference. Here, effective communication is considered central 
to promote respect, reciprocity and maximise recruitment [313,322]. Ensuring that the right information 
reaches the right people in a timely manner, and that clinicians are provided with progress reports and study 
findings, is essential [313]. Improved communication from the researcher directly to the physiotherapists 
involved in recruiting was a finding from this study. To address this, future studies should consider providing 
progress reports and developing a newsletter which includes ‘frequently asked questions’ and tips from 
research sites that have good recruitment rates [322].   
 
Willingness to be involved 
The minimal burden of the study design appeared to be key to both physiotherapists’ and participants’ 
willingness to be involved in the study. As previously discussed, time is a precious commodity to 
physiotherapists. The simplicity of the MAP study was referred to as an enabler to engaging physiotherapists 
and that this simplicity needed to be highlighted more effectively in the training to provide reassurance on 
the minimal impact of time to the physiotherapists. Participants described a positive engagement with the 
website; it appeared to enhance patients’ willingness to participate by being easy to navigate and ensuring it 
gave them all the information they required. In addition, the short duration of the questionnaire appeared a 
significant factor for participants to be willing to be involved. Previous research shows participants appear 
to start abandoning questionnaires after around 9 minutes, regardless of whether they are told the survey 
would take 8-10 minutes or 20 minutes [324]. 
   
Strengths and Limitations 
This study included physiotherapists from all but one recruitment site and this ensured that the views 
expressed were a fair representation of those sites involved. However, the self-selecting nature of recruitment 
may have resulted in ‘volunteer bias’; for example, physiotherapists largely expressed an interest in research, 
meaning perceptions of physiotherapists who felt negatively or ambivalent towards research were not 
obtained. Nevertheless, those taking part offered both positive and negative comments towards the MAP 
study. In addition, 5 of the 6 physiotherapists who volunteered were male which, depending on the gender 
balance at each site, suggests female physiotherapists views were underrepresented.   
Participants who dropped out, but had agreed to be contacted for interview, were invited for interview but 
no responses were received. Again, this may have resulted in ‘volunteer bias’ and therefore alternative views 
were not captured.  
 
Conclusion 
This process evaluation has highlighted some important factors for researchers to consider when planning 
future research studies. Although clinicians are enthused to be involved in research, organisational factors, 
such as time, appear to be key drivers of levels of engagement. Publicising the study to all involved; 
optimising verbal recruitment strategies between the physiotherapists and potential participants; and 
ensuring clarity in communication to recruiting physiotherapists and the participants all appear key to 
optimising the potential success of a study.  
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APPENDIX 15 – COREQ Checklist 
COREQ (COnsolidated criteria for REporting Qualitative research) Checklist  
  
A checklist of items that should be included in reports of qualitative research. You must report the page 
number in your manuscript where you consider each of the items listed in this checklist. If you have 
not included this information, either revise your manuscript accordingly before submitting or note N/A.  
  
Topic  
  
Item 
No.  
  
Guide Questions/Description  Reported on 
Page No.  
Domain 1: Research 
team and reflexivity   
      
Personal 
characteristics   
      
Interviewer/facilitator  1  Which author/s conducted the interview or 
focus group?   
 123 
Credentials  2  What were the researcher’s credentials? E.g. 
PhD, MD   
 123 
Occupation  3  What was their occupation at the time of the 
study?   
 123 
Gender  4  Was the researcher male or female?    123 
Experience and 
training  
5  What experience or training did the researcher 
have?   
 123 
Relationship with 
participants   
      
Relationship 
established  
6  Was a relationship established prior to study 
commencement?   
 123 
Participant 
knowledge of the 
interviewer   
7  What did the participants know about the 
researcher? e.g. personal goals, reasons for 
doing the research   
 123 
Interviewer 
characteristics  
8  What characteristics were reported about the 
inter viewer/facilitator? e.g. Bias, assumptions, 
reasons and interests in the research topic   
 123 
Domain 2: Study 
design   
      
Theoretical 
framework   
      
Methodological 
orientation and 
Theory   
9  What methodological orientation was stated to 
underpin the study? e.g.  
grounded theory, discourse analysis, 
ethnography, phenomenology, content analysis   
 119 
Participant selection         
Sampling  10  How were participants selected? e.g. purposive, 
convenience, consecutive, snowball   
 122 
Method of approach  11  How were participants approached? e.g. face-to-
face, telephone, mail, email   
 122 
Sample size  12  How many participants were in the study?    132 
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Non-participation  13  How many people refused to participate or 
dropped out? Reasons?   
 132 
Setting        
Setting of data 
collection  
14  Where was the data collected? e.g. home, clinic, 
workplace   
 123 
Presence of 
nonparticipants  
15  Was anyone else present besides the 
participants and researchers?   
 1223 
Description of sample  16  What are the important characteristics of the 
sample? e.g. demographic data, date   
 132 
Data collection         
Interview guide  17  Were questions, prompts, guides provided by 
the authors? Was it pilot tested?   
 123 
Repeat interviews  18  Were repeat inter views carried out? If yes, how 
many?   
 no 
Audio/visual 
recording  
19  Did the research use audio or visual recording to 
collect the data?   
 123 
Field notes  20  Were field notes made during and/or after the 
inter view or focus group?  
 125 
Duration  21  What was the duration of the inter views or 
focus group?   
 132 
Data saturation  22  Was data saturation discussed?    122 (all 
participants 
were invited) 
Transcripts returned  23  Were transcripts returned to participants for 
comment and/or  
 125 (matrix was 
returned) 
Topic  
  
Item 
No.  
  
Guide Questions/Description  Reported on 
Page No.  
  correction?    
Domain 3: analysis 
and findings   
      
Data analysis         
Number of data 
coders  
24  How many data coders coded the data?    125 
Description of the 
coding tree  
25  Did authors provide a description of the coding 
tree?   
 127 
Derivation of themes  26  Were themes identified in advance or derived 
from the data?   
 134 
Software  27  What software, if applicable, was used to 
manage the data?   
 123 
Participant checking  28  Did participants provide feedback on the 
findings?   
 125 
Reporting         
Quotations presented  29  Were participant quotations presented to 
illustrate the themes/findings?  
Was each quotation identified? e.g. participant 
number   
 Findings  
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Data and findings 
consistent  
30  Was there consistency between the data 
presented and the findings?   
 Findings and 
discussion 
Clarity of major 
themes  
31  Were major themes clearly presented in the 
findings?   
 Findings and 
discussion  
Clarity of minor 
themes  
32  Is there a description of diverse cases or 
discussion of minor themes?        
 - 
  
Developed from: Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research 
(COREQ): a 32-item checklist for interviews and focus groups. International Journal for Quality in Health 
Care. 2007. Volume 19, Number 6: pp. 349 – 357  
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APPENDIX 16 – Invitation Email for Interview  
Dear XXXX 
 
Thank you for taking part in the Managing Achilles Pain study and completing the questionnaires.  
 
I would like to ask you to participate in an interview to discuss your experience of the procedures used in 
the study. The interview can take place over the phone, or using the internet, and would be arranged for 
whenever is most convenient for you. It is expected to take no more than 30 minutes. More information 
can be found in the information sheet, along with a consent form which are attached. You don’t need to 
complete the consent form, but you should be aware of what you may be consenting to.  
 
Could you please let me know if you are willing to take part? Please also ask any questions you may have. 
 
Best Wishes 
 
Adrian 
 
Adrian Mallows  
Lecturer in Physiotherapy 
MSc (pre-reg) Physiotherapy Programme Lead 
School of Sport, Rehabilitaion and Exercise Sciences 
University of Essex 
Room 2S2.5.22 
 
T +44 (0)1206 873847 
E amallows@essex.ac.uk 
►https://www1.essex.ac.uk/sres/  
 
WE ARE ESSEX 
TOP 20 FOR RESEARCH EXCELLENCE 
TEF GOLD 2017 
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APPENDIX 17 – Participant Information Sheet 
Participant Information Sheet 
 
Managing Achilles Pain – a pilot study 
 
Adrian Mallows, PhD Student and Chief Investigator 
Professor Jo Jackson, Academic Supervisor 
 
We would like to invite you to take part in our research study. Before you decide, we would like you to understand 
why the research is being done and what it would involve for you. Please take time to read the following 
information carefully. Talk to others about the study if you wish. Please ask us if there is anything that is not 
clear. 
 
Background to the study 
Having a painful Achilles tendon is fairly common. Recent research suggests how treatment is 
delivered may be influential on the success of treatment.  Based on previous work, we think a 
person’s expectations, beliefs and who delivers the treatment to them may be important. 
 
What is the purpose of the study? 
Exploring these factors has yet to be investigated, and in order to do so we have designed this ‘pilot 
study’ to help us develop a larger study. 
 
Why have I been invited? 
You have been invited because you are currently undergoing treatment for a painful Achilles tendon. 
 
Do I have to take part? 
No, it is up to you to decide to join the study. You can change your mind at any time and decide not to participate. 
The treatment and standard of care you receive will not be affected in any way if you decide not to take part 
now or if you withdraw from the study later. We are happy to answer any questions you may have before 
deciding whether you wish to take part in this study. 
 
What will I have to do? 
We are asking people to complete a questionnaire 3 times over a 3 month period. You will be contacted by 
email to remind you to take the follow up questionnaires. You may then be invited to participate in a follow 
up interview about your experience of the study. This interview will take place using a video call over the 
internet or simply by telephone. The interviews will be audio recorded and transcribed by the Chief 
Investigator, Adrian Mallows. 
 
Expenses and payments 
There are no expenses or payments for your participation. 
 
What are the possible disadvantages and risks of taking part? 
The questionnaire will take around 15 minutes to complete each time. A follow up interview will last around 
30 minutes. There are no anticipated risks associated with your participation. 
 
 
 
What are the possible benefits of taking part? 
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There are no direct benefits to you, but we hope the information derived from this study will help improve 
the future treatment of people with painful Achilles tendons. 
 
What will happen if I don’t want to carry on with the study? 
All information collected prior to your withdrawal with your permission will be used, but no further data 
will be collected. 
 
What if there is a problem? 
If you have any concerns about any aspect of this study, please contact the Chief Investigator, Adrian 
Mallows. You can do this by email amallows@essex.ac.uk or telephone 01206 873847. Alternatively, you 
can contact his PhD supervisor Professor Jo Jackson at the University of Essex. You can do this by email 
jo.jackson@essex.ac.uk or by telephone 01206 874230. They will do his best to answer your questions, 
however, if you remain unhappy and wish to provide any feedback, or formally complain you can do this by 
contacting Sarah Manning-Press, the Research Governance and Planning Manager, Research Office, 
University of Essex, Wivenhoe Park, Colchester, CO4 3SQ or by emailing: sarahm@essex.ac.uk. 
 
Will my taking part in this study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will be handled in confidence 
and will not be shared with anyone, including your physiotherapist. The questionnaire will not collect any 
personally identifiable data, but will ask you for your email address so that you can be reminded to take the 
follow up questionnaires and potentially be invited for a follow up interview. All data storage will comply 
with EU data protection regulation. The data collected are stored on a secure, encrypted website called 
Qualtrics. The website is password protected with only the Chief Investigator having access to the survey’s 
data. If you participate in a follow up interview, the audio recordings will not collect any personally 
identifiable data and will be stored on a secure computer at the University of Essex. Direct quotes may be 
used from the recordings and these will be anonymised. Only the Chief Investigator and his academic 
supervisors will listen to the recordings, and these will be destroyed after they have been transcribed. This 
transcription will then be stored for 5 years.  
 
What will happen to the results of the research study? 
It is anticipated the results from the study will be published and presented at scientific meetings. There is no 
formal plan to make the results available to participants, however if you would like to obtain a copy please 
contact Adrian Mallows by email amallows@essex.ac.uk or by telephone 01206 873847. 
 
Who is organising and funding the research? 
The study is being organised by Adrian Mallows as a part of his PhD at The University of Essex. There is 
no external funding. 
 
Who has reviewed the study? 
The NHS Health Research Authority have reviewed the study and given approval for the conduct of the 
research (IRAS ID: 219457). 
 
Further information and contact details 
For further information, please contact Adrian Mallows by email amallows@essex.ac.uk or by telephone 
01206 873847. 
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APPENDIX 18 – Consent Form 
Managing Achilles Pain - a pilot study 
 
Please read the statements below and ask any questions which may have. 
Your response to the statements below will be audio-recorded prior to starting 
the interview. 
CONSENT FORM   
I confirm that I have read the information sheet dated 19th May 2017(version 
1:1) for the above study. I have had the opportunity to consider the information, 
ask questions and have had these answered satisfactorily. 
 I agree  
 
I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving any reason, without my medical care or legal rights 
being affected. 
 I agree  
 
I understand that the information collected about me will be used to support 
other research in the future, and may be shared anonymously with other 
researchers. 
 I agree  
 
I agree for the interview to be audio-recorded and transcribed by the chief 
investigator. I am aware that this recording will be listened to by the chief 
investigator and academic supervisors. I am aware this recording will be kept 
on a secure computer on University premises and will be destroyed after 5 
years.  
 I agree  
 
I consent to direct quotes being used from the recording of my interview 
 I agree  
 I do not agree  
 
If I choose to withdraw from the study, I understand all information collected 
prior to my withdrawal will be used, but no further data will be collected. 
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 I agree  
 
I understand that relevant sections of my medical notes and data collected 
during the study, may be looked at by individuals from the University of Essex, 
from regulatory authorities or from the NHS Trust, where it is relevant to my 
taking part in this research. I give permission for these individuals to have 
access to my records 
 I agree  
 
I agree to take part in the study. 
 I agree  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
280 
 
APPENDIX 19 – Invitation Email to Physiotherapists 
Dear XXXX 
 
I would be most grateful if you could circulate the following to Physiotherapy colleagues who have been 
identifying participants for the research study ‘Managing Achilles Pain’: 
You have been recently identifying participants for a study about Achilles tendon pain -  I have attached the 
study information sheet as a reminder. Part of the study is looking at how well the processes worked, or 
otherwise, for those who were identifying participants.  
The interview could take place over the telephone at a time convenient to you and would take 20 to 30 
minutes. 
I would be grateful if you would reply directly to this e-mail letting me know whether you would be willing 
to be interviewed or not. 
  
Thanks in advance for considering this. 
  
If you have any questions, please let me know. 
 
Best Wishes 
 
Adrian 
Adrian Mallows  
Lecturer in Physiotherapy & PhD candidate 
MSc (pre-reg) Physiotherapy Programme Lead 
School of Sport, Rehabilitaion and Exercise Sciences 
University of Essex 
Room 2S2.5.22 
T +44 (0)1206 873847 
E amallows@essex.ac.uk 
►https://www1.essex.ac.uk/sres/  
WE ARE ESSEX 
TOP 20 FOR RESEARCH EXCELLENCE 
TEF GOLD 2017 
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APPENDIX 20 – Participant Information Sheet 
Participant Information Sheet 
 
Managing Achilles Pain – a pilot study 
 
Adrian Mallows, PhD Student and Chief Investigator 
Professor Jo Jackson, Academic Supervisor 
 
We would like to invite you to take part in our research study. Before you decide, we would like you to understand 
why the research is being done and what it would involve for you. Please take time to read the following 
information carefully. Talk to others about the study if you wish. Please ask us if there is anything that is not 
clear. 
 
Background to the study 
Having a painful Achilles tendon is fairly common. Recent research suggests how treatment is 
delivered may be influential on the success of treatment.  Based on previous work, we think a 
person’s expectations, beliefs and who delivers the treatment to them may be important. 
 
What is the purpose of the study? 
Exploring these factors has yet to be investigated, and in order to do so we have designed this ‘pilot 
study’ to help us develop a larger study. 
 
Why have I been invited? 
You have been invited because you are a physiotherapist who has been identifying participants for the study. 
 
Do I have to take part? 
No, it is up to you to decide to join the study. You can change your mind at any time and decide not to participate. 
We are happy to answer any questions you may have before deciding whether you wish to take part in this 
study. 
 
What will I have to do? 
We are asking people to participate in an interview about your experience of the study. This interview will 
take place using a video call over the internet or simply by telephone. The interviews will be audio recorded 
and transcribed by the Chief Investigator, Adrian Mallows. 
 
Expenses and payments 
There are no expenses or payments for your participation. 
 
What are the possible disadvantages and risks of taking part? 
The interview will last around 30 minutes. There are no anticipated risks associated with your participation. 
 
What are the possible benefits of taking part? 
There are no direct benefits to you, but we hope the information derived from this study will help improve 
the future treatment of people with painful Achilles tendons. 
 
What will happen if I don’t want to carry on with the study? 
All information collected prior to your withdrawal with your permission will be used, but no further data 
will be collected. 
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What if there is a problem? 
If you have any concerns about any aspect of this study, please contact the Chief Investigator, Adrian 
Mallows. You can do this by email amallows@essex.ac.uk or telephone 01206 874252. Alternatively, you 
can contact his PhD supervisor Professor Jo Jackson at the University of Essex. You can do this by email 
jo.jackson@essex.ac.uk or by telephone 01206 874277. They will do his best to answer your questions, 
however, if you remain unhappy and wish to provide any feedback, or formally complain you can do this by 
contacting Sarah Manning-Press, the Research Governance and Planning Manager, Research Office, 
University of Essex, Wivenhoe Park, Colchester, CO4 3SQ or by emailing: sarahm@essex.ac.uk. 
 
Will my taking part in this study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will be handled in confidence 
and will not be shared with anyone. All data storage will comply with EU data protection regulation. The 
audio recordings will not collect any personally identifiable data and will be stored on a secure computer at 
the University of Essex. Direct quotes may be used from the recordings and these will be anonymised. Only 
the Chief Investigator and his academic supervisors will listen to the recordings, and these will be destroyed 
after they have been transcribed. This transcription will then be stored for 5 years.  
 
What will happen to the results of the research study? 
It is anticipated the results from the study will be published and presented at scientific meetings. There is no 
formal plan to make the results available to participants, however if you would like to obtain a copy please 
contact Adrian Mallows by email amallows@essex.ac.uk or by telephone 01206 874252. 
 
Who is organising and funding the research? 
The study is being organised by Adrian Mallows as a part of his PhD at The University of Essex. There is 
no external funding. 
 
Who has reviewed the study? 
The NHS Health Research Authority have reviewed the study and given approval for the conduct of the 
research (IRAS ID: 219457). 
 
Further information and contact details 
For further information, please contact Adrian Mallows by email amallows@essex.ac.uk or by telephone 
01206 874252. 
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APPENDIX 21 – Consent Form 
Managing Achilles Pain - a pilot study 
 
Please read the statements below and ask any questions which may have. 
Your response to the statements below will be audio-recorded prior to starting 
the interview. 
CONSENT FORM   
I confirm that I have read the information sheet dated 18.06.2018 (version 1.0) 
for the above study. I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily. 
 I agree  
 
I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving any reason, without my legal rights being affected. 
 I agree  
 
I understand that the information collected about me will be used to support 
other research in the future, and may be shared anonymously with other 
researchers. 
 I agree  
 
I agree for the interview to be audio-recorded and transcribed by the chief 
investigator. I am aware that this recording will be listened to by the chief 
investigator and academic supervisors. I am aware this recording will be kept 
on a secure computer on University premises and will be destroyed after 5 
years.  
 I agree  
 
I consent to direct quotes being used from the recording of my interview 
 I agree  
 I do not agree  
 
If I choose to withdraw from the study, I understand all information collected 
prior to my withdrawal will be used, but no further data will be collected. 
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 I agree  
 
I understand that relevant sections of my data collected during the study, may 
be looked at by individuals from the University of Essex, from regulatory 
authorities or from the NHS Trust, where it is relevant to my taking part in this 
research. I give permission for these individuals to have access to my records 
 I agree  
 
I agree to take part in the study. 
 I agree  
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APPENDIX 22 – Topic Guide 
 
TOPIC GUIDE FOR SEMI-STRUCTURED INTERVIEWS 
 
1. Introduction 
 Introduction to researcher and study topic 
 Explanation of the aim of the study 
 Explain confidentiality and anonymity 
 Explain recording length (up to 30 minutes) and nature of 
discussion 
 Go through consent issues and explain they may withdraw at 
any time and they do not have to answer any interviews they 
would prefer not to 
 Check whether they have any questions 
 Check they are happy to continue 
 
 
2. Experience of the study 
 Describe overall experience 
 Establish any perceived strengths or weaknesses of the process 
 Where they feel areas for improvement lie – website 
(information), questionnaires (data collection procedures), 
recruitment process (selling or engaging with the study) – why 
were you interested? How 
 Check for any unintended consequences 
 Check for any other comments 
 
3. In conclusion 
 Summarise and check key issues 
 Thank the participant for their time.  
 Reiterate confidentiality 
 
END RECORDING 
 
 
 
